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Executive Summary 
 
Background 
 
This study is about the development of a Performance Measurement Framework for the Drug and 
Alcohol Task Forces (DATF). The latter are community-based structures which bring together 
Government Departments, State Agencies and the Community and Voluntary sectors to provide a 
collective response to problem substance use. The overall objective is to tackle the harm caused to 
individuals, families and communities by problem substance use by tackling supply, carrying out 
preventive interventions, offering treatment and rehabilitation and by implementing an advanced 
research agenda. 
 
The Department of Health is working on a new National Drugs Strategy which will cover the period 
from 2017 to 2024. The aim of this report is to develop an outline Performance Measurement 
Framework for DATFs to feed into and support their work and to gain a better understanding of how 
they contribute to positive change at local/regional level. The objective is to put the Performance 
Measurement Framework in place before the new National Drugs Strategy commences. 
 
The development of a Performance Measurement Framework for DATFs follows the review 
undertaken by the Department of Health in 2012
1
 and adopts a similar logic to the Healthy Ireland 
strategy. Rather than looking at interventions in terms of inputs and outputs, the overriding concern is 
with the net effect of public policies at the population level. This is the only way of conceptualising 
effectiveness in an evidence-based and sustainable manner.  
 
 
Developing a Performance Measurement Framework for DATFs 
 
In line with the terms of reference for this study, the authors go beyond data-driven approaches to 
evaluation and adopt a theory-driven Performance Measurement Framework for DATFs. Drawing on 
the international literature on problem substance use, spatially-targeted interventions and 
performance measurement systems, they build on an approach known as ‘Confirmatory Programme 
Evaluation’ to develop an ambitious new framework. 
 
At the heart of the Performance Measurement Framework is the concept of problem substance use, 
which is carefully defined and operationalised in this report. The Framework relies on a ‘Theory of 
Change’ model which sets out how the interventions of the DATFs affect problem substance use at 
local level. This leads to the specification of a ‘Logic Model’ and ‘Measurement Model’ which provides 
guidelines for the choice of data sources. 
 
The Framework makes a careful distinction between the risk of problem substance use and actual 
problem substance use, as comparison between these two measures provides the basis for measuring 
performance. As the Performance Measurement System is dependent upon secondary data sources, 
detailed consideration is also given to how these sources should be prepared and improved in the 
future. Estimation of the risk of problem substance use permits the development of a Resource 
Allocation Model for DATFs, which provides a method for achieving a rational and transparent 
allocation of resources commensurate with social need.  
                                                                
1  Department of Health 2012. Report on the Review of Drug Task Forces and the National Structures under which they 
operate. Dublin: Department of Health. 
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The performance of DATFs is defined as the ratio of actual to predicted problem substance use. This 
captures the extent to which the DATFs have been able to reduce problem substance use within their 
area, given the specific risk and protective factors that are present at local level.  
 
The principle aim of the Performance Measurement System is to improve the performance of DATFs 
and to support the National Drugs Strategy. It does so by establishing a virtuous cycle whereby high-
performing and low-performing DATFs participate in a review process and seek to identify good 
practices, on the one hand, and weaknesses in local responses, on the other. Helping to improve the 
performance of weaker DATFs will result in better local services and contribute to systemic 
improvements. The study concludes by setting out a timeline for implementation of the Performance 
Measurement System and by summarising the key findings and recommendations. 
 
 
 
 
1 
1 Introduction 
 
The Healthy Ireland strategy introduces a sea-change in terms of how health and well-being are 
conceptualised, studied and supported. As far as monitoring and assessment are concerned, there has 
been a decisive shift away from reporting outputs (e.g. the number of medical treatments or 
procedures carried out) and towards the monitoring of population health. In order to support and 
promote health, it is important to reduce behaviours that contribute to negative outcomes and 
promote those with positive effects, with particular attention to smoking, drinking alcohol, diet and 
physical exercise. 
 
The development of a Performance Measurement Framework for the Drug and Alcohol Task Forces 
(DATFs), based on the terms of reference for this study, follows a similar logic to the Healthy Ireland 
strategy. Rather than looking at interventions in terms of inputs and outputs, the overriding concern is 
with the net effect of publicly-funded initiatives at the population level. 
 
The measurement of outcomes at the aggregate level raises a number of unavoidably complex issues 
which are discussed in detail in subsequent sections of this report. Our aim is to provide a set of tools 
which can contribute to improving the performance of the Local and Regional DATFs. We also argue 
that these tools are of great relevance to the new National Drugs Strategy (NDS), to be finalised in 
early 2017. This generates valuable synergies between national and local policies and interventions. 
 
The Drugs Initiative which led to the establishment of the DTFs in 1996 is a cross-cutting area of public 
policy which brings together Government Departments, State Agencies and the Community and 
Voluntary sectors to provide a collective response to problem substance use. Its overall objective is to 
tackle the harm caused to individuals, families and communities by problem drug and alcohol use by 
developing the ‘five pillars’ of supply reduction, prevention, treatment, rehabilitation and research. 
 
This policy initiative is now being implemented via the development of national strategies dealing 
with substance use. The Department of Health is working on a new strategy which will cover the 
period from 2017 to 2024, and the aim of this report is to contribute to this process in a targeted and 
effective way. In the next section (1.1) we summarise the terms of reference, in Section 1.2 we 
describe how we address these and in Section 1.3 we summarise our overall approach to the study. 
 
We have held detailed discussions with representatives of the DATFs and the DPU, and this exchange 
of views has contributed greatly to our understanding. As is customary, we assume all responsibility 
for the contents of this report, and have gone to great efforts to ensure that it deals appropriately 
with all of the issues raised in the call for tenders. We are very grateful to the DPU for providing 
detailed feedback on earlier drafts of this report and to the HRB for providing information and 
guidance on data sources and protocols. 
 
 
1.1 Terms of Reference 
 
The terms of reference specified by the Drugs Policy Unit of the Department of Health in its Request 
for Tenders for the “Provision of a Performance Measurement Framework for Drug and Alcohol Task 
Forces” (19 October 2015, Services RFT/2010/00632/JIVCV1/2011) may be summarised as follows: 
 
Premise: 
“The National Coordinating Committee (NCC) for Drug and Alcohol Task Forces, chaired by the 
Department of Health, has decided to develop a new Performance Measurement Framework to 
improve measurement and assessment of the work of the Task Forces and to gain a better 
understanding of how Task Forces contribute to positive change at local/regional level. The objective 
is to have the performance measurement framework in place when the new Drugs Strategy 
commences on 1 January 2017.” 
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Key Deliverables: 
 
D1. An evidence-based Performance Assessment Tool incorporating key performance indicators, 
which will assist with the assessment of the outcomes and impacts of the work of the DATFs. 
 
D2. Guidelines for the DATFs to assist them in providing the reports required for the purposes of the 
Performance Framework. 
 
Requirements: 
R1. The contractor will be required to develop a Performance Measurement Framework for DATFs, 
taking account of best practice internationally, based on: 
 
R1a. A theory of change model. 
 
R1b. A logic model framework. 
 
R2. The framework will need to set out what types of information are required by DATFs, at what 
intervals, for which audience(s) and for what purpose(s). 
 
R3. The framework should specify a set of key performance indicators (process, output and 
outcome indicators) which should fully address the terms of reference of the DATFs, and 
include, inter alia, specific indicators that will enable an assessment of: 
 
R3a. The effectiveness of the approach of individual Task Forces in supporting and strengthening 
community-based responses to drug and alcohol misuse having regard to needs identified in 
their respective catchment areas. 
 
R3b. The extent of overlap and duplication of activity having regard to the need to optimise available 
resources, achieve value for money and maximise the impact of interventions. 
 
R4. The framework should develop templates for reporting and set out mechanisms for data 
capture that will provide for ease of collation and analysis. 
 
R5. The framework should take account of critical success or enabling factors, such as the level of 
engagement the Task Force has with local statutory, community and voluntary services and the 
extent to which the operation of the Task Force is informed by principles of good governance, 
probity, evidence and good practice. 
 
 
1.2 Aims of the Study 
 
Table 1.1 below shows how we address these terms of reference, including a brief summary of the 
aims of the analysis and an indication of where each aim is addressed in the report. We draw on the 
international literature on problem substance use, spatially-targeted interventions and performance 
measurement systems to develop a ‘Theory of Change’ model of the determinants of substance use at 
local level and to link this to the logic of DATF interventions (Sections 3.1 and 3.2). This leads to the 
specification of a ‘Logic Model’ (Section 3.2), which is translated into a ‘Measurement Model’ based 
on objective data from secondary sources (Section 4.1). The combination of Logic Model and 
Measurement Model enable us to measure the key outcome and to assess performance (Section 4.3).  
 
The results of the analysis of impacts feed into the construction of a dynamic Resource Allocation 
Model (Chapter 5), which is articulated with the key performance indicators. The combination of Logic 
Model, Measurement Model and Resource Allocation Model form the backbone of the Performance 
Measurement Framework, whilst the Performance Measurement System relies on a particular kind of 
statistical model, which is described in Section 6. 
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Table 1.1 Terms of Reference, Aims and Elements of the Project 
Terms of Reference Aims of Study Section of Report 
Premise Design a PMF to be operational 1 Jan 2017 Whole report 
D1.  
 Performance Tool 
Develop a PMS for DATFs using key indicators Section 6 
D2.   
 DATF Guidelines 
Provide clear guidelines explaining what is 
required of the DATFs 
Sections 6.4, 6.5 
R1.   
 Performance 
Measurement Framework 
Conduct a literature review; define key 
outcome measures; construct a Framework; 
develop component parts; test and refine 
Section 2.6 
R1a.   
 Theory of Change 
To specify a ‘Theory of Change Model’ which 
indicates the key mechanisms involved in PSU 
in DATF areas 
Sections 3.1, 3.2 
R1b.   
 Logic Model 
To specific a ‘Logic Model’ which shows how 
DATFs can generate impacts; translate this into 
a ‘Measurement Model’ 
Sections 3.3, 3.4 
R2.  
 Information for DATFs 
Provide clear indications regarding information 
to be provided to DATFs 
Section 6.5 
R3.  
 Performance Indicators 
Identify key performance indicators to measure 
processes, outputs and outcomes 
Section 4 
R3a.  
 Measure Effectiveness 
Identify ‘impact measures’ to assess the 
effectiveness of the approach adopted by 
individual Task Forces 
Section 6.3 
R3b.   
 Identify Overlaps 
Identify specific indicators to assess whether 
there are overlaps/duplications in activities 
Cannot be 
achieved, see 
Section 6.3 
R4.  
 Templates for Data 
Evaluate existing data sources; set out 
templates for data reporting/capture 
Sections 4, 7.2 
R5.   
 Critical Factors 
Integrate critical enabling/disabling factors 
within the PMF 
Section 4.3 
Value added Develop a Resource Allocation Model for 
DATFs; evaluate distribution of resources 
Section 5 
 Make observations and formulate 
recommendations relating to National Drugs 
Strategy 
Section 7 
 
PMF: Performance Measurement Framework 
PMS: Performance Measurement System 
PSU: Problem Substance Use 
DATF: Drug and Alcohol Task Force 
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In order to maximise the utility of the Performance Measurement System, we highlight the need to 
develop effective protocols for obtaining access to the external data sources that are needed in order 
to operationalise the framework, as well as the need to pass performance-related information back to 
the DATFs each year to which they themselves are expected to respond. We believe that this will give 
rise to a virtuous cycle of analysis, innovation and performance assessment which will feed into 
continuous improvements at a programme level. The Performance Measurement System thus 
facilitates: 
 
 Assessment of relative risk of problem substance use in DATF areas 
 The setting of appropriate targets for DATFs 
 Improved targeting of resources on the basis of social need 
 Evaluating progress at national, regional and DATF levels 
 Identifying trends and temporal patterns 
 Providing regular, standardised reports at each level 
 Understanding local specificities 
 Testing new interventions and approaches 
 
 
1.3 Overall Approach and Structure of the Report 
 
The approach to performance measurement adopted in this report is informed by the following 
principles: 
 
1. a recognition of the importance of theory in Performance Measurement Frameworks 
2. a concern with conceptual clarity and identifying measurement properties 
3. an attention to composite indicators 
4. an emphasis on social equity and targeting social need 
5. use of objective criteria for performance assessment 
6. a recognition of the ‘open’ character of the social world 
7. an appreciation of the importance of democratic participation and consensus-building 
 
We will briefly review these principles and describe their relevance to performance measurement, 
before describing the structure of the report itself. Firstly, we believe that a successful Performance 
Measurement Framework must be based on a theoretical model of the expected outcomes and their 
determinants. This is particularly important in the public sector, where the efficacy of programmes 
must be assessed in relation to their specific aims. The theoretical model used here comprises a 
‘Theory of Change Model’, a ‘Logic Model’ and a ‘Measurement Model’, and the importance of these 
elements of the Framework cannot be overestimated.  
 
Theory provides crucial guidance regarding the main concepts to be measured, the key factors to 
control for, the measurement of inputs, outputs and impacts, the form and structure of any statistical 
models that may be required, ways of involving different actors and the implications for policy. The 
opposite to theory-driven performance assessment is the ‘data-driven’ approach where indicators are 
expected to ‘speak for themselves’. One of the fundamental findings of a half-century of research on 
performance measurement is that data rarely (never) speak for themselves and that true impact 
assessment requires theoretical sophistication as well as precision in data collection and analysis. 
 
This is one of the first frameworks to measure the performance of a public programme in Ireland in 
relation to its impacts at a population level, and will be of considerable interest to programme 
managers, policy-makers and practitioners working in other policy arenas. 
 
Secondly, we bring considerable conceptual clarity to the treatment of data, indicators and composite 
measures. This is informed by more than 20 years’ experience in developing, monitoring and 
evaluating public programmes in EU Member States and constructing official indices and assessment 
criteria. We believe that the first issue that must be resolved when developing a performance 
measurement system is the identification of a key outcome in relation to which performance is to be 
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assessed. In the case of the DATFs, it was clear from the beginning that the outcome of relevance was 
the level of problem substance use in an area, and this has also been central to successive National 
Drugs Strategies. 
 
However, we were also aware of the need to distinguish between the structured risk of problem 
substance use – which is determined by the characteristics of local communities and areas – and the 
actual level of problem substance use, which is influenced, in addition, by local responses and various 
contingent local factors. Problem substance use cannot simply be observed, however, as we can only 
measure its effects (in relation to health, crime, demand for treatment, early school-leaving etc.). This 
leads to a third concept, the estimated level of problem substance use, which is based on the available 
data and prevailing measurement tools. This set of conceptual distinctions is at the heart of the 
Performance Measurement Framework and is central to the operational system that we derive from 
this. Simplifying, performance may be measured by comparing the risk of problem substance use with 
its estimated actual level, whilst applying appropriate controls. 
 
Thirdly, we emphasise the superiority of composite indicators over single indicators. This aspect of our 
approach is based on the results of more than a century of theoretical and statistical developments in 
the field of measurement theory. The classical common factor model is at the centre of this literature 
and provides a way of measuring complex, multi-faceted concepts which cannot be observed directly 
(such as extraversion, depression, social class, social inclusion). Our work on the measurement of 
affluence and deprivation at the aggregate level is based on this approach (using Structural Equation 
Modelling techniques to estimate confirmatory models, for example), as is our work on social 
gradients in health and well-being. In simple terms, a well-constructed composite indicator tends to 
have higher reliability, validity and sensitivity than single indicators. This leads us to emphasise the 
value of identifying multiple indicators of problem substance use for monitoring purposes. 
 
Fourthly, this report is grounded in a commitment to addressing social need. This fundamental policy 
goal has a dual character and may be defended both in terms of social equity (i.e. in political terms) 
and on the basis of efficiency (i.e. in economic terms). In the context of financial austerity, targeting 
social need appears to be the only way of simultaneously improving efficiency at a systemic level 
whilst reducing the negative impact of existing socio-economic and politico-cultural disparities. 
Reliable measures of social class, deprivation and socio-economic position play an important role in 
relation to this goal, and are also essential in the present analysis. In general terms, we hold that all 
public programmes with a social inclusion dimension should be appropriately targeted in spatial as 
well as economic terms in order to ensure that the weakest and most excluded social groups receive 
the required supports and opportunities. As indicated above, this is also the best way of improving 
the efficacy of public programmes and making optimal use of scarce resources. 
 
Fifthly, we favour the use of objective criteria for measuring performance and we base our 
Performance Measurement Framework for DATFs on independent data. This does not mean that 
subjective views and assessments are unreliable or that they are of no value. On the contrary, we 
argue that subjective assessments and insights are a key mediating factor between performance 
measurement, on the one hand, and systemic improvement, on the other. The positive potential of 
performance measurement resides in the ways in which organisations respond to assessments by 
reflecting on their current activities, procedures and the local context and then instituting change. 
Precisely because we expect subjects to act on the results of our Performance Measurement 
Framework, it is of fundamental importance to ensure that this focuses on key outcomes. There are 
many examples of performance measurement systems which acquire an autonomous logic that is 
somewhat divorced from the outcomes that they ostensibly aim to promote (e.g. the ‘publish or 
perish’ culture of contemporary academia). 
 
Sixthly, we believe that it is important to understand the complex, ‘open’ character of social systems. 
This has several important implications, including the impossibility of controlling for all factors that 
may influence a given social phenomenon. Even if we go to great lengths to theorise a given outcome, 
to measure all key concepts in an appropriate fashion and to specify powerful statistical models, there 
is always the possibility that we have failed to consider an important determinant. This means that 
our conclusions are always, in a certain sense, provisional. A given finding – regarding performance, 
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for example – may be due to the effects of a confounding factor that we failed to consider. When 
building a Performance Measurement Framework, it is therefore important to include this possibility 
and to imagine a process whereby we can incrementally incorporate confounding factors within our 
set of control variables. 
 
Finally, a foundation stone of Performance Measurement Frameworks is democratic participation. As 
noted earlier, performance assessment is effective only to the extent that the individuals and 
organisations involved in the process act successfully and imaginatively on the results of the 
assessment. This can only happen if they freely accept the Framework, agree with the principles upon 
which it is based and accept the technical procedures used to operationalise it. If this is the case, then 
they will ‘take the results to heart’ by reflecting on existing practices and exploring their environment 
to identify possible explanations and alternative approaches. 
 
Indeed, the Performance Measurement Framework can at best suggest why strong or weak 
performance is observed; it is therefore up to the actors involved to identify ways of improving. If the 
actors reject the Framework, then they are more likely to ‘work around it’ and to ignore alternative 
options. We believe that an open discussion, perhaps leading to revisions to the Performance 
Measurement Framework, is the most effective way of building a consensus. Of course, it is not 
always possible to convince everybody, and we should perhaps not expect all actors to welcome every 
aspect of this framework. However, all actors should at least have the possibility to express their 
views, to raise questions and to receive a thoughtful and balanced response to their concerns. 
 
Building on these principles, we have sought to describe our proposals in a comprehensive but 
understandable way. Some of the more ‘technical’ specifications are included in the Appendices, and 
we use figures and tables to present algorithms, model specifications/results and other technical or 
statistical information. The report is structured in such a way as to allow the reader to skip these 
elements of the analysis and to simply read the text of the report if he/she prefers. 
 
In Section 2 we provide a brief history of the Task Forces, including an overview of how their role and 
organisation has evolved over the past 20 years. In Section 3 we set out the conceptual and 
methodological foundations of the Performance Measurement Framework, including the ‘Theory of 
Change Model’, the ‘Logic Model’ and ‘Performance Measurement Model’. In Section 4 we assess the 
available data and provide a detailed analysis of two important data sources: the Drug Prevalence 
Survey and the National Drug Treatment Reporting System (NDTRS). 
 
In Section 5 we discuss a range of issues in relation to funding and introduce the notion of a ‘Resource 
Allocation Model’. We provide an example of a RAM for the DATFs and discuss the practical 
implications of pursuing a rational distribution of funds at the aggregate DATF area level. Section 6 is 
dedicated to the Performance Measurement System, and shows how the elements described in 
Sections 3, 4 and 5 can be operationalised, combined and used for ‘true’ impact assessment. 
 
As noted earlier, the Framework presented in this report represents an innovative and path-breaking 
approach in the context of performance assessment in the Irish public sector. In order to facilitate 
implementation of the Framework, Section 7 provides a detailed set of recommendations, including 
both a Gantt chart and practical steps towards the operationalisation of the Performance 
Measurement System. 
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2 Drug and Alcohol Task Forces: History, Role and Funding 
 
2.1 Origins of the Task Forces 
 
The existence of an explosive situation in relation to the supply and use of drugs became apparent in 
Ireland in the 1980s: 
 
“During the 1960s and 1970s, the use of amphetamines and LSD appeared to be the main 
drug problem in Ireland. Policy responses included the formation of the Garda Drug Squad, 
the establishment of the National Advisory and Treatment Centre for Drug Abuse and the 
enactment of the Misuse of Drugs Act in 1977. However, the early 1980s witnessed a growth 
in heroin use in inner city areas and other deprived communities in Dublin. A number of 
Government Committees were established, which recommended the introduction of a series 
of legislative provisions.”
2
 
 
Against the backdrop of ineffective public policies, people in the affected communities established 
anti-drug campaigns and mobilised against the sale of drugs on their estates. Under growing pressure, 
the Government established the Ministerial Task Force on Measures to Reduce the Demand for Drugs 
in 1996. The aim was to develop initiatives that would address issues relating to the supply of drugs, 
education, prevention, treatment and rehabilitation. One of the results was the establishment of 
Local Drugs Task Forces (LDTFs) to develop a co-ordinated response to the problem: 
 
“These initiatives were developed against a background of considerable public unrest. 
Frustrated with years of lack of response to the problem, people took to the streets and 
marched in protest. Local meetings were held in many areas, with those accused of drug 
dealing being named publicly. Some of the action focussed, as it had done previously, on the 
need to rid communities of drug dealers.”
3
 
 
Comiskey (1996) estimated that there were approximately 10,500 to 12,500 opiate users in Dublin at 
this time
4
, whilst An Garda Síochána estimated that drug users were responsible for 66 per cent of all 
crimes detected in the Dublin Metropolitan area between September 1995 and August 1996
5
. 
Connolly (2002) provides the following summary: 
 
“Hundreds of young people have lost their lives in drug-related deaths, many thousands more 
have been processed through the courts and ended up in prison as a result of drug-related 
criminal behaviour. A study conducted by O’Mahony in 1996 suggested that two out of every 
three prisoners in Dublin’s main jail, Mountjoy, had used heroin. This study also showed that 
most prisoners are from areas characterised by high proportions of Council housing, such as 
the North Dublin Inner City.”
6
 
 
A key aspect of the Drugs Initiative – and its most innovative aspect – was its determination to 
respond to the concerns of local communities by working with them. The Task Forces were expected 
to bring together organisations and individuals from the statutory, community and voluntary sectors 
to develop an integrated locally-based response to problem drug use in designated areas: 
                                                                
2  Department of Tourism Sport and Recreation 2001. Building on Experience: National Drugs Strategy 2001-2008. Dublin: 
Stationery Office, p. 52. 
3  Loughran, H. and McCann M. E. 2006. A Community Drugs Study: Developing Community Indicators for Problem Drug Use. 
Dublin: Stationary Office, p. 20. 
4  Comiskey, C. 1998. Estimating the Prevalence of Opiate Drug Use in Dublin, Ireland during 1996. Dublin. 
5  See Connolly, J. 2002. Drugs, Crime and Community in Dublin: Monitoring Quality of Life in the North Inner City. Dublin: 
North Inner City Drugs Task Force, p. 18. 
6  Connolly, J. 2002. Drugs, Crime and Community in Dublin: Monitoring Quality of Life in the North Inner City. Dublin: North 
Inner City Drugs Task Force, p. 19. 
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“Effective action against drugs requires a sustained, co-ordinated effort across a range of 
Government Departments and Agencies. This is a critically urgent example of what the 
Strategic Management Initiative in the Public Service (SMI) describes as a “cross-cutting” 
issue, which cannot be met satisfactorily by any one Department or Agency.”
7
 
 
The Initiative is widely perceived to have been a success, particularly as the rapid expansion of 
Methadone Maintenance Treatment and its take-up by former heroin addicts led to a reduction in 
deaths, crime and other impacts across the Task Force areas and enabled problem drug users to 
access other services, such as counselling, family support, training and employment opportunities. In 
Section 2.2 we describe the role of the Task Forces, in Section 2.3 we turn our attention to funding 
mechanisms and in Section 2.4 we summarise the results of previous evaluation studies. This 
overview of the Task Forces and the Drugs Initiative from 1996 onwards aims to provide a context for 
the development of the Performance Measurement Framework for DATFs in later sections of this 
report. 
 
 
2.2 Role of the Task Forces 
 
Between October 1996 and May 1997, Local Drugs Task Forces were established in 13 areas, twelve of 
which were in Dublin (Ballyfermot, Ballymun, Blanchardstown, Canal Communities, Clondalkin, Dublin 
12, Dublin North-East, Dun Laoghaire/Rathdown, Finglas-Cabra, North Inner City, South Inner City and 
Tallaght) and one in Cork. Later, in 2000, a fourteenth Local Drugs Task Force was established in Bray. 
Ten Regional Drug and Alcohol Task Forces were introduced between 2001 and 2006 under the 
auspices of the first National Drugs Strategy, Building on Experience (2001-2008). 
 
The main role of these bodies, from the very start, was to develop locally-based responses that could 
complement existing programmes and services, which meant assessing the extent and nature of the 
drug problem in a given area, defining a local strategy, developing and vetting drugs-related projects 
and overseeing the implementation of an action plan: 
 
“The Task Forces comprise a partnership between the statutory, voluntary and community 
sectors. They were mandated to prepare and oversee the implementation of action plans 
which co-ordinate all relevant drug programmes in their areas and address gaps in service 
provision.”
8
 
 
Typical elements of the role of the Task Forces include: (a) carrying out research, (b) 
gathering/distributing information, (c) providing education and training, (d) undertaking preventive 
interventions, (e) working towards the reduction of supply, (f) offering treatment and (g) providing 
rehabilitation services. They tackle these challenges by identifying local needs and developing projects 
which can satisfy these. In other words, the DATFs do not intervene directly and do not determine 
how funding is spent. Rather than duplicating existing services or cutting across the responsibilities of 
other statutory bodies, the Task Forces are expected to work cross-sectorally and inter-institutionally 
to ensure that the local response to problem drug use is coherent, integrated and effective. They 
therefore have a rather indirect, collective influence: 
 
                                                                
7  Department of Tourism, Sport and Recreation 1999. Local Drugs Task Forces Handbook: A Local Response to the Drug 
Problem. Dublin: Stationery Office, p. 50; see also Goodbody Economic Consultants 2006. Expenditure Review of the Local 
Drugs Task Forces. Dublin: Goodbody Economic Consultants. 
8  Department of Tourism, Sport and Recreation 1999. Local Drugs Task Forces Handbook: A Local Response to the Drug 
Problem. Dublin: Stationery Office, p. 4. 
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“...the LDTFs provide a mechanism for the coordination of services in these areas, while at the 
same time allowing local communities and voluntary organisations to participate in the 
planning, design and delivery of those services.”
9
 
 
To meet these objectives, the Task Forces are expected to design action plans that are guided by the 
National Drugs Strategy, on the one hand, and informed by an analysis of the local drug situation, on 
the other. This entails identifying key needs and related gaps in provision and developing strategies 
for addressing these gaps
10
. It also means that the DATFs represent a global, systemic response to 
problem substance use in each area. The Task Forces should thus be treated as a ‘level of analysis’ 
rather than an organisation, and assessing their performance implies determining how effective the 
combined efforts of all local actors have been in reducing problem substance use and its societal 
impacts. The current terms of reference of the Task Forces include the following
11
: 
 
 To oversee and monitor the implementation of projects approved under action plans 
 To ensure the formal evaluation of these projects with a view to ‘mainstreaming’ 
 To prepare action plans which update the area profile, in consultation with relevant state 
agencies, voluntary bodies and community groups 
 To develop networking arrangements for the exchange of information with other Task 
Forces, including the dissemination of best practice 
 To take account of and contribute to other initiatives aimed at improving social inclusion and 
tackling disadvantage 
 To provide information, reports and proposals to the relevant Minister 
 
As far as the organisational structure of the Task Forces is concerned, the Goodbody report provides 
the following overview: 
 
“The Local Drug Task Forces typically operate as a committee, which is made up of 
representatives from statutory agencies, the voluntary sector, representatives of the local 
community and local public representatives. Task Forces usually meet on a monthly basis. The 
mix of people on the committee supports the co-ordination of services, while at the same 
time facilitating the participation of local community and voluntary organisations in the 
planning, design and delivery of such services.”
12
 
 
The composition of the Task Forces has remained fairly stable since their establishment, including 
local or regional representatives of Government Departments, State Agencies, Voluntary 
organisations and Community groups plus elected representatives and 'communities of interest'. 
Representatives of the Area Partnerships and Social Inclusion Measures Group are also expected to 
participate. The conditions for membership, duration of mandates and related rules were formalised 
gradually. 
 
From 1996, the DTFs were under the responsibility of the Cabinet Committee on Social Inclusion, 
whilst from 2011 onwards they came under the Cabinet Committee on Social Inclusion, Children & 
Integration
13
. They originally responded to a National Drugs Strategy Team (NDST), which comprised 
personnel from relevant Government Departments and State Agencies, plus one person each from 
the voluntary and community sectors. Between the NDST and the Cabinet Committee were the Inter-
Departmental Group on Drugs (IDG) and Drugs Strategy Unit (DSU): 
                                                                
9  Department of Tourism Sport and Recreation 2001. Building on Experience: National Drugs Strategy 2001-2008. Dublin: 
Stationery Office, p. 53. 
10  Goodbody Economic Consultants 2006. Expenditure Review of the Local Drugs Task Forces. Dublin: Goodbody Economic 
Consultants. 
11  See http://drugs.ie/features/feature/what_is_a_drugs_task_force, accessed 12 December 2016. 
12  Goodbody Economic Consultants 2006. Expenditure Review of the Local Drugs Task Forces. Dublin: Goodbody Economic 
Consultants, p. 5. 
13  Quigley, E. 2011. National Drug Strategies in Ireland – A Brief Historical Overview. Presentation to the TAIEX Conference in 
Split, Croatia on 26-28 September. 
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“The structures proposed included (i) a Cabinet Committee to confer political leadership on 
the policy and to resolve inter-organisational barriers to effective responses and (ii) an Inter-
Departmental Group (IDG), representing the Assistant Secretaries at those Departments 
serving on the Cabinet Committee, to address policy issues and review progress. It also 
proposed a National Drugs Strategy Team (NDST) to (i) operate on a cross-departmental 
basis and ensure effective co-ordination, (ii) identify and consider policy issues before 
referring them to the IDG and (iii) co-operate with and oversee the work of the Local Drugs 
Task Forces (LDTFs) who were to co-ordinate delivery of the projects in the areas of highest 
heroin use.”
14
 
 
The Oversight Forum on Drugs (OFD) has remained in place since the beginning of the Drugs Initiative. 
It is chaired by the Minister with responsibility for the National Drugs Strategy and meets quarterly to 
oversee progress and to address any emerging issues. It comprises representatives of Government 
Departments and State Agencies involved in implementing the NDS, together with representatives of 
(a) the National Advisory Committee on Drugs and Alcohol; (b) the Community Sector; (c) the 
Voluntary Sector; (d) Chairs of the Local and Regional Drugs Task Forces. 
 
The NDST was replaced by the Drugs Advisory Group (DAG)
15
, which was later replaced by the 
National Coordinating Committee (NCC), on the basis of the Department of Health’s 2012 Report on 
the Review of Drugs Task Forces and the National Structures under which they operate. The NCC 
comprises representatives of key Departments and State Agencies involved in the implementation of 
the NDS (but this time at national level) as well as two representatives of each of the following: (a) the 
Network of LDATF Chairpersons; (b) the Network comprising LDATF Coordinators; (c) the Network of 
RDATF Chairpersons; (d) the Network comprising RDATF Coordinators; (e) the (national) Community 
Sector; (f) the (national) Voluntary Sector. 
 
The introduction of so many new structures, often with overlapping and rather vague responsibilities, 
has led to difficulties in managing the Task Forces and in establishing clear channels of 
accountability
16
. The National Drugs Strategy 2009-2016 introduced a further level of complexity by 
integrating alcohol within the remit of the DTFs, bringing all national strategies relating to substances 
into alignment. Figure 1.1 below provides a graphical representation of this complex institutional 
structure. The Local and Regional Task Forces are at the centre of the figure, and are surrounded by a 
dense network of overlapping and interlocking bodies and committees.  
 
                                                                
14  Department of Tourism Sport and Recreation 2001. Building on Experience: National Drugs Strategy 2001-2008. Dublin: 
Stationery Office, p. 53. 
15  Quigley, E. 2011. National Drug Strategies in Ireland – A Brief Historical Overview. Presentation to the TAIEX Conference in 
Split, Croatia on 26-28 September. 
16  Quigley, E. 2011. National Drug Strategies in Ireland – A Brief Historical Overview. Presentation to the TAIEX Conference in 
Split, Croatia on 26-28 September. 
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Figure 2.1 Overview of Organisational Structure of Drugs Initiative in Ireland 
 
 
 
 
The Drugs Initiative was designed as a multi-tiered programme, articulated across different 
institutional levels, from Central Government to Local Task Force. At each level, a specific 
organisational form was derived in order to ensure cross-sectoral cooperation and to develop a 
coordinated institutional response. Most importantly, significant resources were dedicated to the 
programme and it was given political backing at the highest levels, just as it was expected to produce 
an impact on the ground in a short space of time. The first National Drugs Strategy was introduced in 
2001 to simplify the development and implementation of policy in this area. 
 
The sheer institutional density of the Drugs Initiative indicates the complexity of its aims, which 
involved an iterative, decentralised process whereby the responses of different actors were gradually 
brought into alignment and adapted to problem substance use ‘on the streets’. This process was 
expected to be guided by national strategy and to range across Departments and Agencies (cross-
institutionally), between state and non-state bodies (cross-sectorally), over different scales (at local, 
regional and national levels) just as it adapted dynamically to changing conditions. 
 
Provisions were made from the beginning for the ‘mainstreaming’ of successful projects, which 
promised to overcome the main source of uncertainty for voluntary measures. The influence of the 
‘Partnership’ approach is evident here, in both its cross-sectoral and spatially-targeted forms, and the 
result is a highly innovative and ambitious programme. Given its complexity and due to the difficulties 
involved in defining responsibilities within this kind of institutional architecture, it is perhaps 
unsurprising that much subsequent attention has aimed to improve accountability by strengthening 
the ‘vertical’ links between projects, Task Forces, funding agencies, the NCC and the relevant 
Minister: 
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“There is an urgent need to develop a governance framework which will provide greater management 
and control of expenditure by Drugs Task Force projects and contain the necessary safeguards to 
ensure that Drugs Task Forces carry out their functions in a way which will stand up to external 
scrutiny.”
17
 
 
 
2.3 Funding Arrangements 
 
The Drugs Initiative has quite a different logic to other spatially-targeted programmes in Ireland which 
aim to promote social inclusion. Firstly, as noted in Section 2.2, the Task Forces are not independent 
organisations but committees which bring together people who work for Government Departments, 
State Agencies, Voluntary Bodies or who are involved in the Community, in a local development role 
or as an elected representative. Secondly, they do not have their own budgets, but receive expenses 
and in-kind supports through a range of statutory bodies, from the Partnership/Local Development 
Companies to the Regional Health Authorities. 
 
Drugs Initiative funds were initially paid from the Department of Tourism, Sport and Recreation to 
other Departments and Agencies, with the Office of the Minister for Drugs later coming under the 
Department of Community, Rural and Gaeltacht Affairs, before responsibility was transferred to the 
Minister for Health. The arrangement whereby funding is channelled to projects through relevant 
State Agencies was designed to facilitate the subsequent 'mainstreaming' of projects
18
. The funding 
agencies were expected to take a 'hands-on' role in assisting with the establishment and management 
of projects during their pilot phase, although there was, initially, confusion about the respective roles 
of the different actors: 
 
“The NDST and the Department of Tourism, Sport and Recreation expressed the view that 
responsibility for exercising financial control over the projects rested with the funding 
agencies. However, many of the funding agencies in turn used other agencies within their 
remit to channel funding to projects. This has led to a distancing of accountability for 
Initiative funding from the responsible Department.”
19
 
 
The Task Forces have a chairperson who was originally nominated by the Area Partnerships, in 
consultation with the Task Force and NDST, but later elected directly by DTFs. Each LDTF in the 
Greater Dublin Area was originally assigned a coordinator recruited by the Eastern Regional Health 
Authority (ERHA), with responsibility subsequently being transferred to the HSE. These coordinators 
are full-time, permanent employees and the cost of employing them was, at least initially, borne by 
the Department of Health
20
. 
 
The Coordinators have many important duties, including writing a profile of all existing or planned 
services and identifying the resources available in the local area to combat problem substance use 
and to co-ordinate activities that the Task Force deems necessary to furthering its strategy. Additional 
support staff in the form of a Development Worker (to support projects) and an Administrator (for 
office tasks and financial monitoring) are provided through the Operational Budget. 
 
                                                                
17  Department of Health. 2012. Report on the Review of Drugs Task Forces and the National Structures Under Which They 
Operate. Dublin: Department of Health, p. 5. 
18  Comptroller and Auditor General 2000 Annual Report Dublin: Stationery Office. 
19  Comptroller and Auditor General 2000 Annual Report Dublin: Stationery Office, p. 102. 
20  A situation is now emerging whereby the direct employment of DATF Coordinators by the HSE is no longer guaranteed. In 
some cases, DATFs have requested additional funding in order to recruit a Coordinator, as the HSE was no longer willing or 
able to accept this responsibility; (information based on communications with individual DATF coordinators) 
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In the case of the Local DATFs, staff are normally employed on a distinct funding line
21
. A small 
'Development Fund' covers new or emerging situations or can be used to assist new community or 
voluntary groups. A technical assistance budget is available to each Task Force to assist it in preparing 
its action plan. A ‘Small Grants Fund’ is designed primarily to allow Regional DATFs to respond to new 
situations which are not covered by their action plans. While this budget may be used to respond to 
specific or unanticipated situations, it may also be used to provide "seed" funding to new or emerging 
community or voluntary groups, as a pre-cursor to involving them more actively in the Task Force's 
overall drugs strategy at a later date. 
 
As we noted earlier, the value of services provided to DATFs and projects, aside from the funding they 
receive from Central Government, is highly significant. In the early years of the Initiative, this involved 
the Eastern Region Health Authority providing Coordinators, premises and administrative support, for 
example, and FÁS allocated 1,000 places per annum under its Community Employment Scheme
22
. 
Services provided voluntarily by individuals and groups are also significant, including training courses 
and provision of accommodation (e.g. by Dublin Corporation). 
 
The current situation is shown in Table 2.1 below, which summarises programme funding by source 
from 2009 until 2015. The figures show that funding has been falling steadily since 2009, dropping 
from €277.2m to €232.7m (-16.1%) and that practically all Departments have reduced their financial 
support (with the sole exception of law enforcement). Direct Funding from the Department of Health 
and the HSE for DATF projects amounts to €30m, or 12.6 per cent of total funding. The largest other 
funding providers are the HSE (€86.3m), principally for addiction services, followed by An Garda 
Síochána (€43m). In addition to the monies available under the action plans, the Premises Initiative 
was designed to meet the accommodation needs of community-based drugs projects, most of which 
were in LDTF areas
23
. 
 
Table 2.1 Public Spending on Drugs Programmes in €m, 2009-201524 
Department/Agency 2009 2010 2011 2012 2013 2014 2015 
HSE Addiction Services 104.9 105.4 92.9 89.4 90.4 86.1 86.3 
D/Health 40.3 35.8 33.6 32.4 30.5 8.3 7.4 
HSE Drug and Alcohol Task 
Force Projects 
0.0 0.0 0.0 0.0 0.0 21.6 22.6 
An Garda Síochána 45.0 44.5 45.0 45.9 44.0 43.0 43.0 
D/Children & Youth Affairs 28.5 25.7 25.0 22.7 20.3 19.5 19.5 
D/Justice & Equality 14.8 14.5 18.7 18.6 18.6 18.8 18.9 
Revenue Customs Service 15.9 15.8 15.5 14.2 14.6 16.2 16.2 
D/Social Protection (former 
FÁS area) 
18.8 18.0 15.6 11.9 13.4 14.1 13.7 
D/Education & Skills 3.6 2.5 0.4 0.8 0.8 0.7 0.7 
Irish Prison Service 5.0 5.2 5.2 5.0 4.5 4.2 4.3 
D/Environment, Community 
& Local Government 
0.5 0.5 0.4 0.2 0.0 0.0 0.0 
Total 277.3 267.8 252.2 241.0 237.1 232.5 232.7 
 
 
As far as project funding is concerned, this is generally related to a local action plan. Following a 
central evaluation, funding for specific projects and initiatives can be transferred from the DATFs to 
mainstream Government Departments or State Agencies. Most projects were thus designed, from the 
                                                                
21  National Drug Strategy Team 2011. Local and Regional Drugs Task Forces: Handbook. Dublin: Department for Community, 
Equality and Gaeltacht Affairs. 
22  Comptroller and Auditor General 2000 Annual Report Dublin: Stationery Office. 
23  Loughran, H. and McCann, M. E. 2006. A Community Drugs Study: Developing Community Indicators for Problem Drug Use. 
Dublin: Stationary Office. 
24  Data supplied by Drugs Policy Unit in the Department of Health. 
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beginning, to be ongoing initiatives. The process of mainstreaming has generated quite a rapid 
expansion in the funding of initiatives to tackle problem drug use at local level. The 2011 Handbook 
notes the importance of considering these projects when analysing the Drugs Initiative or the work of 
the DATFs: 
 
“Mainstreamed projects make a significant on-going contribution to the response to 
substance misuse problems in LDTF areas. To maintain the strategic links between Drugs Task 
Forces and mainstreamed projects, it is recommended that the relevant funding body brief 
the Task Force on the activity of the project on an annual basis.”
25
 
 
 
2.4 Previous Evaluation Studies 
 
The first evaluation of the Drugs Initiative was commissioned in October 1998 by the Department of 
Tourism, Sport and Recreation, which was at the time responsible for providing most of the funding. 
The resulting report expressed satisfaction with improvements in co-ordination and co-operation 
between the Government Departments and highlighted the importance of local community 
involvement. It recommended that more formalised structures be put in place for running and 
monitoring the Local Drugs Task Forces, including structures to link together the Task Forces 
themselves and to improve communication between Task Forces, Government Departments and the 
NDST. 
 
Another review, which formed part of the Annual Report of the Comptroller and Auditor General 
(2000) cited earlier, argued that inadequate consideration had been given to the development of 
performance indicators. Another report entitled Evaluation of Local Drugs Task Force Projects: 
Experiences and Perceptions of Planning and Implementation, commissioned by the NDST, was 
published in 2000. This report found that there was considerable scope for improvement in the 
projects in terms of internal management of and external support for projects under the Drugs 
Initiative. The Report makes the following observation: 
 
“No specified objectives or targets were set for the Initiative. The NDST did not set targets for 
reductions in the levels of drug abuse. In particular, no performance measures for 
effectiveness of projects were established. The NDST believed that a speedy and appropriate 
response was required to counter the hostility and suspicion that existed in communities in 
LDTF areas at the time. Measurement of the reduction or otherwise of opiates use in the 
areas covered by the LDTFs would have been a key indicator of the success of the Initiative. 
However, neither the NDST nor the LDTFs considered it appropriate to delay the introduction 
of programmes and services in order to devise performance indicators.”
26
 
 
An important review of the LDTFs was produced by the NDST in 2002, drawing on work by an external 
facilitator. The many recommendations made included: (1) the need for improved financial and 
reporting arrangements for LDTF-funded projects, including mainstreamed projects; (2) the need to 
disseminate models of best practice arising from the work of the LDTFs; (3) the further resourcing of 
LDTFs through the appointment of a project development worker and a full-time administrative 
assistant; (4) the development of a framework to evaluate the impact of the LDTFs. 
 
A report by Goodbody Economic Consultants in 2006 built on these recommendations by exploring 
ways of assessing the effectiveness and efficiency of the LDTF Programme by using performance 
indicators. It examined funding mechanisms, the kinds of measures that were funded, the strategic 
objectives contained in the NDS and the measurement of performance, noting the difficulties 
involved: 
                                                                
25  National Drug Strategy Team 2011. Local and Regional Drugs Task Forces: Handbook. Dublin: Department for Community, 
Equality and Gaeltacht Affairs, p. 39. 
26  Comptroller and Auditor General 2000 Annual Report Dublin: Stationery Office, p. 103. 
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“One of the potential dangers of locally based initiatives is that they can result in a situation 
whereby similar initiatives are developed and tested in a number of different areas without 
any of the areas being able to profit from the experience of others. One way of addressing 
this potential problem is to develop mechanisms for sharing experiences and best practice 
across the local areas involved. In the case of the Local Drugs Task Forces there would appear 
to be very limited interaction across the Task Force areas to date and little or no resources 
available to support cross-task force initiatives or networking.”
27
 
 
The Goodbody report noted that performance indicators for the Task Forces were still absent at the 
time of writing (2006). In particular, it noted the lack of any comprehensive large-scale surveys of the 
prevalence of drug use within the LDTF areas and the shortage of area-based data that could be 
aggregated to this level. In practice, only treatment data could be used in this way. The conclusion 
reached is as follows: 
 
“Establishing the effectiveness and impact of the LDTF Programme in a definitive manner is 
very difficult. This is not only because of the lack of data on the outputs of the Programme, 
but also because of the difficulties in disentangling the effects of the Programme from other 
elements of the National Drugs Strategy.”
28
 
 
The benefits of drug intervention measures are also difficult to fully capture for a number of reasons, 
as “some of the benefits do not accrue for a number of years”, “the benefits encompass impacts 
other than those on drug abuse” and “the benefits do not accrue solely to drug users and their 
families”
29
. Finally, at the project level, the case studies and interviews reported in the Goodbody 
report highlight the lack of quantitative information available on outputs and outcomes of funded 
projects: 
 
“Discussions with Task Force co-ordinators and with Task Force members have highlighted 
the low level of resources available to the Task Force to formally monitor and evaluate the 
projects that it is funding. While efforts have been made to address this situation by a 
number of the projects, to date, most have been unable to allocate adequate resources to 
develop or implement proper monitoring and evaluation systems.”
30
 
 
The report underlines the need for: 
 
 clearer reporting relationships between projects and LDTFs 
 use of standard monitoring templates for projects 
 greater learning from individual projects 
 more detailed evaluation of drug problems in each area 
 greater cross-LDTF and cross-project networking and learning 
 stronger evaluation prior to 'mainstreaming' based on performance indicators 
 long-term follow up surveys of clients 
 research and analysis at NDST level to derive high-level policy conclusions 
 
The 2011 Local and Regional Drugs Task Forces Handbook gave responsibility for the development of 
a Performance Measurement Framework to the Drugs Advisory Group, whilst the 2012 Report on the 
Review of Drugs Task Forces and the National Structures under Which They Operate assigned this 
responsibility to the NCC, making reference to a “common evidence-based assessment tool 
                                                                
27  Goodbody Economic Consultants 2006. Expenditure Review of the Local Drugs Task Forces. Dublin: Goodbody Economic 
Consultants, p. 51. 
28  Goodbody Economic Consultants 2006. Expenditure Review of the Local Drugs Task Forces. Dublin: Goodbody Economic 
Consultants, p. 46. 
29  Goodbody Economic Consultants 2006. Expenditure Review of the Local Drugs Task Forces. Dublin: Goodbody Economic 
Consultants, p. 48. 
30  Goodbody Economic Consultants 2006. Expenditure Review of the Local Drugs Task Forces. Dublin: Goodbody Economic 
Consultants, p. 51. 
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incorporating key performance indicators to measure the impact of the Drugs Task Forces” 
(Recommendation 6). 
 
None of the evaluation studies carried out since the inception of the Drugs Initiative have raised the 
issue of targeting in relation to the distribution of resources. If it is appropriate to measure the 
performance of DATFs, one might argue, then it is necessary to ensure that resources are distributed 
on an equitable basis. Resource provision refers here to the overall, ‘global’ funds and resources that 
are available to tackle problem substance use within a given area. Defining this is clearly not an easy 
task, given the large number of actors involved, the difficulty of quantifying certain kinds of resources 
(such as access to premises, training or administrative support) and the ‘sharing’ of various facilities 
between different projects and services.  
 
It is also striking that several reports have referred to the need to develop a system of impact 
assessment without specifying how this could be achieved in such a complex, decentralised, multi-
actor and multi-funder programme. The PA Consulting Group identified 80 performance indicators, 
NEXUS Consultants proposed impact indicators based on the assessments of project managers, 
Ballyfermot LDTF suggested adopting a system of 60 performance indicators, Loughran and McCann 
(2006) identified 32 indicators and Goodbody Economic Consultants adopted 24 performance 
indicators. 
 
Like the other publications, the Goodbody report draws several useful lessons from this literature, 
emphasising the need to focus on a limited number of impacts and to recognise that projects 
supported by the DATFs may act in synergy with projects supported by other funding sources, just as 
projects can have beneficial effects not just on participants but also on the wider community. 
 
Other complexities pose additional challenges, as the measures proposed by DATFs may provide 
funding to support or expand existing projects which receive funding under other official 
programmes, or via private fund-raising, EU schemes or donations etc. A measure can be anything 
“from a once-off community day out, to the employment of a development worker, to a fully operating 
drop-in centre or crèche, with a full complement of staff”
31
. Over 450 measures were allocated funding 
under Round 1 and Round 2 of the Drugs Initiative (see Table 2.2 below). 
                                                                
31  Goodbody Economic Consultants 2006. Expenditure Review of the Local Drugs Task Forces. Dublin: Goodbody Economic 
Consultants, p. 72. 
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Table 2.2 DATF Funding, 2015 
DATF Name 
Funding 
€ 
Funding 
% 
Funding 
% 
Dublin North East 594,836 2.76  
Ballymun 697,957 3.24  
Finglas - Cabra 627,960 2.92  
Blanchardstown 913,589 4.24  
North Inner City 1,734,723 8.06 21.23 
South Inner City 1,868,014 8.68  
Canal Communities 1,141,309 5.30  
Ballyfermot 1,231,286 5.72  
Dublin 12 993,150 4.61  
Clondalkin 1,007,948 4.68  
Tallaght 893,514 4.15  
Dun Laoghaire - Rathdown 786,755 3.65  
Bray 916,271 4.26 41.06 
North Dublin (City and County) 467,486 2.17  
North Eastern 927,813 4.31  
East Coast (of Dublin and Wicklow) 508,500 2.36  
South Western 696,497 3.24  
Midland 125,861 0.58 12.66 
North West 461,730 2.14  
Western 524,155 2.43  
Mid-West 1,260,007 5.85  
Cork (LDTF) 1,108,299 5.15  
Southern 973,178 4.52  
South East 1,065,760 4.95 25.05 
Total 21,526,598 100.00  
Source: Drugs Policy Unit in the Department of Health, unpublished data. 
 
 
In some cases, it may be possible to measure the 'outputs' of these kinds of projects, but it is difficult, 
in practical terms, to identify their impacts. An intervention in the realm of preventive education, for 
example, may take place alongside a myriad of other programmes working on the same issues in 
parallel, offering training for teachers, providing free-time activities for children or improving access 
to training for young people. How might we measure whether this intervention is effective in reducing 
the prevalence of problem substance use in the area? We are therefore in agreement with Goodbody 
Economic Consultants’ finding that there is a need to consider area-wide performance indicators that 
capture these synergistic and spill-over impacts”
32
. 
 
Goodbody Economic Consultants mention the need for monitoring performance at other levels, 
including that of the project and the process, as well as that of the national programme as a whole, 
but limit the assessment of impacts to the DATF area level, which we also agree with. Evaluating 
projects which vary in terms of activities, sector, size, target group etc. essentially demands a mixed 
approach involving qualitative assessment and inspection of quantitative data on outputs  and results. 
True impact assessment at the project level would require a scientific study design with a control 
group and a relatively large sample size, which would be incompatible with the cost and 
characteristics of these projects. 
 
                                                                
32  Goodbody Economic Consultants 2006. Expenditure Review of the Local Drugs Task Forces. Dublin: Goodbody Economic 
Consultants, p. 57. 
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We do not agree with the Goodbody report in relation to the utility of commissioning a household 
survey of drug prevalence and drug impacts every three years, including perceptions of local drug 
problems, whether respondents have been directly or indirectly affected by these problems, whether 
this has influenced their quality of life and their assessment of actions taken to address these 
problems in their area
33
. Even in the period when the LDTFs covered a restricted number of areas in 
Dublin, this would not have yielded reliable data for impact assessment, as our own analysis of the 
Drug Prevalence Survey data suggests. As the Task Forces now encompass the whole country, it 
seems more useful to draw on existing national surveys to the extent that they can shed light on 
substance use and its spatial distribution, as well as considering where such surveys might be 
improved to enhance their usefulness for the purpose of performance measurement. 
 
The 2011 Local and Regional Drugs Task Forces Handbook gives Task Forces a role in “overseeing and 
monitoring the effectiveness” of projects approved under their respective action plans (p. 12). From 
this point onwards, the DTFs were asked to develop three-year strategies for their area, reflecting 
local needs and circumstances, to support implementation of the National Drugs Strategy, as well as 
an operational plan each year to identify priorities.  
 
In 2014, the Terms of Reference of the DATFs where revised and are since summarised as follows
34
:  
 
 To coordinate the implementation of the National Drugs Strategy in the context of the needs of 
the region/local area 
 To implement the actions in the National Drugs Strategy where Task Forces have been assigned a 
role 
 To promote the implementation of evidence-based local/regional drug and alcohol strategies and 
to exchange best practice 
 To support and strengthen community based responses to drug and alcohol misuse 
 To maintain an up-to-date overview on the nature and extent of drug and alcohol misuse in the 
area/region 
 To identify and report on emerging issues and advocate for the development of policies or actions 
needed to address them 
 To monitor, evaluate and assess the impact of the funded projects and their continued relevance 
to the local/regional drugs task force strategy and to recommend changes in the funding 
allocations as deemed necessary 
 
We will now proceed to discuss the components of a Performance Measurement Framework for 
DATFs, before discussing data and operationalisation in later sections of this report. 
 
                                                                
33  Goodbody Economic Consultants, 2006, p. 66; cf. Loughran, H. and McCann, M. E. 2006. A Community Drugs Study: 
Developing Community Indicators for Problem Drug Use. Dublin: Stationary Office. 
34  Revised Terms of Reference supplied by Drugs Policy Unit in Department of Health. 
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3 Conceptual and Methodological Foundations 
 
In this chapter, we lay the foundations for the Performance Measurement Framework by developing 
some of its key concepts and theoretical elements. The aim is to describe the basic structure of the 
Framework and its rationale. We start, in Section 3.1, by describing our general approach to 
performance measurement, which is informed by a theory-driven or ‘confirmatory’ analytical stance. 
This motivates the development of a theoretical model which describes the key drivers of problem 
substance use at local level and identifies ways of intervening. 
 
The Performance Measurement Framework is developed at a conceptual level in this section, and 
then operationalised in later sections using the available data. We define the key concepts in Section 
3.2 and express their inter-relationships in the form of a Logic Model in Section 3.3. The Logic Model is 
translated into a Performance Measurement Model in Section 3.4, and this provides the ‘blueprint’ 
for the Performance Measurement System, which is described in more detail in Section 6. 
 
3.1 Confirmatory Programme Evaluation 
 
A fundamental choice must be made at the outset between a theory-driven and a data-driven 
approach to performance measurement. The terms of reference, by focusing on the development of a 
‘Theory of Change Model’ and ‘Logic Model’, make clear the client’s preference for a theory-driven 
approach, and we share this orientation. It may be helpful to begin by summarising the approach 
known as Confirmatory Programme Evaluation, as this clarifies a number of the issues at stake, 
including the kinds of questions that measurement frameworks should address and the kinds of 
methods that can be used. 
 
Confirmatory Programme Evaluation is a method for conducting theory-driven assessments, including 
performance measurement, impact assessment and other kinds of evaluations. It is in harmony with 
both the “Theory of Change” approach and the use of “Logic Models” to specify the relationship 
between key concepts
35
. It emphasises the development and testing of theories relating to 
programme impacts and the underlying mechanisms which produce these. This is useful, as it forces 
decision-makers to be clear about what they intend to measure when developing a performance 
measurement framework, and facilitates a shared understanding of this objective between the 
decision-maker, the analysts and the stakeholders. 
 
In a theory-driven approach to evaluation, the expected operation of a programme is theorised in 
order to establish an a priori model of how interventions exert their influence. It is therefore well-
suited to the assessment of public interventions or programmes which have clear goals. Uncertainty 
regarding the direction and strength of relationships is reduced by comparing the expectations 
inherent in the model with a set of empirical observations. The assumptions that are encoded by the 
theoretical model are thus tested empirically and the model is also informed by the findings of 
previous studies, including random control trials and pilot studies. 
 
By developing an explicit Logic Model, we make several steps towards the specification of the data 
required to carry out an evidence-based performance assessment. Whilst data-driven approaches 
tend to apply exploratory analytical techniques to existing indicators – often without fully 
understanding what these indicators actually measure – confirmatory approaches lay great emphasis 
on the careful development of powerful and well-crafted indicators that capture precisely the 
definitions that are required. 
 
                                                                
35  Chris, C. et al. 2011. ‘A Systematic Review of Theory-Driven Evaluation Practice from 1990 to 2009’. American Journal of 
Evaluation, 32(2): 199–226. 
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The main steps involved in Confirmatory Programme Evaluation may be summarised as follows
36
: 
 
1. Describe the various elements of the programme and the processes that are expected to affect 
outcomes using a Logic Model. 
2. Identify how to measure outcomes over the short, intermediate, and long term using a 
Measurement Model. 
3. Collect or obtain data on the key background variables that are necessary in order to obtain 
unbiased estimates of programme impacts. Identify possible mediators that intervene between 
background variables and outcomes. 
4. Estimate the main effects of interventions for relevant groups, quantifying the temporality, size, 
gradient, specificity, consistency and coherence of programme effects. 
5. Where main effects are detected, test the hypothesised causal mechanisms in an attempt to 
explain how these effects were generated. 
6. Interpret the pattern of findings to facilitate knowledge transfer. 
7. Identify ways of using the findings for programme improvement in a dynamic fashion over time. 
 
This framework is perfectly suited to the task of developing a Performance Measurement Framework 
for the DATFs. As noted earlier, we begin by developing a Logic Model, drawing on what is known 
about problem substance use and its determinants. We then specify a Measurement Model that 
enables us to operationalise all the main concepts, starting with problem substance use itself. We use 
the resulting measures to estimate impacts and to explore the pathways involved. Finally, we draw 
provisional conclusions and seek to learn from examples of ‘good practices’. The last element of the 
Framework is of central importance, as its ultimate aim is to shape policies that can improve the 
performance of individual DATFs and the programme as a whole. 
 
This overview of Confirmatory Programme Evaluation confirms the importance of understanding how 
a whole system of influences and effects functions, and how interventions to tackle problem 
substance use relate to this broader set of relationships involving a dense network of risk and 
protective factors operating at various levels. In other words, as well as measuring problem substance 
use itself, we must identify these factors and how they influence individual behaviour, we must 
understand the logic of different intervention strategies and we must use appropriate methods and 
statistical models to estimate overall performance. As we will see, this generally involves comparing 
the values that are observed with those that would be expected, given the characteristics of each 
DATF area. 
 
Together, these theoretical, methodological and empirical elements provide solid foundations for the 
development of a Performance Measurement Framework that can guide policy and practice in coming 
years and contribute to continuous improvements in publicly-funded interventions to reduce the 
prevalence of and harm caused by problem substance use in Ireland. The Performance Measurement 
Framework presented in the following pages is dynamic and flexible, rooted in a theoretical 
understanding of the determinants of change and makes optimal use of available data. 
 
3.2 Components of a Performance Measurement Framework 
 
When seeking to develop a Performance Measurement Framework for DATFs, it is important to be 
clear about the relationship between policies, research and empirical evidence. At the most 
fundamental level, effective policies in relation to problem substance use must be based on an 
understanding of the risk and protective factors that influence this, as well as its impact on health and 
well-being. 
 
These risk and protective factors include social, economic and cultural influences as well as 
behavioural, environmental and institutional aspects which vary across areas and over time. As well as 
                                                                
36  Reynolds, A. J. (2005) ‘Confirmatory program evaluation: Applications to early childhood interventions’, Teachers College 
Record, 107(10): 2401-2425. 
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providing treatment and pursuing harm reduction strategies, a key concern of the DATFs is to 
evaluate the long-term effects of interventions to reduce the prevalence of problem substance use. 
This requires a sophisticated approach to measuring impacts which has as its ultimate objective the 
promotion of population health and well-being. 
 
Effective evidence-based policy-making in this area requires a longitudinal framework for measuring 
the prevalence of substance use and problem substance use and for monitoring health and well-
being. By analysing repeated measures and indicators, trends and emergent needs can be identified 
and resources can be targeted effectively on the basis of need. This longitudinal analytical framework 
provides the most appropriate and powerful means of assessing the impact of initiatives and 
interventions in the context of the National Drugs Strategy. In the context of performance 
measurement, this means that each successive wave of analysis complements and adds value to those 
which have preceded it, enabling us to identify areas where performance appears to be improving 
and those where there are signs of deterioration. It also means that the first set of performance 
estimates are the most difficult to analyse and interpret, as this dimension is lacking. 
 
 
Performance Indicators 
 
One common way of approaching the topic of performance measurement is by reference to four 
types of performance indicators, namely input indicators, output indicators, result indicators and 
impact indicators. This approach informed the 2006 Expenditure Review of Local Drug Task Forces 
carried out by Goodbody Economic Consultants
37
. 
 
Input indicators, in this context, might refer to the additional resources that the Drugs Initiative has 
made available to tackle problem substance use at local level, including (a) funds assigned directly to 
DATFs; (b) funds assigned to projects; (c) other new resources made available (such as premises, 
administrative support, services, placements etc.); (d) social capital, skills of staff members, cultural 
assets and other intangible resources. 
 
Appropriate output indicators would include information on the number and types of measure 
supported and the number of people reached by each initiative. This information should be 
subdivided by type of initiative, using a comprehensive typology. The different types of projects 
supported under the DATF Initiative is included in Table 4.1 of the Goodbody report (p. 19) and 
reproduced in Appendix A of this report. 
 
Result indicators typically capture the characteristics of the beneficiaries reached by a programme 
and facilitate the assessment and improvement of targeting. Different initiatives are targeted at 
various sub-populations – such as problem substance users, people at risk of using drugs or 
developing problems with substances, early school-leavers, homeless people, those with mental 
illnesses or living in disadvantaged areas – and it is essential to ascertain how successful they are at 
achieving this aim. In addition, appropriate indicators of results would measure the degree of 
involvement of each individual with project activities (such as the proportion of sessions attended, 
performance in any assessments or tests, degree of satisfaction etc.). 
 
The Terms of Reference indicate that the new Performance Measurement Framework for DATFs 
should make progress towards ‘true’ impact assessment, implicitly acknowledging the difficulties that 
are inherent in this task. Meeting the challenge of measuring impacts in a realistic and reliable way is 
methodologically demanding and costly in terms of data and organisational resources. Credible 
impact assessments are quite rare in the Irish context, particularly when dealing with programmes 
that are implemented through multiple local structures/actors. There is therefore a gap between the 
‘rhetoric’ of impact assessment and the ‘reality’ of evaluations and systems for performance 
                                                                
37  Goodbody Economic Consultants (2006) Expenditure Review of the Local Drug Task Forces. Dublin: Goodbody Economic 
Consultants. 
 
 
22 
monitoring. We noted in the previous section that several different reports have called for impact 
assessment on various occasions over the past ten years (and more). In line with this requirement, 
this study concentrates on the measurement of impacts in relation to the work of the DATFs. 
 
As far as inputs, outputs and results are concerned, we feel that previous reports have done an 
excellent job in summarising the main issues involved and explaining how the relevant information 
should be gathered and analysed. It is also apparent that good progress has already been made in 
implementing these recommendations at the project level, with the result that we now know a great 
deal more about how these are structured, about their aims and the number, characteristics and 
participation of key target groups. We know much less, however, about the impacts that these 
projects have had on problem substance use within each DATF area. The bulk of this report is 
therefore dedicated to this crucial question, with the aim of finally identifying a way of producing 
reliable knowledge on the performance of the DATFs and the impact of the drugs programmes at local 
level. 
 
 
Definition of Problem Substance Use 
 
The Performance Measurement Framework presented here centres on the measurement of problem 
substance use, and it is therefore appropriate to start by defining this term. Problem substance use 
obviously includes both problem alcohol and problem drug use, in line with the extension of the 
National Drugs Strategy to include misuse of alcohol. The National Drugs Strategy (2009-2016) uses 
this term more than a hundred times, in different contexts, whilst referring to different aspects of 
current situation, but never actually defines the term. This means that the meaning of the term 
remains implicit, and can only be reconstructed by carefully inspecting the different ways in which it is 
used. 
 
The overall objective of the National Drugs Strategy 2009–2016 is “to continue to tackle the harm 
caused to individuals and society by the misuse of drugs through a concerted focus on the five pillars 
of supply reduction, prevention, treatment, rehabilitation and research”
38
, and one of the five 
strategic aims is “to minimise problem drug use throughout society”. Insights into what constitutes 
problem substance use may be gleaned from the key performance indicators that are mentioned in 
the Strategy, including reductions in the number of opiate users, in the number of illicit drug users 
and in the level of drug use amongst school students. This clearly suggests that problem substance 
use includes the use of illicit drugs (particularly injecting heroin) and substance use more generally 
amongst vulnerable groups such as young people. 
 
It is also interesting to look at the different ways in which this term has been used by the EMCDDA in 
recent years, although it recently shifted its focus from ‘problem drug use’ to ‘high-risk drug use’: 
 
"This key indicator collects data on the prevalence and incidence of high-risk drug use (HRDU) 
at national and local level. It was formerly called problem drug use (PDU). The indicator, 
which has recently been revised mainly due to the changing drug situation, focuses on 
recurrent drug use that is causing actual harms (negative consequences) to the person 
(including dependence, but also other health, psychological or social problems), or is placing 
the person at a high probability/risk of suffering such harms. This is operationalised by drug, 
with high-risk drug use measured as the use of psychoactive substances (excluding alcohol, 
tobacco and caffeine) by high-risk pattern (e.g. intensively) and/or by high-risk routes of 
administration in the last 12 months."
39
  
Whilst extending the range of drugs considered, in light of changing patterns of use, the notion of 
HRDU is clearly related to the previous definition, which tended to prioritise intravenous opiate use. 
                                                                
38  National Drugs Strategy Team 2009. National Drugs Strategy (Interim) 2009-2016. Dublin: Department of Community, 
Equality and Gaeltacht Affairs. 
39  See, for example: http://www.emcdda.europa.eu/activities/hrdu. 
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Despite the slight change in emphasis, problem substance use remains closely tied to the risk of harm 
to the user. However, what is notably missing from this definition is the notion of harm to others, 
including family members (and children in particular) and members of the community and wider 
society (as evident in the restricted use of local facilities, early school-leaving, modelling of risky 
behaviour, neighbourhood degradation, substance-related crime, substance-related morbidity etc.). 
 
Many European countries have followed the EMCDDA in adopting a narrow, health-related definition 
of problem drug use. In the Irish context, policy documents have arguably established a much broader 
definition, which is reflected in the role of the DATFs and the innovative institutional architecture 
described in Section 2 of this report. As we suggested earlier, policies on substance misuse in Ireland 
have been strongly influenced by Partnership and by the positive experience of spatial targeting that 
took shape during the early years of local and community development programmes. 
 
This is not merely an academic issue, as the centrality of the notion of problem substance use to the 
National Drugs Strategy and to the policy response more generally means that this concept must 
inevitably be positioned at the core of the Performance Measurement Framework. How are impacts 
to be evaluated, if not in relation to this key outcome measure? The ambivalent use of the term 
throughout the National Drugs Strategy and in official documents thus leads to a conundrum: how can 
we measure impacts if the strategic objectives of pubic programmes embrace such a wide range of 
different issues? If performance is to be assessed across all of these distinct arenas, how can we 
obtain a single overall measure of effectiveness? 
 
We believe that the answer to these questions is already present in the National Drugs Strategy, 
although this is not rendered explicit. This is because all of the different problems that are referred to 
share certain common features. In essence, problem substance use coincides with a range of different 
situations in which substance use is harmful (either to individuals or society, to users or other people), 
and where there is a broad consensus regarding the need to tackle this situation. This definition aims 
to integrate behavioural, medical and social perspectives, and explicitly acknowledges that the term 
‘problem substance use’ contains a relativistic and normative dimension. This definition is in line with 
the 2001-2008 National Drugs Strategy, which suggests that problem drug use is any form which 
causes “social, psychological, physical or legal difficulties as a result of an excessive compulsion to 
continue taking drugs”, drawing on a definition developed previously by the HRB
40
. 
 
At first sight, however, this definition appears to raise more questions than it purports to answer: 
 
(i) Although it is relatively straightforward to estimate the prevalence of substance use, it is much 
more difficult to measure problem substance use. Even if this could be achieved at national level 
using representative surveys, it certainly cannot be achieved at a spatially disaggregate level 
using existing data sources. In this regard, the limitations of the Drug Prevalence Survey – the 
most appropriate and powerful source of survey data in Ireland in this area – are discussed in 
Section 4.2. 
(ii) Whilst harm to the health status of individuals may, at least in theory, be measured, the wider 
and more indirect forms of harm experienced by individual users, their families and the wider 
community are extremely difficult to quantify. 
(iii) Possibly the most interesting aspect of the way in which the term ‘problem drug use’ is deployed 
in the National  Drugs Strategy is the assumption that we – as members of society – have an 
obligation to do something about it. This implies that it is morally and politically unacceptable to 
‘look the other way’ or to ignore the suffering and harm caused by substance misuse. 
 
The concept of ‘problem substance use’ is arguably too complex to measure if we treat it as a set of 
normatively-defined negative impacts. The potential impacts are simply too varied, in terms of the 
domains affected and the different levels involved, to permit reliable quantification without making a 
                                                                
40  Department of Tourism, Sport and Recreation (2001) Building on Experience: National Drugs Strategy 2001-2008. Dublin: 
Stationery Office, p. 24. 
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series of arbitrary decisions. This is one reason why previous evaluations have generated varying lists 
of dozens and dozens of indicators. The problem is that any list of indicators which aims to capture all 
aspects of problem substance use, as it affects different groups in society, is likely to be incomplete 
and contentious. How can we ever be sure that we have captured all of the harmful effects of 
substance misuse, as well as combining and weighting them in a meaningful way to obtain a measure 
of ‘overall problem substance use’? 
 
We therefore believe that the only way that the concept of problem substance use can be 
operationalised is in relative terms. For example, we might base our operational definition on what is 
actually done at the moment to tackle problem substance use, assuming that problem substance 
abuse is greater in areas where more treatment is needed, where people commit more substance-
related criminal offences, where they have more substance-related health problems and so on. 
Although a single indicator is sufficient to obtain estimates, our measure of problem substance use 
would clearly become more reliable if we add indicators, as these provide additional information on 
the same underlying variable. Rather than seeking to measure types of substance use or forms of 
harm, we measure the responses to this harm. This provides a way of automatically ‘weighting’ the 
contribution of different kinds of substance use and so on. We measure the resources allocated to 
treating addiction, dealing with health problems, tackling policing etc. and then we use this to infer 
the entity of problem substance use within each area. 
 
The first question that comes to mind is whether this entails a circularity, as more resources not only 
imply a larger problem, but presumably also indicate a stronger response. How can we identify 
performance if we are measuring both the problem and the response to that problem using the same 
information? This is where the relativistic nature of the definition is useful: we do not ask whether 
performance is high or low in absolute terms, or whether problem substance use is high or low in 
absolute terms, we merely ask whether relative performance, given the underlying risks, is above, 
below or in line with the average. We will show in the following pages how these calculations are 
actually carried out, and explain why they provide a reliable indication of performance (subject to 
certain assumptions, as in all such models). 
 
In summary, therefore, problem substance use can be defined in relative terms as relating to (a) 
specific forms of substance use behaviour which (b) are viewed by most members of society as 
causing harm and (c) trigger a response by the state and voluntary bodies to address this harm.  
 
The behaviours, the definition of harm and the responses can all change over time and vary across 
different localities, giving this definition great flexibility. What we do is we calculate the ‘average’ set 
of responses using information from all localities, controlling for their underlying risk factors, and then 
assess whether the response in each of these areas is above, below or in line with the average, again 
controlling for social risk factors. An average performance is thus defined as being in line with the 
interventions that society, on average, considers is appropriate to undertake when faced with the 
harm caused by substance use. Poor performance may therefore consist in a quantitative or 
qualitative shortfall in the provision of services and supports, including drug treatment, family 
support, prevention, education, training, law and order, access to opportunities and so on.  
 
The task of the Performance Measurement Framework is to identify DATF areas where the 
response to the harm determined by substance use is lacking in some way, to identify why this is 
the case and to stimulate a process of collective reflection which can generate systemic 
improvement and lead to the diffusion of good practices. 
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3.3 The Logic Model 
 
When discussing ways of assessing the impact of the work of the DATFs, it is necessary to distinguish 
between two different kinds of assessment. The first involves the individual-level impact of DATF 
interventions on people who are exposed to risks as a result of using substances. The second kind of 
impact relates to the aggregate-level effects of interventions that are targeted at a specific 
population. A significant part of the work of the DATFs falls under the heading of prevention, and is 
targeted at those who may be at risk of substance use. It would therefore be inappropriate to assess 
the DATFs exclusively in relation to their work with substance users. This is an obvious point for 
anyone who is familiar with the work of the DATFs, but it is important to underline its implications for 
performance assessment. 
 
The first implication is that overall performance cannot be assessed by following the individual 
beneficiaries of DATF interventions. Indeed, it will often be impossible to follow or even identify them, 
if we consider the role of informational leaflets, posters, websites, training courses for teachers or 
community leaders, meetings with other community organisations and low-threshold services. But 
there is another more profound reason why impacts cannot be measured at the individual level, and 
that is because many interventions and services are targeted at a population rather than at a specific 
set of individuals. 
 
At its core, the National Drugs Strategy has population-based objectives, and the various initiatives 
that are funded by the State to tackle problem substance use intervene within multiple domains of 
society. This means that local responses to problem substance use can only be evaluated by 
measuring their impact at a population level. This is an important point of departure which has quite 
far-reaching implications for our Logic and Measurement Models, as we will show below. It implies 
that our attention – and consequently our data – cannot be confined to service recipients alone. At 
the same time, we should have confidence in making this shift, as it reflects best practice and is 
entirely in line with the Healthy Ireland strategy.  
 
As we indicated earlier in Section 3.1, at the heart of the Performance Measurement Framework lies a 
Logic Model that specifies how local initiatives and services affect problem drug and alcohol use. 
Figure 3.1 shows these components and pathways, and is followed be a brief description of each of 
these elements. 
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Figure 3.1 The Logic Model 
 
 
 
Components 
 
We will first describe the constituent parts of the Logic Model, denoted by the capital letters A to I 
and will subsequently discuss the pathways that link these, which are indicated by lower-case letters 
(a to m). At the centre of the Logic Model is the concept of problem substance use and we would like 
to determine the risk of problem substance use. Risk of problem substance use (B in the Logic Model) 
is a latent concept, which cannot be measured directly, although we have a series of risk factors (A) 
which can be used to predict it. The Logic Model also includes actual problem substance use (D), 
which can be measured in various ways, as we will see later.  
 
As noted earlier, it is essential to distinguish between the risk of problem substance use, on the one 
hand, and actual problem substance use, on the other. The very purpose of preventive actions is to 
identify people who may be at risk of problems and to attempt to alter, reduce or prevent their use of 
substances. Preventive actions can take many forms and may engage directly with the individual or 
work through communities, schools, families or peer groups. These actions involve the DATFs and the 
statutory organisations, State Agencies, voluntary bodies and community associations that are 
represented within the DATFs. 
 
Examples of preventive actions may involve the education sector (schools, curriculum, SPHE etc.), 
health (awareness campaigns), the justice system (Gardaí, community liaison, the courts etc.) or 
housing (housing conditions, estate management etc.). The precise nature of (C) needs to be defined, 
in order to gain greater clarity about the different actors and interventions which are operating on the 
ground, and this is the subject of Section 6 where we discuss the relationship between the DATFs and 
the organisations that are represented within them. However, it is already apparent that evaluating 
the DATFs means measuring the impact of all interventions carried out by the organisations that are 
represented by the DATFs and thus contribute to achieving the objectives of the NDS within a 
particular DATF area. As we pointed out in Section 2, the DATFs have a global responsibility and bring 
together all of the key actors involved in tackling problem substance use at local level. Assessing their 
performance involves evaluating the effectiveness of local responses to substance-related harm. 
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E refers to services provided by the DATFs, including treatment for substance use problems (G) and 
referral to other treatment providers (F). Other Treatment Providers (F) can be divided into Inpatient 
services (Medical Detoxification Treatment Units, Hospital-based Treatment Units, Residential Drug 
Treatment centres, Therapeutic Communities and Treatment Units in Prisons) and an Outpatient 
services (Specialised Drug Treatment Centres, Low-Threshold Agencies, Services provided through 
General Health Care Centres, General Practitioners, Treatment for Prisoners and Opioid Substitution 
(Methadone) Treatment). Measures H and I refer to the health status of people who are involved in 
problem substance use before and after receiving treatment. 
 
 
Pathways 
 
The pathway marked d indicates the direct effects of preventive interventions undertaken by the 
DATF and its constituent organisations at local level, including schools, health care providers, housing 
services, the Gardaí or other agents of the criminal justice system. Preventive interventions may be 
universal (addressed to a whole cohort or population) or targeted at groups with a relatively high risk 
of problem substance use. These paths are shown as c.  
 
A similar set of direct and indirect pathways are indicated for treatment. Problem substance users 
may access treatment (G) through various routes. Treatment may have a positive effect by reducing 
problem substance use (k). Finally, the effect of treatment may be assessed by comparing the 
individual’s health status before and after treatment (paths n and o).  
 
3.4 The Performance Measurement Model 
 
The Logic Model described in the previous section provides an overview of the complex network of 
effects that surround and shape problem substance use. It reflects the multiplicity of public and 
private actors who are involved in providing information, treatment, training, support, preventive 
interventions etc., and the wide range of factors which influence the risk of problem substance use. It 
is necessary to build the Performance Measurement Framework on an awareness of this complexity 
and on a recognition of the difficulties that it generates. We will now describe how we move from the 
Logic Model to the Measurement Model, bearing this in mind. 
 
Several different aspects of performance must be considered in the Performance Measurement 
Model, including: 
 
(i) the effectiveness of preventive actions in reducing problem substance use within a given 
area 
(ii) the effectiveness of interventions in reducing the prevalence of problem substance use via 
treatment 
(iii) the effectiveness of interventions in reducing risks and improving the health of people who 
use substances, in terms of harm reduction 
 
We will begin by discussing these three forms of intervention, before addressing the difficult 
questions raised above in relation to the measurement of the performance of the DATFs. 
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Measuring the effectiveness of preventive actions in reducing problem substance use 
 
The risk of and actual problem substance use are closely related, although contingent factors and 
preventive interventions have the potential to prevent individuals who are at risk from becoming 
problem substance users. It turns out to be very difficult to demonstrate the effectiveness of 
preventive actions, however, and a recent review study
41
 was unable to identify unambiguous, high-
quality evidence of effective actions. It is possible, in principle, to design experimental studies which 
use treatment and control groups to isolate the effect of various kinds of intervention. In practice, 
however, it is difficult to match these groups and/or control for the full range of factors that influence 
outcomes, whilst avoiding ‘contamination’ between them. 
 
If an experimental study succeeds, in the future, in reliably identifying the impact of the kinds of 
preventive interventions undertaken in DATF areas, it may be possible to estimate their contribution 
to preventing problem drug use by measuring the quality and targeting of these interventions and by 
estimating or counting the number of participants. This would obviously be based on the assumption 
that interventions are effective and in line with models that have been shown to work. In the absence 
of this information, we must accept that improvements may be due to a combination of different 
interventions to prevent substance use and problem substance use, whose individual contribution 
may be difficult to identify. 
 
 
Measuring the effectiveness of treatment in reducing problem substance use 
 
Measuring treatment effects is somewhat easier than measuring the effectiveness of preventive 
interventions, because (a) we are dealing with a more precisely-defined sub-group of the population, 
(b) because interventions are typically more intensive and standardised, (c) because ongoing contact 
with recipients facilitates repeated measurements and (d) because more evidence is available 
regarding the impact of treatment. 
 
The aforementioned review by Bates et al. identifies a number of high-quality studies that report on 
the effectiveness of various treatment regimes. Many such studies relate to particular forms of 
substance use and particular social groups. However, when reflecting on the great variety of 
interventions and treatments provided in DATF areas (see Appendix A), it is clear that not all 
treatments can be matched with intervention models of proven effectiveness.  
 
The effectiveness of treatments provided through the network of inpatient services is more 
straightforward to identify than those provided in an outpatient setting. This is due to the nature of 
these services and the difficulties involved in collecting data in specific contexts. We know, for 
example, that the provision of data to the NDTRS by GPs is rather uneven, whilst the effects of low-
threshold services are particularly difficult to measure. For all these reasons, we can once again 
estimate the impact of treatment services on problem substance use only by making assumptions, 
and only as part of a combined local response to problem substance use. 
 
 
Measuring the effectiveness of interventions in reducing risks and improving the health of people 
who use substances 
 
The third dimension of performance relates to the effectiveness of various kinds of interventions on 
the health of people who use substances and on the well-being of the wider population. This is often 
referred to as ‘harm reduction’, and encompasses a very wide range of interventions such as needle 
exchange, information leaflets, screening for blood-borne viruses, drug testing facilities, drug 
consumption rooms, procedures for reducing the risk of overdose and so on. Opioid substitution 
                                                                
41  Bates, G. et al. (forthcoming) The effectiveness of interventions related to the use of illicit drugs: prevention, harm reduction, 
treatment and recovery - A “review of reviews”. Liverpool: Centre for Public Health at Liverpool John Moores University. 
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programmes can involve treatment for problem drug use as well as reducing harm and associated 
risks. Studies have found evidence that such programmes are associated with significant reductions in 
use of opioids, injecting, sharing equipment, HIV and HCV infection and risk of overdose. 
 
The ultimate aim of treatment is to improve the health and well-being of recipients and to reduce the 
risk of harm to the wider society. An important aim of service provision over the past decade has been 
to reduce harm, but few studies have looked at the long-term effects of treatment on the health and 
well-being of people involved in problem substance use. Instead, research tends to focus on proxies 
for future health status such as injecting drugs, presence of blood-borne viruses and risky sexual 
behaviours. Assessment of medium to long-term health impacts are complex and costly, as they 
require large samples and a longitudinal component, combined with an experimental design which 
includes problem substance users who do and do not receive treatment as well as people who do not 
use substances. This is another objective limit of current knowledge on the harm generated by 
substance use which constrains our ability to evaluate interventions. 
 
 
Towards Performance Measurement 
 
In previous paragraphs, we showed that measuring the performance of the DATFs involves assessing 
the combined impact of local interventions to tackle problem substance use at this spatial level. 
Understood in this way, the Performance Measurement Framework provides a potential for constant 
improvement in performance, and can itself evolve as new knowledge and data become available. As 
the latter improve, the Framework can move closer to ‘true’ impact assessment. In this sense, ‘true’ 
impact assessment should be treated as a reference point or a horizon, and performance 
measurement as a dynamic process whereby an organisation makes progress towards its goals. 
 
This conceptualisation has a number of important aspects. Firstly, it entails a focus on the aggregate 
area level as opposed to the individual, thus allowing us to focus attention on the characteristics of 
specific populations as they evolve over time, which simplifies several aspects of performance 
measurement. Secondly, and in principle, it provides us with a way of measuring the impact of 
interventions whose effectiveness have yet to be demonstrated. These issues have already been 
discussed, we are merely highlighting the fact that they have a role to play within the Framework. 
Thirdly, it is not necessary to identify and trace all individuals who participate in prevention or harm-
reduction programmes, which is clearly impossible. Fourthly, spatial indicators can be used as 
aggregate-level predictors, avoiding the need to gather data on individual-level risk factors. This is the 
‘positive’ side of the limitations described above, and it means that the information requirements of 
the Performance Measurement Framework are relatively modest and will not inconvenience the 
DATFs or add to their tasks. 
 
In brief, performance measurement should rely on data sources which are readily available and 
should draw on current knowledge. These sources are inadequate to reliably and accurately identify 
the unique contribution of schools, housing management bodies, doctors, hospitals, clinics, voluntary 
bodies, local groups and the Gardaí to reducing the harm associated with problem substance use in 
DATF areas. However, the other encouraging result of the previous discussion is that the combined 
impact of these separate contributions can nevertheless be evaluated at DATF level. As this is 
precisely what is required for the Performance Measurement Framework, the positive result of this 
conceptual discussion is that the latter is already, in principle, feasible given existing data. 
 
At the DATF level, what we are measuring is the combined impact of the interventions that are 
undertaken locally, embracing all actors engaged in tackling problem substance use and reducing its 
negative effects. Rather than requiring expensive ad hoc research, which would not allow for regular 
updates of the Performance Measurement System, a well-designed system of routine data collection, 
combined with available aggregate-level data, can enable us to make important progress towards the 
operationalisation of the Framework. 
 
We will now describe how an operational Performance Measurement System can be developed, with 
a view to providing robust evidence on whether interventions are effective in reducing problem 
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substance use and its negative consequences, against the backdrop of the underlying risks. This will 
provide a dynamic measurement environment for assessing performance at the Task Force level, as 
well as facilitating an evaluation of the effectiveness of the NDS as a whole, which is another objective 
of this project. Figure 3.2 describes the overall structure of this model of aggregate systemic 
performance, which we refer to as the Performance Measurement Model. This model is at the heart 
of the Performance Measurement System, which in turn operationalises the principles set out in the 
overarching Framework. 
 
Figure 3.2 The Performance Measurement Model 
 
 
At the core of the Performance Measurement Model lies the precise measurement of problem 
substance use. The latter is estimated here using data from the NDTRS and operationalised as the 
number
42
 of episodes of treatment provided for drug or alcohol problems during a given year. In 
Section 4, we will discuss how the measurement of aggregate-level problem substance use might be 
improved by drawing on other data sources, which are shown in the blue boxes to the left of Figure 
3.2 (involving substance-related morbidity, mortality, criminal offences etc.). 
 
An important aspect of the Measurement Model is the way in which it compares actual and predicted 
problem substance use. The former represents our best current information on the extent of problem 
substance use in a given area. It is based on the definition provided earlier, which refers to responses 
to problem substance use and can incorporate multiple, partial and imperfect measures to create a 
more powerful composite indicator. For example, it might rely on treatment demand as well as crime 
data and measures of morbidity and mortality related to drug use and alcohol consumption. A 
                                                                
42  The NDTRS records treatment episodes, although it is “de-duplicated” with respect to multiple treatments which are 
received by the same person from a given treatment provider. 
 
 
31 
discussion of potentially relevant data sources is provided in Section 4.1. By regressing this key 
outcome measure on a set of powerful aggregate-level predictors (population size, deprivation, local 
authority housing and a rural-urban classification of areas), we obtain a new variable: predicted 
problem substance use (and this can be done separately for drugs and alcohol, as required)
43
. This 
variable captures the level of problem substance use that would be expected in each DATF area. 
 
It is then possible to look at the variations which are not explained by the model, which can be 
summed to calculate the difference between predicted and actual problem substance use at the DATF 
level. This is a very valuable measure of the effectiveness of the DATFs and can direct attention at 
areas which are favourably or unfavourably classified. This exercise can be repeated over time and the 
resulting data series can be used to identify changes which are due to DATF interventions and to 
evaluate the ability of the DATF to address local problems or gaps in services. How this can be 
achieved, and its great potential in terms of achieving systemic improvements in efficiency and 
efficacy, will be described in Section 6.5. 
 
Where there are significant changes in the difference between predicted and actual problem 
substance use over time, or large differences between DATFs, it will be possible to study these in 
greater detail. These differences may have to do with the availability/provision of preventive 
programmes, harm reduction initiatives or treatment. There may, alternatively, be differences in 
targeting or the quality of service provision. Thirdly, the social composition of the area may be 
changing due to the effects of development or decline, or it may have benefited or suffered in specific 
ways as a result of broader processes. 
 
In other words, the Performance Measurement System facilitates a series of analyses and reflections 
on the effectiveness of the DATFs in the local context in which they operate. The DATFs themselves 
can play a crucial role in this process by reflecting on their actions and on their local environment. 
These ad hoc analyses can generate new hypotheses to be explored or tested, but cannot provide 
definitive evidence on causes, as it is always possible that unobserved factors influence the data. This 
does not need to be looked at as a drawback. On the contrary, any critique that draws attention to 
the omission of an important or relevant factor potentially leads to the formulation of a new 
hypothesis and an improvement in the model which can subsequently be tested empirically. This 
dynamic aspect of the Performance Measurement System is an explicit and desired element of the 
overall Framework. 
 
Some guidelines can already be provided in relation to these assessments. If actual PSU falls below 
predicted PSU, then this suggests a favourable situation where models of good practice might be 
identified. If actual PSU is above predicted PSU, then an area may have recorded a below-average 
performance and questions may need to be raised. The latter situation does not necessarily imply 
poor performance on the part of the DATF, as exceptional circumstances may apply relating to the 
supply of drugs, for example, or local cultural norms. 
 
In all these scenarios, by identifying the reasons for differences in outcomes we can gain valuable 
information to help the DATFs to improve their actions and to upgrade their interventions. Within the 
overarching framework of the NDS, the DATFs play a key role in coordinating responses to problem 
substance use within their respective areas.  It is therefore appropriate that the DATFs should play a 
leading role in interpreting and interrogating the results of the Performance Measurement System, 
with the aim of understanding heterogeneities in risk factors, interventions and outcomes across time 
and space. This, in turn, means that the DATFs should have a full understanding of the Performance 
Measurement Framework and System and should, in principle, support its implementation. 
                                                                
43  A Poisson regression model is estimated at the level of Small Areas (or clusters of Small Areas), and the resulting predictions 
summed to obtain a prediction for each DATF area. 
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4 Key Findings of the Data Analyses 
 
For the Performance Measurement Framework described here to become an effective tool for 
improving the delivery of programmes for reducing problem substance use, it is desirable to create a 
consensus amongst stakeholders about its purpose and key components. In particular, it is important 
to develop a shared understanding in relation to: 
 
 the measurement of problem substance use, treatment and preventive actions 
 the strengths and weaknesses of available information 
 the outcomes to be assessed 
 the purpose of the Performance Measurement Framework 
 
This, in turn, requires the following: 
 
 reliable measures that quantify the extent of problem substance use 
 a rigorous definition of the objectives of interventions 
 evidence regarding the impact of preventive measures, treatment and harm reduction 
 reliable measures of the different interventions undertaken 
 
 
4.1  Potential Data Sources 
 
At least nine data sources are relevant to the Performance Measurement Framework, namely the 
Drug Prevalence Survey, the National Drug Treatment Reporting System, the Central Treatment List, 
the Capture-Recapture Study, the National Drug-Related Death Index, the ESPAD survey, the Healthy 
Ireland Survey, the Hospital Inpatient Enquiry system and the CSO/Garda Síochána Crime Data. These 
are described below, in order to provide a brief overview of the possible sources of information on 
substance use in Ireland. Previous evaluation reports have provided similar overviews, and we draw 
partly on this information and partly on other sources. What is different from previous reports, 
however, is that we carried out an in-depth analysis of two of these data sources – the Drug 
Prevalence Survey and the National Drug Treatment Reporting System – and present the results of 
these studies in the following sections. 
 
 
NACDA Prevalence Data 
 
Drug prevalence data have been collected in Ireland since 2002 using a sample-based survey which is 
repeated every 4 years (2002/3, 2006/7, 2010/11, 2014/15). These surveys have always been 
conducted by IPSOS MORI/MRBI on behalf of the NACDA. The data facilitate the estimation of key 
indicators required by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The 
Drug Prevalence Survey has the following characteristics: 
 
 The target population comprises people aged 15 and over (from 2002-2010, people aged 15-64) 
 An effective sample size of 7,000 for the most recent survey 
 Data collection relies on Computer Assisted Personal Interviewing (CAPI) 
 The sampling methodology follows EMCDDA guidelines and comprises a three-stage stratified 
cluster sampling design: (i) EDs are the Primary Sampling Units, (ii) A random sample of 
households is drawn from each PSU using the An Post/Ordnance Survey Ireland GeoDirectory, (iii) 
at household level, the “last birthday” rule is used to randomly select one adult for interview. 
 
A detailed analysis of the 2014/15 Prevalence Data is provided in a separate document and a 
summary of an evaluation of its suitability for inclusion in the Performance Measurement System  is 
included in Section 4.2 of this report. 
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The National Drug Treatment Reporting System (NDTRS)  
 
The NDTRS is an epidemiological database that records treatments for problem drug and alcohol use 
in Ireland. Managed by the HRB, the NDTRS forms the basis for the Treatment Demand Indicators 
which are used by the EMCDDA, based on: 
 
 Data on demographic characteristics, access to treatment, status (new versus existing patients), 
recent problem substance use, risk behaviours and initial treatment type 
 Treatment is defined as “any activity which aims to ameliorate the psychological, medical or 
social state of individuals who seek help for their drug problems” 
 Treatments include brief intervention, addiction counselling, medication-free therapy, alternative 
therapy, psychiatric treatment, medication and social/occupational reintegration 
 Clients of needle-exchange services are not included 
 Data collection for the NDTRS is continuous and based on reports from treatment providers. The 
protocol was revised during 2016 and will, in the future, include the Small Area code for the area 
of residence of the beneficiaries. 
 
A detailed analysis of the 2014 NDTRS Data and its role in the Performance Measurement System is 
provided in Section 4.3. 
 
 
The Central Treatment List (CTL) 
 
The Central Treatment List (CTL) is administered by the Drug Treatment Centre Board (DTCB) on 
behalf of the Health Service Executive (HSE) and is a register of all patients receiving methadone 
treatment for problem opiate use. It has the following characteristics: 
 
 When a person is considered suitable for methadone detoxification or maintenance, the 
prescribing doctor applies to the CTL for a place on the list and a unique code 
 The CTL records the client’s name, address, date of birth, gender, starting date, type of 
treatment, prescribing doctor and dispensing pharmacist 
 The CTL is considered to be complete with respect to the number of clients who start or 
recommence methadone treatment because of the statutory obligation for general practitioners 
to supply data to the CTL 
 
Registration with the CTL is continuous and up-to-date, as this is an essential element in the 
management of methadone treatment. The authors have requested access to the full CTL data with a 
view to conducting an analysis which focuses on the identification of risk factors for problem (opiate) 
drug use and its spatial distribution. However, the data can only be used for the purposes of the 
Performance Measurement Framework if it is fully geocoded (i.e. if a Small Area code is provided for 
the residential address of each individual in the CTL) so that a spatial analysis of methadone 
treatment can be undertaken. 
 
An appropriate way of pursuing this objective is to help the DTCB to geocode the CTL themselves with 
the assistance of the HSE/Health Intelligence Unit/Health Atlas. The latter have already coordinated 
similar tasks with TUSLA and the Department of Education and Skills with regard to the complete 
geocoding of the Primary and Post-Primary Pupil Databases. We have proposed this course of action 
to the relevant actors (for whom there would be no additional costs) and are willing to provide 
support if the DTCB decides to pursue thus possibility. Once geocoded data from the CTL become 
available, this will enhance our capacity to derive reliable estimates of problem drug use. 
 
 
The Capture-Recapture Study 
 
The 2014/15 Capture-recapture Study was carried out on behalf of the NACDA by Dr. Gorden Hay 
from the Centre for Public Health (Faculty of Health & Applied Social Sciences) at Liverpool John 
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Moores University. It aims at deriving a more accurate estimate of the overall number of opiate users 
in Ireland using the following techniques: 
 
 The study uses a 3-Source Capture-Recapture method. The three population sources used are the 
Central Treatment List (CTL), the Hospital In-Patient Enquiry Scheme (HIPE) and the Garda list of 
opiate users 
 Capture-recapture studies were also carried out in 2003 and 2009 
 
The Capture-Recapture study is effectively an extension of the CTL which draws on additional 
information from other data sources. It would acquire added value if the CTL itself were to be 
geocoded, as noted above, as it may shed light on the selectivity of treatment demand by area and/or 
social background. 
 
 
The National Drug-Related Death Index (NDRDI) 
 
The NDRDI is a complete register of drug-related deaths (such as those due to accidental or 
intentional overdose) and deaths among drug users (such as those due to Hepatitis C and HIV) in 
Ireland. It also records alcohol-related deaths. The NDRDI is collated by the HRB on behalf of the 
Department of Health and comprises annual data from 2004 onwards. This information is used to 
develop policy responses involving the health and social services. The number of deaths among drug 
users is also one of the EMCDDA key indicators. 
 
The total number of drug-related deaths over a ten-year period (2004-2013) is 3,519 (about 350 
deaths per annum). Even though the deaths are identified by DATF area, the numbers are too small to 
undertake meaningful analysis at this level of spatial aggregation. 
 
 
The ESPAD Survey 
 
The European School Survey Project on Alcohol and Other Drugs (ESPAD) is a collaborative effort of 
independent research teams in more than forty European countries and the largest cross-national 
research project on adolescent substance use in the world. It has the following characteristics: 
 
 The overall aim of the project is to repeatedly collect comparable data on substance use among 
15-16 year-old students in as many European countries as possible 
 Ireland has participated in all ESPAD surveys, including 1995, 1999, 2003, 2007, 2011 and 2015 
 The sample size for Ireland in 2015 was 1,470 pupils 
 
On its own, data from the ESPAD survey are unlikely to contribute to the refinement of estimates of 
problem substance use. However, it may be worth investigating whether data from the ESPAD survey 
could inform preventive interventions. 
 
 
The Healthy Ireland Survey (HI) 
 
The Healthy Ireland Survey (HI) is a new annual survey of the population aged 15 and over based on 
face-to-face interviews. The sample size is about 7,500 and the survey has a repeated cross-sectional 
design. The first survey was conducted in 2014-15, and the second in 2015-16. The aim of HI is to 
provide an up-to-date snapshot of the health of the population, with particular emphasis on 
behavioural patterns that may negatively affect health outcomes. In-depth analysis of the first wave 
of data is soon to commence and results of the analysis are expected by September 2017. 
 
Healthy Ireland is unlikely to contribute to the measurement of problem substance use at 
disaggregate level, although it may provide insights into problem alcohol use. It will facilitate 
identification of how risk behaviours cluster together, it can provide up-to-date estimates of the 
quantity of alcohol consumed and allow assessment of the impact of alcohol use on overall health. 
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This will complement the information provided by the NACDA Drug and Alcohol Prevalence Survey 
and provide additional insights regarding health effects. 
 
 
The Hospital Inpatient Enquiry system (HIPE) 
 
This archive of health data is managed by the Economic and Social Research Institute (ESRI) in 
association with the Department of Health and the HSE. It contains demographic, medical and 
administrative data on all admissions, discharges and deaths from acute general hospitals in Ireland. It 
was started on a pilot basis in 1969 and then expanded and developed as a national database of 
coded discharge summaries from the 1970s onwards (HRB, 2013). HIPE does not record information 
on individuals who attend A&E Departments but are not admitted as inpatients. It can be used to 
quantify non-fatal overdoses, more serious accidents and injuries related to substance use and 
treatments for conditions which are associated with substance use. 
 
Given the (fortunately) relatively small number of deaths associated with substance use in Ireland, it 
may be appropriate to use data on drug-related morbidity to estimate problem substance use. The 
construction of this kind of indicator (substance-related morbidity) is well-established at international 
level, and has been studied in the course of previous projects funded by the HSE
44
. It may therefore 
be possible to obtain independent estimates of the ‘burden of disease’ or ‘preventable morbidity’ 
associated with substance use in Ireland. As in the case of treatment data, the linkage of such data to 
Small Areas, EDs or DATF areas would undoubtedly require additional work and geocoding. 
 
 
The CSO/Garda Síochána Crime Data 
 
Since 2006, the management of crime data has been the responsibility of the Central Statistics Office 
(CSO). The CSO data are derived from the computerised systems used by An Garda Síochána. The vast 
majority of substance-related offences reported come under one of three sections in the Misuse of 
Drugs Act (MDA) 1977: section 3 – possession of any controlled drug without due authorisation 
(simple possession); section 15 – possession of a controlled drug for the purpose of unlawful sale or 
supply (possession for sale or supply); and section 21 – obstructing the lawful exercise of a power 
conferred by the Act (obstruction). Other MDA offences regularly recorded relate to the importation 
of drugs (section 5), cultivation of cannabis plants (section 17) and the use of forged prescriptions 
(section 18). Another category of substance-related offence relates to driving under the influence of 
drugs or alcohol, which are statutory offences in Ireland under the Road Traffic Acts, 1961-2002.  
 
Doubts have been raised about the reliability of this source
45
, and the 2013 National Focal Point 
report for Ireland makes the following additional observations: 
 
“It should be noted that drug offence data are primarily a reflection of law enforcement 
activity. Consequently, they are affected in any given period by such factors as law 
enforcement resources, strategies and priorities, and by the vulnerability of drug users and 
drug traffickers to law enforcement activities. Having said that, when compared with other 
data sources such as drug treatment for example, drug offence data can provide a useful 
indicator of overall drug trends.”
46
 
 
                                                                
44  Hope, A. 2008. Alcohol Related Harm in Ireland. Dublin: Health Service Executive - Alcohol Implementation Group. Available 
from http://www.lenus.ie/hse/handle/10147/45838 (consulted October 2016). 
45  see, for example, CSO (2006) Review of the quality of crime statistics. Dublin: CSO; Loughran, H. and McCann, M. E. (2006) A 
Community Drugs Study: Developing Community Indicators for Problem Drug Use. Dublin: Stationery Office. 
46  Health Research Board (2013) 2013 National Report (2012 Data) to the EMCDDA by the Reitox National Focal Point. Ireland: 
New Developments and Trends. Dublin: Health Research Board, p. 127. 
 
 
36 
Discussion 
 
This summary overview of the main sources of information on substance use in Ireland shows that 
each of these datasets were designed with specific aims. The three surveys  were intended to be used 
for monitoring but are of limited use at the sub-regional level where the sample size precludes 
reliable estimation. At the same time, each dataset is pertinent to the work of the DATFs and contains 
potentially useful information, which suggests that all could usefully be analysed in coming months 
and years with a view to supporting the National Drugs Strategy. As these are secondary data sources, 
this would be a cost-effective way of generating new and helpful forms of knowledge about substance 
use in Ireland. 
 
As most of the sources comprise some element of longitudinal monitoring, there is considerable 
scope for identifying trends at national (and perhaps even regional) level. As far as performance 
measurement is concerned, however, it is less clear which data sources are likely to be most useful. 
For this reason, we evaluate in the following sections a survey-based data source and an 
administrative data source. The analysis of these two datasets – the Drug Prevalence Survey and the 
NDTRS – lead to relatively clear conclusions regarding the kinds of data that are needed in order to 
derive reliable estimates of problem substance use and related risk and protection factors. As we will 
see, the main finding is that administrative sources and registry data are particularly useful from this 
perspective, particularly when data collection protocols are backed up by statutory obligations. 
 
 
4.2 Analysis of NACDA Drug Prevalence Data 
 
The Drug Prevalence Survey is a valuable source of data on substance use in Ireland. As this is a 
relatively large sample survey, which is regularly repeated, it is important to assess whether and how 
it can contribute to the Performance Measurement Framework for DATFs. This assessment has three 
different aspects: (a) the identification of risk and protection factors for substance use; (b) 
identification of patterns of problem substance use and its extent; (c) estimation of the spatial 
distribution of problem substance use. 
 
We will begin by providing an overview of the characteristics of the sample before – for the first time 
– presenting the results of a sophisticated analysis of risk and protection factors for substance use in 
Ireland using this under-utilised data source. We finish with a discussion of the utility of the Drug 
Prevalence Survey for informing the Performance Measurement Framework. 
 
The most challenging aspect of drawing conclusions from the Drug Prevalence Survey for the work of 
the DATFs is due to conceptual difficulties in identifying problem drug and alcohol use from data on 
the frequency of substance use. For example, people may use tranquillisers and anti-depressants 
without perceiving this as a problem, and the effects for the individuals concerned (and for their 
families and the wider community) may even be positive. At what point should this kind of pattern of 
consumption be considered ‘problem substance use’? Similar observations apply to many other 
substances, and it is apparent that ‘problem substance use’ cannot be equated with consumption of a 
determinate quantity or a certain frequency of use alone, but only in terms of harm to the individual 
and others. Harm cannot generally be inferred from substance use per se, and must be measured 
using appropriate data. 
 
As we saw in the previous section, many institutional actors have treated heroin use, or other illicit 
drugs, as inherently problematic. There is nothing particularly objectionable about this assumption, 
although this category of substance use has a low prevalence in the population. This means that it is 
extremely difficult to identify risk and protection factors reliably using sample surveys and to obtain 
sub-regional estimates. A further difficulty is that there is a relatively high level of experimentation 
with substances like ecstasy, LSD and cocaine, which is associated with relatively affluent social 
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groups and areas, whilst problem drug use is known to be associated with disadvantaged groups and 
deprived areas
47
. If lifetime use or consumption of a given substance over the last year are used as 
indicators, this contradictory pattern can easily lead to confounding and misleading conclusions can 
be drawn. For all these reasons, we find this source to be rather problematic from the perspective of 
performance measurement. 
 
 
Sample Characteristics 
 
The key outcome variables in the Drug Prevalence Survey include: 
 drug use during last month, last year or in lifetime for various substances (Tobacco, alcohol, 
pharmaceuticals, cannabis, ecstasy, amphetamines, cocaine, heroin, LSD) 
 frequency of use/amount 
 age of first use, and  
 age of first regular use 
 
The substances analysed in this section are illustrated in Figure 4.1 below. The categories we use are 
based not on the type of substance or its legal status, but on broad social distinctions in relation to 
how substances are used in contemporary society, as this provides us with greater statistical power to 
identify the determinants of substance use. Alcohol, tobacco and cannabis are treated separately, 
whilst heroin is grouped with methadone. Sedatives, tranquillisers, anti-depressants and anabolic 
steroids are grouped to form the category “Other legal drugs”, whilst cocaine, crack, ecstasy, LSD, 
amphetamines and mushrooms are taken together to form the category “Other illicit drugs”. 
 
Figure 4.1 Main Categories of Substance Use in Drug Prevalence Survey 
 
 
 
Available covariates include socio-economic group, employment status, respondent has held a paid 
job, chief income-earner currently has a paid job, employment status of chief income-earner, socio-
economic group of chief income-earner, housing tenure, age ceased education, highest education 
                                                                
47  A study by the Royal College of Psychiatry shows that use of all drugs is more common among people under 30 who are 
living in neighbourhoods classified as reasonably well-off or prosperous. However, injecting, dependence, polydrug use, 
heroin and crack cocaine use are more commonly found among deprived populations (Royal College of Psychiatrists and the 
Royal College of Physicians Working Party (2000) Drugs: Dilemmas and choices. London: Gaskell, p. 66; quoted in Loughran 
and McCann, 2006, p. 40). 
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level attained, gender, age, marital status, children, age of dependent children, ethnicity and 
disability. These are summarised in Figure 4.2 below. 
 
The mean age of respondents is 43 years, and women account for 50.9 per cent of the sample. Almost 
two-fifths of respondents are married, whilst almost a third are single and just under a tenth are 
separated, divorced or widowed. One third have a dependent child under 16 years of age and the vast 
majority describe themselves as members of the ‘white settled’ population (1.9 per cent are Black, 
Asian or African). More than 60 per cent own their own homes, 17.4 per cent are in private rented 
accommodation and 6.8 per cent are renting from a Local Authority or Housing Association. Just over 
half are at work and 27 per cent are either retired, unable to work or on home duties. Almost 30 per 
cent left school having completed secondary education, followed by 22.8 per cent with a degree and 
21.3 with a post-secondary certificate. 
 
Figure 4.2 Explanatory Variables in Drug Prevalence Survey 
 
 
 
4.2.1 Identifying the Risk and Protective Factors for Substance Use 
 
As mentioned above, we have prepared a rather detailed study of the prevalence of substance use by 
category, including its distribution across the former Health Board areas, and this is presented in a 
separate document. The emphasis here is on the results of individual-level logistic regression models 
where the dependent variable is a dichotomous variable that indicates whether a respondent used a 
given substance during the past year. 
 
This analysis sheds considerable light on the risk and protective factors for substance use across the 
six categories described above (Figure 4.1). As noted earlier, this is the first time that multivariate 
statistical analysis techniques have been applied to data from the Irish Drug Prevalence Survey, and 
the results will be of considerable interest to researchers, policy-makers and practitioners who work 
in this area. It is also critical for the analysis of the NDTRS data presented in the Section 4.3 below.  
We will conclude this section by making some general observations regarding the relevance and utility 
of this data source from the perspective of the Performance Measurement Framework. 
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Table 4.1 Odds Ratios for Regression on Use of Substances in Last Year 
Variables and Categories Alcohol Tobacco 
Other 
legal 
Cannabis 
Other   
illicit 
Health Board Area (Ref. Eastern)      
Midland 0.63* 0.62* 0.82* 0.93* 0.93 
Mid-Western  0.80* 0.74* 0.74* 0.59* 0.49 
North-Eastern 0.77* 0.95* 1.29* 1.33* 1.18 
North-Western 0.43* 0.60* 0.46* 0.75* 0.84 
South-Eastern 0.78* 0.76* 1.20* 0.72* 1.05 
Southern 0.80* 0.66* 0.70* 0.78* 0.50 
Western 0.69* 0.74* 0.75* 1.16* 1.48 
North Dublin 0.79* 0.82* 0.92* 1.27* 0.84 
South-Western 1.04* 0.98* 0.90* 1.23* 1.18 
Age in Years 0.98* 0.97* 1.01* 0.93* 0.93* 
Marital Status (Ref. Single)      
Married or cohabiting 1.21 0.87* 0.98* 0.78 0.48* 
Separated, divorced, widowed 1.15 1.27* 1.53* 1.41 0.73* 
Male Gender 1.54* 1.35* 0.66* 2.96* 3.61* 
Ethnicity (Ref. White settled)      
Traveller or Roma 0.23* 0.57* 1.29* 0.79* 0.65 
African, Black or Asian 0.14* 0.25* 0.35* 0.19* 0.00 
Other ethnicity 0.31* 0.66* 2.71* 1.12* 2.39 
Housing Tenure (Ref. Owner occup.)      
Private rented 0.70* 2.58* 1.13* 2.33* 2.56* 
Local Authority rented 1.01* 2.46* 1.72* 2.72* 2.83* 
Other housing tenure 0.83* 0.89* 0.95* 1.21* 1.34* 
Has a young child 0.77* 0.95 0.94 0.52* 0.52* 
Employment Status (Ref. At work)      
Unemployed or on scheme 1.14* 1.45* 1.48* 1.94* 3.88* 
Retired, home duties, unable 0.75* 0.95* 1.83* 1.05* 2.58* 
Student 0.41* 0.52* 0.77* 0.65* 1.30* 
Other employment status 0.40* 1.34* 2.21* 1.28* 1.49* 
CIE Employment (Ref. At work)      
CIE is unemployed 1.06 1.40* 1.70* 1.09 1.09 
CIE is retired 0.98 1.01* 0.94* 1.06 0.56 
Other CIE status 1.15 1.27* 1.54* 1.11 0.61 
Social Class (Ref. A-B)      
Social Class C 0.89* 1.17* 1.09 0.82 1.83 
Social Class D-F 0.72* 1.45* 0.93 0.86 1.64 
Education (Ref. Degree or higher)      
No more than primary school 0.34* 1.72* 0.85 0.74* 0.53* 
Lower secondary 0.47* 1.70* 0.93 0.89* 0.36* 
Upper secondary 0.80* 1.84* 0.88 1.02* 0.37* 
Post-secondary certificate 1.04* 1.45* 1.16 1.45* 1.31* 
HP Deprivation Index 1.00 1.00 1.00 1.02* 1.05* 
Constant 19.60 0.60 0.06 0.43 0.12 
Source: 2014-15 Drug Prevalence Survey; * indicates statistically significant (p <= 0.05) 
“Ref.” indicates the reference category for contrast-coded indicator variables 
 
  
 
 
40 
Table 4.1 contains the results of the multivariate analysis of a set of variables potentially associated 
with substance use. As already noted, heroin must be excluded from this analysis as the number of 
cases recorded is too small
48
. The association between each attribute and substance use is expressed 
in the form of ‘odds ratios’, and categorical variables are broken down into a number of binary 
contrasts, for which the reference category is indicated. An odds ratio of one indicates that there is no 
empirical association between the variable in question and substance use. An odds ratio below one 
implies that a person with the respective characteristic is less likely to use a substance, whilst an odds 
ratio above one tells us that they are more likely to use the substance. We will now summarise the 
results of the analysis for each broad category of substance use. 
 
 
Prevalence of Alcohol Use and Associated Risk and Protection Factors 
 
As far as alcohol use over the past year is concerned, there are nine explanatory variables with a 
statistically-significant effect. These are age (older people are less likely to drink alcohol), gender (men 
are considerably more likely), having a young child (less likely to drink), ethnicity (white settled people 
are much more likely), education (those with higher educational attainments are more likely to drink), 
housing tenure (owner occupiers are more likely), employment status (those who are in the labour 
force are more likely to drink than those who are retired, studying, on home duties etc.), socio-
economic group (higher status groups are more likely to drink) and former Health Board area (those 
living in the South-Western or Eastern areas are more likely to drink).  
 
This suggests that recent drinkers of alcohol are more likely to be younger, male, white, economically 
active, home owners and of higher social class, indicating a relatively ‘affluent’ profile. 
 
 
Prevalence of Tobacco Use and Associated Risk and Protection Factors 
 
As far as tobacco use over the past year is concerned, there are again nine explanatory variables with 
a statistically-significant effect. These are age (older people are less likely to smoke tobacco), gender 
(men are more likely), marital status (those who are single, separated, divorced or widowed are more 
likely), ethnicity (white people are much more likely), education (those with lower educational 
attainments are much more likely to smoke tobacco), housing tenure (those who are renting their 
homes are more likely), employment status (those who are in the labour force – and unemployed, in 
particular – are more likely to smoke), employment status of chief income earner (those who live in 
households headed by an unemployed person are more likely to smoke), socio-economic group 
(lower status groups are more likely to smoke) and former Health Board area (those living in the 
Eastern area are more likely to smoke). 
 
This suggests that recent tobacco smokers are more likely to be younger, male, white, unemployed, 
not married and of lower social class, indicating a relatively ‘disadvantaged’ profile. 
 
 
Prevalence of Other Legal Drug Use and Associated Risk and Protection Factors 
 
As far as other legal drug use over the past year is concerned, there are eight explanatory variables 
with a statistically-significant effect. These are age (older people are more likely to use these 
substances), gender (women are more likely), marital status (those who are separated, divorced or 
widowed are more likely), ethnicity (Travellers and Roma people are more likely), housing tenure 
(those who are renting their homes are more likely), employment status (those who are not at work 
or studying are more likely), employment status of chief income earner (those who live in households 
headed by an unemployed person are more likely to use these substances) and former Health Board 
                                                                
48  Note: This is why access to a geocoded version of the CTL is important, as this is the most reliable data source on opiate use 
and can clarify issues surrounding the social profile of heroin users. 
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area (those living in the North-Eastern and South-Eastern areas are more likely to use other legal 
substances). 
 
This suggests that those who uses tranquillisers, anti-depressants etc. are more likely to be older, 
female, economically inactive and of lower social class, which indicates a relatively ‘disadvantaged’ 
profile. However, by contrast with tobacco, the profile is distinctively older and more ‘female’. 
 
 
Prevalence of Cannabis Use and Associated Risk and Protection Factors 
 
As far as cannabis use over the past year is concerned, there are again nine explanatory variables with 
a statistically-significant effect. These are age (younger people are more likely), gender (men are 
much more likely), marital status (those who are single, separated, divorced or widowed are more 
likely than those who are married), having young children (much less likely), ethnicity (those who 
describe themselves as ‘White, settled’ are more likely), housing tenure (those who are renting their 
homes are more likely), employment status (those who are unemployed are more likely), education 
(those with higher levels of education are more likely to use cannabis) and former Health Board area 
(those living in the South-Western Dublin and North Dublin areas are more likely to use cannabis). 
 
This suggests that those who use cannabis are more likely to be younger, male, unemployed, single or 
separated without young children, to have a degree or post-secondary qualification and to live in 
North Dublin or South West Dublin. This indicates a mixed profile suggesting life-cycle effects, 
involving young people from relatively affluent backgrounds who are in transition from education to 
(possibly) stable employment. The particularly large coefficients for marital status, rented 
accommodation and unemployment suggest that people who are living on their own, and who are 
outside traditional family and work situations, are more likely to use cannabis. 
 
 
Prevalence of Heroin/Methadone Use 
 
It is not possible to determine the profile of heroin/methadone users, as just 0.3 per cent of the 
population used these substances over the past year. 
 
 
Prevalence of Other Illicit Drug Use and Associated Risk and Protection Factors 
 
As far as other illicit drug use over the past year is concerned, there are eight explanatory variables 
with a statistically-significant effect. These are age (younger people are more likely to use these 
substances), gender (men are much more likely), marital status (those who are single are more likely), 
having young children (much less likely), housing tenure (those who are renting their homes are more 
likely), employment status (those who are not at work are more likely), education (those with higher 
levels of education, such as a post-secondary qualification or degree are more likely to use other illicit 
substances) and deprivation score (those living in more affluent areas are more likely to use other 
illicit substances). 
 
This suggests that those who use substances like cocaine, LSD, ecstasy etc. are more likely to be 
younger, male, outside the workforce, single or separated without young children, to have a diploma 
or degree and to live in rented accommodation in more affluent neighbourhoods. This indicates a 
mixed profile suggesting life-cycle effects, involving young people from relatively affluent 
backgrounds who are in transition from education to employment. The particularly large coefficients 
for gender, housing and unemployment suggest that people who are living on their own, outside 
traditional family and work situations, are more likely to use not only cannabis (see above), but also 
other illicit drugs. 
 
Tables 4.2-4.4 below summarise the prevalence data analysed above, by category of substance and 
former Health Board area. Regional variations are due, at least in part, to compositional factors, 
involving the variables described above. 
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Table 4.2 Lifetime Use of Substances by former Health Board area  
Health Board Alcohol Tobacco 
Sedatives 
etc. 
Cannabis Heroin 
Other 
illicit 
Eastern 87.5 57.1 25.3 32.7 2.0 18.0 
Midland 78.7 50.6 19.7 21.2 0.8 15.7 
Mid-Western 84.0 49.3 19.7 18.7 0.1 10.4 
North-Eastern 84.0 51.1 25.0 25.9 1.6 16.2 
North-Western 71.4 46.2 16.4 13.0 0.2 11.2 
South-Eastern 82.2 51.5 23.4 19.8 1.0 9.2 
Southern 84.8 47.1 17.8 19.8 0.5 8.4 
Western 78.0 47.2 19.7 15.8 0.0 9.7 
North Dublin 82.9 51.9 21.7 31.4 1.4 15.2 
SW Dublin 85.9 54.1 20.4 32.2 0.9 18.8 
Source: 2014-15 Drug Prevalence Survey 
 
Table 4.3 Use of Substances Over Past Year by former Health Board area 
Health Board Alcohol Tobacco 
Sedatives 
etc. 
Cannabis Heroin 
Other 
illicit 
Eastern 80.2 30.1 12.4 6.7 0.9 3.5 
Midland 72.9 27.0 10.6 6.4 0.3 3.2 
Mid-Western 77.6 27.3 9.2 3.9 0.0 1.4 
North-Eastern 76.9 31.9 14.4 7.6 0.5 2.9 
North-Western 63.8 25.5 6.7 5.2 0.2 2.6 
South-Eastern 75.8 27.7 14.0 4.2 0.4 2.3 
Southern 77.1 25.6 9.1 5.3 0.3 1.7 
Western 73.5 26.3 9.1 6.8 0.0 3.9 
North Dublin 77.3 29.2 11.1 8.2 0.1 2.9 
SW Dublin 81.6 32.6 10.3 9.2 0.2 5.0 
Source: 2014-15 Drug Prevalence Survey 
 
Table 4.4 Use of Substances Over Past Month by former Health Board area 
Health Board Alcohol Tobacco 
Sedatives 
etc. 
Cannabis Heroin 
Other 
illicit 
Eastern 65.9 25.2 7.1 3.8 0.6 0.6 
Midland 55.9 24.4 8.4 3.9 0.0 1.9 
Mid-Western 59.4 23.1 5.8 1.6 0.0 0.6 
North-Eastern 63.5 29.3 10.0 4.9 0.5 1.3 
North-Western 52.8 23.7 5.4 2.6 0.0 0.6 
South-Eastern 59.0 25.1 10.2 1.4 0.2 0.9 
Southern 62.9 21.8 7.3 2.6 0.3 0.8 
Western 59.4 24.6 6.8 3.7 0.0 1.6 
North Dublin 65.8 24.6 9.3 4.3 0.0 0.8 
SW Dublin 66.8 28.4 7.1 6.6 0.2 2.9 
Source: 2014-15 Drug Prevalence Survey 
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4.2.2 Discussion 
 
It is somewhat surprising that the NACDA Drug Prevalence Data have never before been used for 
analysing the risk and protective factors that affect substance use. This is a prime example of how the 
commissioning of secondary analyses of a survey which has been conceived for one purpose can 
nevertheless be of huge benefit for other uses, yielding new knowledge and insights. A number of 
important observations flow from this analysis of substance use and the factors that influence it: 
 
 Risk factors vary greatly from one category of substance use to another 
 There appears to be widespread experimentation with cannabis and other illicit drugs, with 
lifetime use for cannabis at 33.5 per cent among young people and lifetime use of other illicit 
drugs at 21.1 per cent
49
 
 Young, relatively affluent and well-educated social groups have a higher prevalence of last-
year use of cannabis and other illicit drugs 
 Smoking and using sedatives, anti-depressants etc. are associated with deprivation 
 Drinking alcohol over the past year has a relatively ‘affluent’ profile 
 Gender, marital status and housing tenure are very significant predictors 
 There are significant differences between Health Board areas in terms of prevalence, 
although this variation is partly due to the demographic and social composition of each 
region 
 
This suggests, firstly, that it is important to be careful when aggregating across different kinds of 
substances due to their different prevalence rates and risk profiles. The common practice of 
categorising substances into ‘legal’ and ‘illegal’ is likely to lead to confusing results, for example. By 
contrast, we would suggest that substances should be grouped on the basis of empirical patterns of 
use, rather than the chemical properties or legal status of the substances. This approach would also 
facilitate the mapping of risk factors, which is one of the core requirements for developing a 
Performance Measurement Framework. 
 
Secondly, it suggests that prevalence data – even when combined with information on frequency of 
use – do not generally allow us to identify ‘problem substance use’ (see Section 3.1 for a detailed 
discussion of the issues involved here). 
 
Thirdly, this analysis shows that problem substance use (e.g. use of heroin, problems deriving from 
alcohol use or cannabis) is a relatively ‘rare’ phenomenon in the population. This means that sample 
surveys do not yield a large enough group of problem substance users to allow us to derive reliable 
estimates for smaller areas. We do not have enough observations to obtain reliable sub-regional 
estimates of problem substance use, and certainly too few to make estimates for individual DATF 
areas. 
 
Fourthly, this situation is compounded by the fact that lifetime and recent use of many substances is 
associated with indicators of affluence and indicators of specific phases in the life cycle. This is 
consistent with evidence of widespread ‘experimentation’ by relatively well-educated and resource-
endowed young people. This poses numerous risks for society and for individual health, but is not 
unequivocally associated with ‘problem substance use’ as defined in Section 3.1. It is so widespread 
within society and within specific groups that it would be difficult to include this within the 
Performance Measurement Framework without undermining its ability to target more determinate 
forms of problem substance use involving addiction, repeated use, exposure to systematic health 
risks, involvement in criminal behaviour and powerful effects on other social roles. 
 
 
                                                                
49  See Haase, T. and Pratschke, J. forthcoming. Analysis of the 2014/15 Drug Prevalence Survey. Dublin. 
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4.3 Analysis of NDTRS Data on Treatment 
 
The Local DATFs originated as a response to the acute drug crises that emerged in specific urban areas 
in the early 1980s. 30 years on, problem drug use is no longer confined to a small number of areas, 
but affects almost every area in the country. Problem drug use, whilst being geographically dispersed, 
clearly does not affect all areas in the same way. There remains a strong urban-rural gradient and a 
significant association with deprivation (what is sometimes referred to as a ‘social gradient’). The 
measurement of these gradients is crucial for the development and implementation of the National 
Drugs Strategy. This is also critical for the definition of DATF intervention areas, the preparation of 
appropriate responses, the construction of resource allocation models and, above all, for the 
Performance Measurement Framework at the centre of this report. 
 
The purpose of this section is to analyse the NDTRS data and to assess whether it can be used to 
measure problem drug and alcohol use at aggregate level. We will show that by linking treatment 
data with census data via area of residence, we can estimate the demand for treatment in all areas of 
the country, even those where the NDTRS do not have precise geographical identifiers. 
 
 
The 2014 NDTRS Data 
 
The 2014 NDTRS data were supplied by the HRB, including 13,545 individual-level records regarding 
problem alcohol use and 22,799 records regarding problem drug use. The data relate to treatment 
episodes, which means that individuals may be represented more than once in the file if they received 
treatments from different providers during 2014. However, where more than one treatment episode 
was provided by the same service provider within the same calendar year, this is counted only once. 
This potential double-counting has little (if any) effect on the measurement of demand for treatment 
at local level, as this is assessed on a purely relative basis. Table 4.5 shows the composition of the 
2014 NDTRS data in terms of new/ongoing clients, reason for referral and acceptance. 
 
Table 4.5 2014 NDTRS Data 
  
Main reason for referral 
Accepted 
into 
Treatment 
Continued v.  
New Treatment 
Alcohol 
Illicit 
Drugs 
Licit 
Drugs 
Other 
Problem 
Total 
Yes 
Continued Treatment 4,530 10,024 1,046 82 15,682 
New Treatment 2014 7,790 8,336 1,667 203 17,996 
Sub-total 12,320 18,360 2,713 285 33,678 
No 
Continued Treatment 8 73 4 1 86 
New Treatment 2014 1,217 1,324 325 1,370 4,236 
Sub-total 1,225 1,397 329 1,371 4,322 
Total 
Continued Treatment 4,538 10,097 1,050 83 15,768 
New Treatment 2014 9,007 9,660 1,992 1,573 22,232 
Total 13,545 19,757 3,042 1,656 38,000 
Source: 2014 NDTRS  
 
 
4.3.1 Estimation of Problem Substance Use 
 
One of the key findings of the analysis of the drug prevalence data presented in Section 4.2 was that 
the socio-economic profile underlying alcohol use is distinctly different from that of other substance 
use, and we therefore decided to undertake two separate regression analyses using the NDTRS data. 
This is also appropriate given the relatively recent integration of alcohol misuse within the 
responsibility of the DATFs and the resulting need to use distinct and varying weights for these two 
categories of substance use in different contexts. 
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When drawing on the NDTRS to estimate the extent of problem substance use, we use the data in a 
rather different way to that found in the EMCDDA reports
50
. The EMCDDA reports relate to those who 
have been accepted for treatment during a given year (shown in blue in Table 4.5). As we aim to 
estimate overall problem drug and alcohol use, we also include those who have not been accepted 
and those who are receiving ongoing treatment (this overall figure is highlighted in pink in the table). 
 
Key to identifying area-level predictors of problem substance use is identification of the residential 
area of each user. The NDTRS contains incomplete information in this regard, as it provides the 
Electoral Division (ED) code only for individuals living in six Local Authority areas across Counties 
Dublin, Kildare and Wicklow. This partial coverage will dramatically improve in the near future, as the 
HRB changed its data collection protocol during 2016. This change is of utmost importance for the 
implementation of the Performance Measurement system, as it will ensure that, as of mid-2016 
onwards, residential locations can be identified by Small Area (SA) throughout Ireland.  
 
This partial coverage of geocoded data in the 2014 NDTRS dataset has ramifications for the 
calculations outlined in this section and for the Resource Allocation Model described in Section 5. In 
their current form, the estimates should thus be considered “proof of concept” calculations, as they 
are based on fairly rudimentary (but effective) estimation techniques. The data will gain in accuracy as 
the Performance Measurement Framework is implemented from 2017 and will be based on more 
precise count data. The estimation is described in detail in the Appendix. If we use treatment demand 
as an indicator of problem substance use, in line with the definition and considerations set out 
above
51
, these estimates allow us, for the first time, to derive ED-level estimates for the whole 
country. By showing where problem substance use is concentrated, it provides a new tool for DATFs 
to improve their targeting and enables the NDS as a whole to develop a rational resource allocation 
model that distributes resources on an objective, transparent and needs-related basis. 
 
A number of consequences follow from this analysis, which have the potential to enhance the 
effectiveness of the DATFs. Firstly, the analysis confirms the utility of our earlier definition of problem 
substance use (see Section 3.1) and supports the hypothesis that the key drivers of the spatial 
distribution of problem drug use are social deprivation and the urban-rural spectrum. A report 
commissioned by the Combat Poverty Agency and published in 1998 showed that most people 
receiving drug treatment were unemployed, had low educational attainment and came from deprived 
areas in Dublin.
52
 
 
The mere fact that by using just two variables we are able to accurately predict the spatial distribution 
of treatment (see the Appendix B for details) points to the socially-structured nature of the 
phenomenon of problem drug use. This distribution is shown in Figure 4.3 for Ireland and Figure 4.4 
for Dublin, Limerick and Cork. These unprecedented maps are of considerable relevance to the DATFs, 
and could help them to target their work and interventions more precisely and to gain a greater 
understanding of the local context. 
                                                                
50  The EMCDDA reports exclude cases treated for alcohol as the main cause and episodes of care where a person has returned 
to treatment for a second or subsequent time (in the same centre) in the same year. Data from prisons are included. 
Therefore the number of cases reported by the EMCDDA is usually slightly lower than the national estimate, which currently 
excludes data from prisons but includes episodes of care where a person has returned to treatment for a second or 
subsequent time (in the same centre) in the same year.  The NDTRS includes separate data on alcohol misuse (see 
http://www.drugsandalcohol.ie/tables) 
51  As noted above, problem substance use can be conceptualised as a latent concept, i.e. one that cannot be measured 
directly and must be assessed using multiple indicators. This enables us to overcome shortcomings with individual 
indicators, such as the availability of treatment, willingness to seek treatment and so on. A crucial aspect of the dynamic 
development of the Performance Measurement Framework will be the enhancement of this outcome measure by drawing 
on additional data sources (see Section 5.3). 
52  O’Higgins, K. 1998. Review of Literature and Policy on the links between Poverty and Drug Abuse. Dublin: Combat Poverty 
Agency/ESRI. 
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Figure 4.3 Estimated Prevalence of Problem Drug Use in Ireland 
 
 
 
Estimate of PDU per Population
DATF NDTRS 2014
> 2 %   (139)
1  to 2 %   (194)
0.5 to 1 %   (498)
0.2 to 0.5 %   (1321)
< 0.2 %   (1257)
The black diamonds show the 193 Census Towns 
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Figure 4.3 illustrates the concentration of problem drug use in the proximity of major cities and 
towns. Figure 4.4 shows areas of high and very high problem drug use, which generally coincide with 
well-known deprived urban areas. In Limerick, these include Moyross and Southill, in Cork the areas of 
Knocknaheeny, Gurranebraher, Togher and Mahon, and in Dublin, Coolock-Darndale, Ballymun, 
Finglas, Cabra, parts of Blanchardstown, North and South Inner City, Kilmainham, Cherry Orchard, 
Crumlin, Tallaght, and pockets in DunLaoghaire-Rathdown (following the compass points in an anti-
clockwise direction). 
 
 
Figure 4.4 Estimated Prevalence of Problem Drug Use in Limerick, Cork and Dublin 
 Limerick      Dublin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cork   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.6 shows the estimates that we obtain after aggregating to DATF area. The first data column 
shows our estimate of the number of people requesting treatment (the details of this calculation will 
be provided in Section 5). The second data column shows the number of treatment episodes recorded 
in the NDTRS (including both actual as well as requested treatment). The third column shows the 
adult population in each area and the fourth column indicates the prevalence of problem drug use 
(people requesting treatment as a percentage of the adult population). The table is sorted from the 
highest levels to the lowest and allows us to make a number of additional observations: 
 
 The broad distinction between Local and Regional DATFs finds support in the prevalence of 
estimated problem drug use. Local DATFs have levels above 1 per cent, whilst regional DATFs 
have concentrations below 1 per cent. 
 The only exception to this pattern is Dún Laoghaire-Rathdown, which is more similar in its values 
to the Regional DATFs. 
 As the maps indicate, this does not mean that Regional DATFs do not include, within them, major 
concentrations of problem drug users who are typically clustered in deprived urban areas. This 
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means that the RDATFs must adopt effective methods for targeting interventions within their 
catchment area. 
 In the case of the Southern Region, Cork City is designated as a separate Local DATF. By contrast, 
Limerick and Waterford Cities are treated as forming part of their respective Regional DATFs. 
 Questions might be raised about the comparatively small number of problem drug users found in 
some DATFs and whether there is a strong enough rationale for their continued existence. This 
issue is addressed in Section 5.6. 
 
Table 4.6 Estimation of the Extent and Treatment of Problem Drug Use by DATF Area 
DATF Name 
Estimated 
PDU 
Observed 
Treatments 
Adult 
Population 
Prevalence 
of PDU 
LDTF: Ballymun 470 469 12,399 3.78 
LDTF: Canal Communities 363 362 12,333 2.94 
LDTF: North Inner City 1606 1604 60,222 2.66 
LDTF: Ballyfermot 458 457 17,677 2.59 
LDTF: Dublin South Inner City 1557 1554 60,513 2.57 
LDTF: Finglas-Cabra 769 768 43,142 1.78 
LDTF: Tallaght 896 899 65,936 1.36 
LDTF: Dublin North East 1,061 1,056 80,022 1.32 
LDTF: Cork LDTF 1,337 1,339 101,733 1.32 
LDTF: Blanchardstown 698 650 50,052 1.30 
LDTF: Dublin 12 560 560 45,666 1.23 
LDTF: Clondalkin 731 734 60,720 1.21 
LDTF: Bray 130 254 24,659 1.03 
RDTF: South East 2,155 2,524 387,700 0.65 
RDTF: Midland 876 1,244 216,057 0.58 
RDTF: Mid-West 1,653 1,409 298,681 0.47 
RDTF: East Coast 289 473 101,889 0.46 
LDTF: Dun Laoghaire-Rathdown 994 763 168,726 0.45 
RDTF: South West 1,005 1,072 269,045 0.40 
RDTF: North Eastern 1,125 1,190 333,776 0.36 
RDTF: North Dublin City and County 794 766 219,028 0.35 
RDTF: Southern 1,134 1,245 423,946 0.29 
RDTF: Western 1,022 805 352,277 0.23 
RDTF: North West 703 411 202,463 0.20 
Total 22,386 22,608 3,608,662 0.63 
Source: Estimates based on analysis of 2014 NDTRS data 
 
 
Summary 
 
The analysis presented above confirms the existence of a strong ‘social gradient’ in relation to 
problem drug use and indicates that this is particularly concentrated in (deprived) urban 
neighbourhoods. The rationale for maintaining a dual approach, involving Local and Regional DATFs, 
receives support. Nevertheless, it may be helpful to develop a clearer understanding of how the local 
and regional approaches differ and where they should be implemented. As noted earlier, there are 
Local DATFs which may have to adopt a more ‘extensive’ approach to tackling problem drug use, 
whilst there are Regional DATFs which may have to adopt a more ‘intensive’ approach in their urban 
centres. These aspects of the NDS should be developed on an objective evidence base. 
 
Of greatest importance, for the purpose of developing a Performance Measurement Framework, is 
the fact that the NDTRS data provide impressive initial estimates of the spatial distribution of problem 
drug use. As we are primarily interested in the relativities between areas, it is of little concern to us 
whether treatment demand underestimates the true extent of problem drug use. What is important is 
that these two variables are correlated. Moreover, these estimates will significantly improve as the 
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new HRB data collection protocol for the NDTRS takes effect, providing SA-level data on the 
residential location of problem substance users across the country. This will mean that the separate 
estimation described in the Appendix will now longer be required. As we indicated when discussing 
the Performance Measurement Model in Section 3, these data can – and should – be complemented 
by insights from other data sources, and we will return to this issue below. 
 
 
4.3.2 Estimation of Problem Alcohol Use 
 
As already indicated, the drug prevalence data presented in Section 4.2 suggests that the socio-
economic profile underlying alcohol use is distinctly different from that of other substances, and it is 
possible that the covariates of alcohol misuse also differ from those associated with drug misuse. To 
test this hypothesis empirically, we estimated the extent of problem alcohol use using the same 
procedure described above for problem drug use. 
 
All of the predictors of problem drug use are also statistically significant predictors of problem alcohol 
use. Population size, the urban-rural spectrum and the percentage of households in local authority 
rented accommodation yield coefficients that are statistically significant at the 0.01 level. The HP 
Deprivation Index is significant at the 0.05 level. As expected, when comparing the coefficients for 
predicting problem alcohol use with those for problem drug use, the coefficients for problem alcohol 
use are smaller, indicating shallower social and spatial gradients. Problem alcohol use is concentrated 
in urban and deprived neighbourhoods, but not to the same extent as problem drug use. 
 
This is a very important finding and is entirely in line with the findings of the 2015 Irish Health Survey 
(IHS), which were recently published by the CSO
53
. Using quintiles of the HP Deprivation Index, the IHS 
data show that regular consumption of alcohol increases with affluence, but regular binge drinking is 
more prevalent in disadvantaged areas (see Figure 4.6 below). 
 
Figure 4.5 Alcohol Consumption, 2015 Irish Health Survey 
 
                                                                
53  See http://www.cso.ie/en/releasesandpublications/ep/p-ihs/irishhealthsurvey2015/ 
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5 A Resource Allocation Model for DATFs 
 
5.1  Building on Good Practice 
 
In this chapter we will develop a Resource Allocation Model (RAM) for DATFs, which is an important 
part of the proposed Performance Measurement Framework. As performance is always expressed 
relative to resources and context, there are compelling arguments for targeting resources at 
underlying need. This means that funding, and other forms of resource provision (personnel, 
premises, etc.), should take account of the distribution of problem substance use at a geographical 
level. A further implication is that interventions should be defined in relation to the specific local 
context in which DATFs are operating and that performance should be assessed in relation to these 
aspects of their situation. These are logical implications, rather than being based on theoretical or 
empirical reasoning: public programmes can only be effective in reducing problem substance use if 
resources are distributed appropriately and if interventions are targeted in accordance with the 
distribution of problem substance use. 
 
We are in the fortunate position of being able to build on our prior experience in developing resource 
allocation models for major government initiatives in the social inclusion arena. In recent years, the 
HSE Health Intelligence Unit and Trutz Haase jointly developed the HSE Resource Analyser. This 
provides a tool for the spatial analysis of existing resource allocations throughout the HSE, as well as 
providing a means for deriving target allocations from rational objectives and criteria. Whilst the 
Resource Analyser does not make decisions – these are made by the relevant policy-makers and 
personnel – it does provide a tool that can greatly facilitate the decision-making process in a rational, 
objective and transparent manner. 
 
The development of the HSE Resource Analyser was preceded by more than a decade of experience 
and experimentation with the development of Resource Allocation Models for the local development 
partnerships under the auspices of POBAL. In 2013, a similar RAM was adopted by the City of Dublin 
Youth Services Board (CDYSB) and, in 2014, a formal RAM was developed for expenditure under the 
LEADER programme. More recently, TUSLA decided to reorganise the delivery of all services using the 
Resource Analyser and the Department of Education and Skills is currently reconfiguring the 
designation and funding of DEIS schools along the same lines. 
 
 
5.2 Conceptual Design 
 
Whilst there are minor variations in each of the aforementioned RAMs, there are several common 
elements which we will now describe. Firstly, these RAMs were specifically designed for expenditure 
programmes where the key outcome(s) – be it in health, education or other arenas – have a ‘social 
gradient’. The existence of a social gradient in health implies that poorer people tend to have poorer 
health, all else being equal, and thus have a greater need for health services. A similar set of 
implications follow from the existence of social gradients in other domains. 
 
Secondly, social inclusion programmes are typically developed in response to crises which become 
visible at a particular point in time and in particular geographical areas, with expenditures being 
driven initially by perceptions regarding the extent and distribution of the problem. It is only with time 
that the need for more formal and more transparent resource allocation methods is appreciated. 
 
Thirdly, the core rationale for the RAMs developed by the authors in the past is that modern 
computing methods, data and information technology make it possible to model the underlying 
relationships that drive social and spatial gradients in each of these sectors. In particular, access to 
geocoded census and administrative data greatly facilitate this task. By bringing together reliable 
outcome measures, spatial definitions and aggregate-level indicators (including composite measures 
of deprivation, for example), it is possible to define a model for equitable resource distribution. This is 
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often a very effective way for public organisations and agencies to meet their strategic goals, as 
resources that are targeted at areas of need are more likely to yield overall improvements. 
 
Fourthly, an important step towards achieving this goal is to identify a core outcome measure which 
can provide a focus for the overall model. By analysing the relationship between this outcome and a 
deprivation measure, a set of weights can be obtained which effectively captures the social gradient. 
The final element of the system is a set of carefully measured control variables which is necessary in 
order to isolate the specific influence of deprivation and to identify other important factors. 
 
Fifthly, these coefficients are used to design a formal RAM which allocates resources in accordance 
with the objectives of the programme and in line with the social gradients that have been identified. 
Outcomes which are characterised by a sharper social gradient warrant a higher level of targeting of 
resources, whilst those which have a more uniform distribution in the population demand a lower 
level. 
 
A sixth component which is common to all of these RAMs is the method by which the social gradient 
is determined. In most cases, we have access to detailed client data regarding the outcome measure 
(health, educational outcomes etc.), but do not have reliable information on the beneficiary’s socio-
economic position. This is obviously a prerequisite for measuring the social gradient, but these data 
are not routinely included in administrative databases, for quite obvious reasons. To overcome this 
problem, it is possible to geocode the residential area of each client and to use the Pobal HP 
Deprivation Index as a proxy for socio-economic position. When aggregated to functional areas (such 
as catchment areas, Health Board areas, DATF areas etc.), this yields a reliable indicator of socio-
economic composition. 
 
The overall purpose of the RAM is to shift the focus away from a discussion of ‘historical’ funding 
levels and towards the key objectives of each programme. These objectives can be given a weight 
within the RAM, allowing for an optimal distribution of resources. The actual allocations are thus 
computed using an evidence-based algorithm that accounts for the social and spatial gradients 
previously identified and weighted in accordance with the priorities associated with the objectives of 
each aspect of the programme. 
 
 
5.3 First Round Allocations 
 
Data Sources 
 
The aim of this report is to develop a Performance Measurement Framework which specifies the 
structure and components of a system that can be agreed upon and implemented now, as well as 
being improved upon and extended in the future. This provides a dynamic element to the evolution of 
the Performance Measurement Framework. With a view to facilitating this process, we have ensured 
that the foundations of the framework are solid and its structure flexible enough to accommodate 
future improvements. This means that we have included some components which cannot be fully 
exploited at the current point in time. 
 
As we indicated in our evaluation of existing data sources (Chapter 4), none of these datasets was 
originally designed with a Performance Measurement Framework in mind. This means that it is often 
necessary to carry out further work to bring the data into line with the requirements of the 
framework and thus realise their potential. Our emphasis here is on the importance of finding ways of 
amending these protocols (e.g. for administrative or registry data), rather than collecting new data. 
These existing sources are the most useful for performance assessment, as they provide comparable 
data on an ongoing basis at a minimal cost. As noted earlier, one key change that we would welcome 
– in this as in other areas of policy delivery – is the routine geocoding of residential addresses. This 
procedure is cheap and easy to apply, and should arguably be carried out with every survey and 
(particularly) with every periodic set of administrative data. As far as surveys are concerned, it is also 
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possible to identify straightforward improvements in sampling designs that can improve their 
efficiency. 
 
As we showed in Section 4.1, the Drug Prevalence Survey proved to be of little use from the 
perspective of the Performance Measurement Framework. This is largely because it is a survey, and 
straightforward representative surveys do not have a large enough sample size to reliably identify 
people with substance use problems. Problem drug use is a relatively rare phenomenon within the 
population and its accurate measurement at sub-national level requires the application of dedicated 
methodological techniques. 
 
In Section 4.2, we observed that if we focus on the use of drugs or alcohol over the lifetime, in the last 
year or even in the last month, what emerges is primarily a pattern of experimentation with 
substances. This phenomenon is widespread amongst young people and is correlated more strongly 
with affluence than with deprivation. This means that not only does problem drug use disappear from 
view (due to sample size constraints), but the picture that emerges in its place is centred on 
experimentation with substances. 
 
By contrast, the NDTRS data (Section 4.3) proved to be of great utility when seeking to identify social 
and spatial gradients for problem drug use. We believe that this data source can provide a firm basis 
for a first-round calculation of the DATF-RAM. As we mentioned earlier, attempts have been made to 
achieve geocoded data from the CTL and other data sources. If this happens in the future, the CTL, 
Capture-Recapture Study and the NDRDI may all have a contribution to make to the Performance 
Measurement Framework, together with substance-related morbidity and crime data. 
 
 
Design and Calculations 
 
We begin by distinguishing between three levels of problem drug use: where the number of problem 
drug users is below 1 per cent of the adult population, where it is above 1 per cent and where it 
exceeds 2 per cent. The rationale is that the latter two categories identify areas of high prevalence 
where we might expect problem drug use to have a more significant impact on the community and 
where preventive and harm-reduction interventions are likely to be of particular importance. Thus, 
each category gives rise to a specific set of differentials between DATF areas and can be used to 
calibrate funding. 
 
Predicted problem alcohol and drug use is based on the analysis of NDTRS data described earlier and 
uses the formulae shown in Tables 5.1 and 5.2. The formulas build directly on the coefficients 
identified in the two regression analyses reported in Section 4.3
54
. A separate calculation is 
undertaken for each stratum, and the declining prevalence rates as we move from Dublin Inner City to 
rural areas is reflected in the shrinking of the constant
55
. The population size, HP Deprivation Index 
and Local Authority Housing have identical weightings in each stratum but the influence of 
deprivation, in particular, is smaller in the formula for problem alcohol use compared to problem drug 
use, as explained in Section 4.3. 
 
                                                                
54  The terms are expressed using the original logit coefficients, which must be applied and then exponentiated. 
55  Dublin City is the reference category and has a constant of 2.4 for problem alcohol use and 3.65 for problem drug use. As 
we move from urban to rural, a growing share is deducted from this constant in line with the waning prevalence. 
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Table 5.1 Estimation of Problem Alcohol Use 
Stratum 
Estimation 
Rural Areas EXP(2.4 - 2.0 + ADTPOP11*.000113 - HP2011rel*.01 + LARENT11*.015) 
Small Towns EXP(2.4 - 1.0 + ADTPOP11*.000113 - HP2011rel*.01 + LARENT11*.015) 
Towns 5,000+ EXP(2.4 - 0.5 + ADTPOP11*.000113 - HP2011rel*.01 + LARENT11*.015) 
Other Cities EXP(2.4 - 0.5 + ADTPOP11*.000113 - HP2011rel*.01 + LARENT11*.015) 
Dublin and Environs EXP(2.4 - 0.9 + ADTPOP11*.000113 - HP2011rel*.01 + LARENT11*.015) 
Dublin Inner City EXP(2.4         + ADTPOP11*.000113 - HP2011rel*.01 + LARENT11*.015) 
Source: Parameters based on analysis of 2014 NDTRS data (see Section 4.2) 
 
 
Table 5.2 Estimation of Problem Drug Use 
Stratum 
Estimation 
Rural Areas EXP(3.65 - 4.3  + ADTPOP11*.000135 - HP2011rel*.052 + LARENT11*.020) 
Small Towns EXP(3.65 - 2.5  + ADTPOP11*.000135 - HP2011rel*.052 + LARENT11*.020) 
Towns 5,000+ EXP(3.65 - 1.8  + ADTPOP11*.000135 - HP2011rel*.052 + LARENT11*.020) 
Other Cities EXP(3.65 - 1.7  + ADTPOP11*.000135 - HP2011rel*.052 + LARENT11*.020) 
Dublin and Environs EXP(3.65 - 1.2  + ADTPOP11*.000135 - HP2011rel*.052 + LARENT11*.020) 
Dublin Inner City EXP(3.65          + ADTPOP11*.000135 - HP2011rel*.052 + LARENT11*.020) 
Source: Parameters based on analysis of 2014 NDTRS data (see Section 4.2) 
 
 
An important aspect of the RAM that should be noted is that it does not imply any particular 
distribution of overall resources between these four categories of problem substance use; i.e. 
problem alcohol use, problem drug use and high and very high prevalence of problem drug use. The 
weighting of these programme aims should be determined in line with the NDS, involving the 
Department of Health and other key stakeholders in a broad discussion of objectives. In essence, the 
degree to which resources are targeted at areas where problem drug use is more prevalent will 
depend on the weights associated with the last two categories. The RAM is thus a tool for supporting 
and orienting decision-making. 
 
The RAM is based on the predictions from the regression model rather than the recorded number of 
treatments. The Poisson regression models generate these predictions on the basis of the 
composition and characteristics of each ED, and the ED-level counts are then aggregated to DATF 
level. If we were to base the DATF-RAM directly on the number of treatments, this would tend to 
reinforce prevailing patterns of service provision rather than reflecting underlying need. The use of a 
model to generate predictions has the effect of averaging across areas with different degrees of 
service access and different experiences of preventive interventions. In this way, the DATF is not 
unduly influenced by specific local services and the historical legacy of past interventions. 
 
This distinction is also important from the perspective of change over time. For example, if a DATF is 
particularly successful in reducing problem drug or alcohol use through preventive actions, this would 
lead to a reduction over time in demand for treatment. If we were to use recorded treatments as a 
measure of problem substance use, this kind of decline in demand would lead to a reduction over 
time in the resources allocated to ‘successful’ DATFs. During the stakeholder consultations that were 
held during this project, it was suggested that this kind of negative feedback mechanism should be 
avoided. We are therefore in no doubt that resource allocation should be based on the risk of 
problem substance use rather than actual substance use or responses to substance use. 
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Figure 5.1 Prospective Resource Allocations for DATFs 
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Figure 5.1 is a snapshot from the cover worksheet of the DATF-RAM
56
. On the bottom, we have 
abbreviations for the 24 DATFs, divided into Local and Regional Task Forces. These two groups are 
further subdivided by grouping together the LDATFs which are located North and South of the Liffey 
and the RDATFs of the North-Eastern and Dublin-Midlands regions, on the one hand, and the Western 
and Southern regions, on the other. 
 
Each component shown in the RAM is expressed as a percentage and can be measured on the same 
percentage point scale. The green diamonds show the share of the total adult population in a DATF. 
As might be expected, the LDATFs have significantly smaller population shares than their regional 
counterparts. The core of the RAM are the stacked bars, which indicate the funding share that each 
DATF would receive under the proposed system. 
 
Each stack bar is made up of four components: their share based on the extent of problem alcohol use 
(light blue), problem drug use (light pink), high-prevalence problem drug use (medium pink), and very 
high-prevalence problem drug use (dark pink). As can be seen, problem alcohol use constitutes a 
comparatively larger part of the funding to RDAFTs, as it is more closely related to the size of the adult 
population. The proportions allocated for high and very high prevalence problem drug use, by 
contrast, are concentrated in the deprived urban areas. The yellow dots indicate the share of funding 
received by DATFs in 2015. 
 
As pointed out before, the RAM does not prescribe any specific set of funding shares, but facilitates 
the systematic application of rules or principles, in line with the objectives of the NDS. The share 
allocated to each component of funding can be altered and should be based on discussions among 
stakeholders. The digital form of the DATF-RAM facilitates simulations and projections, allowing 
different hypotheses to be tested. 
 
Attention is drawn to the fact that there are three DATF areas where the actual number of treatments 
differs significantly from the model-based prediction. These are shown in Table 4.7, and involve (i) 
Bray LDATF, where the actual number of treatments is about twice the predicted level; (ii) the East 
Coast RDATF, where this is about 1.6 times higher; and (iii) the North-West RDATF, where the number 
of treatments is significantly lower. As can be seen from Figure 5.1, in the cases of Bray and the East-
Coast DATFs, this could be a result of the high level of funding currently provided to these areas 
relative to their population, their urban-rural mix or socio-economic composition. 
 
 
                                                                
56  DATF-RAM v54 (25/01/2016) 
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5.4 Some Comments on the Existing Distribution of Resources 
 
The combined funding by the Department of Health and HSE to the DATFs during 2015 is shown by 
the yellow points in Figure 5.1 and a number of observations can be made with regard to the current 
distribution of resources. We will discuss these in the following three sections, starting with the 
distribution between Local and Regional Drug and Alcohol Task Forces. 
 
 
Imbalances between Local and Regional Drug Task Forces 
 
At the outset of this study, it was evident that the Local and Regional DATFs tend to have rather 
different perspectives on the criteria to be used for the distribution of resources. The Regional DATFs 
generally feel that problem drug use has spread beyond the capital city to reach smaller towns and 
rural areas, justifying a more uniform distribution of resources. The Local DATFs, however, fear that 
this could lead to a penalisation of deprived urban areas where problem drug use reaches much 
higher levels and where there is a stronger rationale for engaging in community, family and school-
based preventive and harm-reduction actions. 
 
Our analysis of the NDTRS presented in Section 4.2 gives support to both views: problem drug use has 
indeed become a spatially diffuse phenomenon, although high incidences are almost exclusively 
observed in highly deprived urban areas. A key element of the analysis presented in this report is that 
we should not be overly concerned with the distinction between Local and Regional DATFs, but rather 
should seek to systematically measure and quantify these social spatial gradients at a fine spatial scale 
(currently EDs and SAs in the future). In this way, we can account for the underlying composition and 
associated risk of problem substance use for each DATF, be it Local or Regional. 
 
As we noted earlier, some Local DATFs need to adopt a model of relatively ‘extensive’ interventions, 
whilst some Regional DATFs need to adopt a model of ‘intensive’ intervention in specific areas. To the 
extent that the NDS identifies prevention and harm reduction as priorities in areas of high incidence 
of problem drug use, a proportionately higher share of funding for more deprived urban DATFs is 
arguably justified. At the same time, Regional DATFs which include deprived urban areas (i.e. Cork, 
Limerick and Waterford) will also receive a higher relative share of funding for the same reasons, 
because they would be expected to intervene in these deprived areas using a more ‘intensive’ 
approach. 
 
 
Imbalances within the Dublin Region 
 
When looking at the pattern of aggregate funding across Dublin, an interesting picture emerges. If we 
use a RAM based on a weighting of 10 per cent (problem alcohol use), 60 per cent (problem drug use), 
15 per cent (high-prevalence PDU) and 15 per cent (very high-prevalence PDU), the share allocated to 
Northside LDATFs is equal to 23.9 per cent, compared to a 2015 funding share of 22.7 per cent. In 
other words, the RAM suggests an optimal share that is roughly in line with the current distribution. If 
we compare the equivalent figures for Southside LDATFs, their collective prospective funding share 
(26.9 per cent) is well below their current share of funding (41.3 per cent). This suggests that the 
latter group of LDATFs receive a disproportionate share of total funding. 
 
This way of aggregating the data overcomes the objection that certain DATFs deserve a larger share of 
funding because they play a role in providing services to problem substance users from outside their 
designated areas. Once we have aggregated the DATFs to form two blocks (Northside and Southside), 
this argument loses much of its force, as it is rarely claimed that clients migrate systematically from 
North to South to receive treatment, nor should this be necessary. 
 
The point that we are making here is not that certain Dublin LDATFs receive a disproportionate share 
of funding, although this is arguably the case. A broader and more important issue must be tackled 
regarding the distribution of funds at the macro level. Unless a much stronger justification is advanced 
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for the systematic over-funding of LDATFs in Southside Dublin, it is difficult to avoid the conclusion 
that a redistribution of resources is required. 
 
 
Imbalances between Regions 
 
A similar observation can be made with regard to the RDATFs. If we group the North-Eastern and 
Midlands RDATFs, and compare these with the Western and Southern ones (including Cork LDATF in 
the latter), the RAM suggests a share of 14.3 per cent might be provided to the former, compared to a 
current funding share of 12.3 per cent. These two figures are well-aligned, but the same is not true for 
the Western and Southern RDATFs, which would receive a share of 35.0 per cent under the RAM, 
compared to a current funding share of just 23.7 per cent. 
 
It would therefore appear that the Regional DATFs have not been given the resources needed to 
provide the kinds of community, family and school-based programmes to residents in the deprived 
urban areas of Cork, Limerick and Waterford that their Dublin counterparts are accustomed to 
receiving. In overall terms, therefore, the new NDS will need to address a fundamental issue: what 
level of services and interventions should be provided in different kinds of areas, given our current 
knowledge of the prevalence of problem substance use? Once this has been decided, it is relatively 
straightforward to determine its consequences for the distribution of resources using the resource 
allocation model presented here. 
 
 
Transitional Arrangements 
 
These observations raise another question, namely how to manage the introduction of a new system 
of funding allocation which implies a significant redistribution of resources compared to current 
practice. If the RAM were to be introduced in its present form, the funding share of some DATFs 
would be significantly reduced, whilst others would receive a significantly larger share. This possibility 
is always present when a rational framework for resource allocation is introduced, as the status quo is 
rarely in line with the distribution of social need. ‘Historical’ allocations are rarely based on an 
assessment of underlying risk, but are the product of changing perceptions of how problems have 
emerged and evolved. 
 
We do not suggest that the RAM depicted in Figure 5.1 be immediately implemented. This would 
create a risk of paralysis, with some DATFs unable to maintain their current activities and others 
unable to spend their newly-acquired funding. However, we do think that it is important to start 
thinking about how the resources of all of the public programmes which fund interventions and 
services to tackle problem substance use in DATF areas are allocated. This debate should be as open 
and transparent as possible, and the DATFs and other relevant actors should be empowered to reflect 
collectively on the criteria to be used in the RAM. However, once a specific set of criteria has been 
adopted, and the reasons for this decision are clear to all, the consequences of this decision should 
also be shared and respected by all actors. 
 
If a formal RAM is introduced, a gradual transition from current funding shares to the new shares is 
inevitable, not least because of current contractual obligations. It is obviously important to ensure 
that continuity is maintained and that negative consequences for staff members and others involved 
in the delivery of services are reduced or avoided. Moreover, DATFs should be given enough time to 
plan for this transition so that any disruption is reduced to a minimum. New funding allocations might 
be designed so as to move one-half or one-third of the way from ‘historical’ funding shares to the new 
funding shares indicated by the RAM. 
 
At the same time, there are strong ethical principles at stake, and it is clearly inequitable for services 
and resources to be targeted in a sub-optimal way, potentially leaving problem drug users without the 
support and treatment that they require, and potentially exposing disadvantaged communities to 
even greater risks. In short, the transition from one system to another is likely to be painful in some 
areas and beneficial in others, but this process should be discussed in advanced, prepared for and 
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then managed in a responsible way. All actors involved should identify with and accept the basic 
principles which motivate the transition, which provides the overall system of DATFs with the 
coherence and consensus that it requires in order to overcome any (temporary) difficulties and allows 
it to face future challenges in a stronger state. 
 
It is also important to note that the RAM outlined above represents a first-round estimation that is 
based on data with certain limitations. As we will show in the following pages, these estimates will 
improve over time, making the measurement of problem drug and alcohol use and the calculation of 
funding shares more precise. A relatively gradual adoption of the RAM will thus incorporate robust 
safeguards against any small changes in shares that may occur when using improved data, or when 
additional indicators of problem substance use are introduced. 
 
 
5.5 Future Improvements 
 
The Request for Tenders specifically required that the Performance Measurement Framework be 
designed in a dynamic fashion so that it can act as an evolving system with scope for refinement over 
time. It is already possible to provide an outline of some potential areas of improvement where the 
Resource Allocation Model could be developed in the future. 
 
 
Improvement of the Measurement of Problem Substance Use within the NDTRS 
 
We have already discussed in some detail how the NDTRS data are destined to improve in the 
immediate future on the basis of the new data collection protocol introduced by the HRB. This will 
involve residential locations being coded to SA level for the whole of Ireland and will represent a great 
improvement over the data used in this report. The new data protocol was introduced during 2016, 
although it may take some months for data providers to comply with its requirements. 
 
A second improvement to the NDTRS will flow from greater compliance with the data transmission 
protocols. At the moment, stakeholders believe that there are significant differences between 
different areas of the country in terms of record-keeping and data collection. Differential compliance 
has the potential to influence the coefficients used to measure the social and spatial gradients 
underlying the RAM. For example, systematic under-reporting of treatments in certain areas could 
lead to lower estimates for problem drug use in these kinds of areas. This would penalise DATFs with 
similar area characteristics, as they would appear to have lower levels of problem drug use than is 
actually the case. 
 
The RAM creates an incentive for all DATFs to improve data collection and reporting procedures 
amongst local organisations and to place pressure on neighbouring (or similar) DATFs to do the same. 
This is a welcome process, although it could also create the impression that problem substance use 
has worsened in certain kinds of areas. It is important, in these cases, to identify from the NDTRS data 
where any such developments represent a real change in treatment and where it merely reflects 
improved compliance with data reporting procedures. As the RAM is based on predicted rather than 
actual problem drug use, changes within individual DATFs will not unduly influence the overall funding 
distribution. This means that we can always use the latest and most accurate indicators to make 
decisions about resource allocations and to evaluate performance. 
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6 The Performance Measurement System 
 
6.1 Towards ‘True’ Impact Assessment 
 
When outlining our methodological approach to the construction of a Performance Measurement 
Framework for DATFs in Chapter Three, we stressed that it is important to be clear about the 
relationship between empirical evidence, research and policy-making. At the most fundamental level, 
effective policies in relation to problem substance use should be based on an understanding of the 
risk and protective factors that influence this as well as its impact on the health and well-being of 
substance misusers, those around them and other members of society. 
 
We also observed that impact assessment remains an elusive objective, particularly when dealing with 
programmes that are implemented through a multiplicity of local actors. A core aim of this study is to 
move towards developing a framework for ‘true’ impact assessment and to narrow the gap between a 
pervasive ‘rhetoric’ of impact assessment and the reality of less useful approaches to evaluation and 
measurement. 
 
As a consequence, we placed considerable emphasis on the development of a precise and well-
defined measure of the key outcome of drug and alcohol programmes. We defined the outcome of 
DATF interventions as reductions in problem substance use, which is a central concept in the National 
Drugs Strategy. In Section 3.1 we discussed how to define this concept and in Section 5 we compared 
historical funding patterns to the results of an evidence-based resource allocation model. 
 
In Section 3 we also described the main components of the Performance Measurement Framework, 
including a Logic Model that specifies how inputs are thought to affect problem substance use via 
specific kinds of interventions and a Performance Measurement Model. In Section 4 we explored 
possible data sources and discussed the requirements of the Framework. 
 
In Section 2 we noted that DATFs are not independent organisations, but a structure that brings 
together all relevant service providers in a given area. The precise relationship between the direct and 
indirect influences of the DATFs and the agencies represented on them is a complex one, and these 
distinct effects can only be distinguished if we have access to large amounts of very precise 
information. This leads us to treat ‘true’ impact assessment as a theoretical reference point, although 
we showed that it is already feasible to evaluate DATFs by comparing actual and predicted rates of 
problem substance use. This brings us to the heart of the Performance Measurement System, which is 
the topic of this Section, and represents the operational form of the Performance Measurement 
Framework when it is implemented using appropriate data. 
 
 
6.2 The Purpose of a Performance Measurement System 
 
We begin, therefore, by distinguishing between the Performance Measurement Framework and the 
Performance Measurement System. The former responds to the question of how we understand 
actions to affect outcomes and impacts, as depicted in the Logic Model, and how we believe that 
these key variables can be operationalised (Measurement Model). The Performance Measurement 
System describes how we apply this knowledge in a systematic manner to achieve better programme 
outcomes. The Performance Measurement System thus forms part of the overall Performance 
Measurement Framework. 
 
As we indicated in a previous section, a change management process needs to be engaged in that 
seeks to achieve the widest possible agreement on the nature and parameters of the Performance 
Measurement Framework amongst the stakeholders involved in the delivery of the NDS prior to 
engaging in performance measurement. This will contribut to a shared vision of how to define key 
concepts, how to use and interpret data and how to evaluate the effectiveness of the DATFs. 
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As we showed in Section 2, one of the aims of the 2006 expenditure review, commissioned by the 
Department of Community, Rural and Gaeltacht Affairs and carried out by Goodbody Economic 
Consultants, was to set out how a Performance Measurement Framework might be implemented. Ten 
years later, a Performance Measurement System still needs to be defined and implemented, which 
suggests (a) that this is a more complex task than was initially assumed by policy-makers, (b) that 
previous evaluation reports have been of limited use in this respect and (c) that this situation is 
related, at least in part, to the complexity of the organisational forms and funding mechanisms that 
characterises the Drugs Initiative since the beginning.   
 
 
The Need for a Performance Measurement Framework 
 
As noted in Section 2, responsibility for funding, monitoring and evaluating ‘mainstreamed’ projects 
rests with the relevant Departments/Agencies, which also undertake actions which are related to 
substance misuse without being directly related to the DATFs or the Drugs Initiative. Thus, one of the 
first questions we need to tackle relates to the role of the DATFs in relation to the full range of 
interventions carried out at local level. Although the DATFs have a global role of coordination and 
monitoring in relation to local services and projects, they are only directly responsible for a small 
proportion of these. As we indicated earlier, the DATF comes to represent the collective response to 
problem substance use of statutory and voluntary bodies within a given area. If this is found to be 
weak, then the organisations represented on the DATF also have a collective responsibility to address 
this situation. 
 
 
6.3 Evaluating the Performance of DATFs 
 
The Performance Measurement Framework is conceptually simple, and is based on the relationship 
between actual problem substance use and the risk of problem substance use in a given area. If the 
ratio is “1”, it means that the DATF is in line with average performance. If the ratio is below “1”, this 
indicates better-than-average performance, and if it is above “1”, this suggests that performance may 
be below-average. 
 
The Performance Measurement System indicates how far the DATF area is situated from mean 
performance. It may be useful to think about this in terms of distributions of performance scores. 
With enough observations, such scores often trace a normal (‘bell-shaped’) curve (see Figure 6.1). 
Statistical theory indicates that, in the presence of such a ‘normal’ distribution, about two-thirds of 
scores are within one standard deviation of the mean (shown as the dark blue area in Figure 6.1). 
About 16 per cent fall below -1 standard deviation units, indicating a performance significantly below 
the average, and the same number of DATFs perform above 1 standard deviation (i.e. significantly 
above the average). 
 
Figure 6.1 Distribution of Performance Scores under the Assumption of Normality 
 
 
 
We can therefore group the DATFs in terms of low, medium and high performance, using standard 
deviation units to mark these distinctions. If we subdivide the values of our measures of the risk of 
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problem substance use and actual problem substance use in the same way, we obtain a 3x3 
performance matrix (Figure 6.2). 
 
Figure 6.2 Hypothetical Performance Matrix 
H M L High performing DATFs
H PSU 1 2 1 Models of Good Practice
M PSU 2 10 2
L PSU 1 2 1
Underperforming DATFs 
Identify reasons for poor performance
Actual PSU 
Risk of PSU
 
 
On the leading diagonal (light beige), we see 12 DATFs which have average performance. The green 
segments to the top right of the Figure show the high-performing DATFs. These have medium to high 
risk of problem substance use, but the actual rate will be lower than this. This means that something 
has happened in these DATFs to counteract the risks and to reduce problem substance use. As this is 
the principle aim of the NDS, these DATFs have the potential to provide models of good practice, 
meaning that it is relevant to explore how those DATFs (and all the agencies represented on them) 
differ from the rest.  
 
The opposite applies to the DATFs in the red squares to the bottom left of Figure 6.3. Here actual 
problem substance use is significantly higher than estimated problem substance use. This constitutes 
significant under-performance relative to other DATFs, and this is worrying as we know that higher 
performances in comparable situations can be achieved. It has to be made absolutely clear in this 
context that the purpose of the Performance Measurement System is not to “blame and shame”. 
Penalising is not an option, as problem substance users in these areas must already deal with a below-
average response. Hence, the only option is to identify the reasons behind the poor performance and 
to remedy the situation by whatever means possible. 
 
By raising poor performers to at least average performance, average performance is also improved 
significantly across the DATFs, and this is the main way in which the Performance Measurement 
System can lead to better systemic performance. Of course, it is always possible that exceptional 
circumstances prevail in a specific area, as we noted earlier. What initially appears to be poor 
performance may therefore turn out to be an effect of drug markets, migration flows or adverse 
labour market events in the local area. This is also crucial knowledge, as these unmeasured risks can 
be brought into the Framework and used to develop more effective policies. It is thus important to 
maintain a constructive attitude towards the Performance Measurement System as a tool for learning 
and understanding through sustained engagement with data, other actors and models. 
 
Finally, we would like to pre-empt concerns about whether the Performance Measurement System 
can actually be operationalised. Far from being utopian, a similar system has been adopted by the 
HSE-HIU to analyse Hospital In-patient Enquiry (HIPE) data. This system records the characteristics of 
well over 1 million hospital stays every year and (broadly) covers the 40 acute hospitals. The HSE 
Resource Analyser relies on the same principles as the DATF-RAM and Performance Measurement 
System. It allows each ISD-10 entity to be assessed, comparing the performance of different hospitals 
relative to the mean and using a traffic light system to mark low, average and high performance. The 
system controls for the intake of patients in terms of relative affluence/deprivation, which can affect 
comorbidities and medical complexity, just as the risk of problem substance abuse can influence 
outcomes in DATF areas. 
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A similar system was also devised to evaluate progress in all acute and a selection of community 
hospitals under the Hospice-friendly Hospital Programme, which aims to improve end-of-life care. In 
another significant development, TUSLA is implementing a change management programme which 
will reorganise service delivery in light of the HSE Resource Analyser. Finally, the Department of 
Education and Skills is currently undertaking a redesign of its Delivering Equality of Opportunity in 
Schools (DEIS) programme, which will base both the designation of disadvantaged schools and the 
resource allocation model on similar criteria. Far from being utopian, therefore, the Performance 
Measurement Framework and System presented here reflect a strong trend or movement in Public 
Sector Management in Ireland and other Anglo-Saxon countries. By participating in this process, the 
National Drugs Strategy, DATFs and the Drugs Initiative as a whole will be in an excellent position to 
defend their funding levels, to situate themselves at the forefront of evidence-based policy-making 
and to make progress on their central objectives in coming years. 
 
 
6.4 Review of DATFs with High and Low Performance 
 
We referred in previous sections to the importance of identifying DATFs which may be performing 
either significantly above or below the average. In this section, we elaborate on how these results 
might be interpreted and explained. 
 
The nature and determinants of DATF performance are illustrated in the Logic Model (Figure 3.1) and 
Measurement Model (Figure 3.2), highlighting the complex relationships that must be considered. 
This is further illustrated by the funding patterns shown in Table 2.1: in 2015, funding to the DATFs, 
including mainstreamed projects, amounted to €30 out of a total of €232.7 of direct drugs-related 
public expenditure. This means that the DATFs were directly about sixteen per cent of national 
spending on substance-related programmes. Of course, not all of this expenditure has a regional or 
local dimension, but Table 6.1 shows that the main items of expenditure include areas which are likely 
to have an effect on the relative performance of the DATFs. Clearly, another question one has to ask is 
whether an appropriate share of substance-related expenditure across all of these programmes has 
been benefitting DATFs, in light of the underlying risk of substance misuse.  
 
It is interesting to consider what kind of information might be needed to offer a response to this 
question. As a first step, it would require a breakdown of the expenditure items shown in Table 6.2, 
but by DATF area. To our knowledge, disaggregate funding data of this type do not exist and may be 
difficult to construct. We did highlight, at an earlier stage in this report, that an unambiguous 
assessment of the performance of each actor within the complex DATF system would require 
complete and perfect information on the mechanisms involved, including data on the resources 
deployed in each DATF area. This serves to dispel ingenuous beliefs about performance assessment, 
and underlines the exploratory nature of this process. 
 
What we aim at here is an assessment that treats all of these programmes as determining a single 
systemic impact which we equate with the DATFs. We then try to identify areas where some 
combination of systemic factors has pushed problem substance use above or below the level that one 
would otherwise have expected, given their size, socio-economic characteristics and location. This 
finding is only the beginning, however, as we must then study the local context in order to identify the 
‘active ingredient’. 
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Table 6.1 Selective Substance-related Public Expenditure Affecting DATFs, 201357 
Agency/Service Purpose of Expenditure 
Expenditure 
€m 
Department of Health Total Expenditure 30.524 
Local DATFs Treatment and rehabilitation services 
provided to drug users 
19.110 
Regional DATFs 8.935 
Department of Children and Youth Affairs Total Expenditure 20.310 
YPFSF Round 1 Youth programmes with drug-specific 
initiatives 
5.905 
YPFSF Round 2 13.209 
Department of Education and Skills Total Expenditure 0.810 
DATF Area Projects Drug education and prevention projects 0.398 
Drug Court – education support Drug Court - education support 0.412 
Health Services Executive Total Expenditure 90.392 
Drug-related health services Drug-related health services 63.662 
National Drug Treatment Service Drug-related health services 7.462 
Primary Care Reimbursement Service Drug-related health services 19.268 
Department of Social Protection Total Expenditure 13.434 
Community Employment Programme 
Training and rehabilitation places for drugs 
referred clients on Community Employment 
12.772 
LDATF mainstream projects Support for community-based drugs projects 0.662 
Department of Justice and Equality Total Expenditure 18.553 
Irish Youth Justice Service – Education Youth crime diversion programmes 16.734 
Irish Prison Service Drug treatment services in prisons 4.500 
An Garda Síochána Policing and investigation costs 44.000 
Revenue’s Customs Service 
Supply reduction – border policing and anti-
smuggling 
18.624 
 
 
One of the central roles of the DATFs, in the context of the NDS, is to improve the coordination and 
funding of local actors who seek to reduce problem substance use and the harm that it can cause to 
individuals and communities. This means that the DATFs have overall responsibility for investigating 
why high or low levels of actual problem substance use are observed in some areas, relative to 
expectations. They will thus be the key actors in identifying factors that may have contributed to 
these performance outcomes. 
 
 
Addressing Underperformance 
 
Addressing underperformance is a key purpose of the Performance Measurement Framework, and 
the Performance Measurement System provides the means to identify when and where it occurs. 
However, identifying underperformance is not enough; we also have to identify how it can be 
addressed and ameliorated. By identifying the factors that contribute to underperformance, we put 
ourselves in the position to address these issues and to provide better outcomes. This means first and 
foremost better services to those either at risk of or actually engaging in problem substance use, 
including better health outcomes and a reduction in the harm to families and communities. Simply 
put, if we improve the performance of the worst performing DATFs, then average performance will be 
improved in the next cycle. 
 
We should also be aware that we will never be able to ‘move beyond underperformance’. 
Underperformance is defined in strictly relative terms and this means that some DATFs will always, by 
definition, be defined as ‘underperforming’. This is a strength, not a weakness: the Performance 
                                                                
57  HRB 2014. 2014 National Report (2013 Data) to the EMCDDA by the Reitox National Focal Point. Ireland: New 
Developments, Trends. Dublin: Health Research Board, p. 29. 
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Measurement System provides an evolving and flexible measure of performance which will always 
drive forwards improvements in overall performance. This dynamic element was explicitly requested 
in the term of reference and is an important aspect of all successful Performance Measurement 
Frameworks. 
 
So, how do we then proceed with respect to DATFs whose performance has been found to be 
significantly below average? A first step would be to explore whether any specific mechanisms 
contributed disproportionately to this outcome, such as: 
 
(i) The amount of resources allocated to the area 
(ii) The poor performance of specific agencies or bodies 
(iii) The poor performance of the DATF in coordinating services and supports 
(iv) Exceptional local factors  
 
We will briefly elaborate on some of these possible explanations. 
 
Resource Allocations: 
Resource allocation comprises funding accessed through the DATF system (including mainstreamed 
projects) and funding with a local/regional dimension (such as educational and health services or 
voluntary treatment providers) that is not part of the DATF system. As noted above, ‘direct’ funding 
could amount to as little as one-tenth of the total expenditure to be evaluated. 
 
With respect to this ‘direct’ source of funding for projects and measures, we have to take into account 
that the performance of DATFs will continue to be significantly affected by historical spending 
patterns, which may not be in line with need, as this is captured by the DATF-RAM. In other words, 
the legacy of sub-optimal resource distribution in the past will continue to influence the performance 
of DATFs into the foreseeable future. 
 
It is, of course, rather difficult to ascertain whether the expenditure of Government Departments and 
State Agencies in DATF areas have been commensurate with the population, degree of deprivation 
and population density. We have been told by many DATFs that this question regularly surfaces in 
their discussions, but that these Departments and Agencies are often not in a position to provide a 
clear response to this question, even where they are represented on the DATF. This anecdotal 
evidence hints at the continuing existence of a culture of reticence regarding the criteria underlying 
expenditure decisions. Without full accountability by Departments and Agencies which are 
represented on the DATF (either directly or indirectly) with regard to spending which affects residents 
in the DATF area, the Performance Measurement Framework is likely to fail. This has to be identified 
as one of the major risks facing the Framework and as one of the great challenges that evidence-
based policy-making faces in its real-world battle against realpolitik. 
 
On the positive side, breaking down expenditures and resources for individual entities by DATF area 
no longer poses particular technical problems, given the great progress made by information 
technology and Geographical Information Systems over past decades
58
. Evidence-based policy-making 
appears to contain an expansive systemic dynamic which makes it difficult to accept the continued 
existence of inefficient and irrational management criteria. Evidence-based policy-making is ultimately 
about accountability; if Government requires DATFs to be accountable to tax-payers, then this 
accountability requirement logically extends to all actors represented on and by the DATFs. 
 
                                                                
58  For example, many of the issues raised by Loughran and McCann (2006) regarding the uneven size of EDs, their failure to 
coincide with the boundaries of local communities and the difficulty of obtaining data for LDTF areas, can now be 
overcome. 
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Performance of DATF as organising entity: 
We turn now to the performance of the DATFs themselves, involving how they work, how they reach 
decisions and how they coordinate the work of local actors/organisations. There is likely to be a 
degree of unevenness in the success of the DATFs in creating a climate of mutual respect and 
constructive coordination of services and interventions. This will have to do with personalities, roles, 
organisational cultures, local traditions and other factors. An interesting issue relates to the authority 
of individuals who are seconded to the DATF: the more influence they have within their respective 
spheres, the more decision-making power they will be able to ‘bring to the table’. 
 
This is a well-known phenomenon in area-based initiatives in Ireland. If area-based entities become 
too small, it is inevitable that they will be populated by more junior figures who are likely to occupy a 
less influential position within their respective Departments or State Agencies. This will inevitably lead 
to difficulties in reaching decisions, as these individuals may not have a mandate to commit 
organisational resources and may not have the authority to introduce new priorities or ways of 
thinking. It is interesting, in this context, to note the emphasis placed in the 1999 and 2011 
Handbooks on the importance for Government Departments to fully support their representatives 
within the DATFs and to value the role of the latter. To what extent is this actually happening? How 
can the Performance Measurement System provide information on this crucial point? 
 
This consideration has ramifications for the number of Local DATFs which should be maintained and 
for their characteristics. A recurrent theme in previous reviews of the DATFs suggests that the number 
of DATFs ought to be reduced in order to facilitate participation by important Departments, Agencies 
and Voluntary Bodies. In Section 7, we make some recommendations in relation to this issue, 
supporting the immediate amalgamation of the two smallest DATFs into their neighbouring or 
surrounding DATFs. We do not believe that there is a case for making any other changes to the 
network of DATFs at this point in time. The further rationalisation of the DATF network should 
arguably be on a quid pro quo basis: as the members of the DATFs bring more decision-making power 
to the table it is possible that smaller DATFs come to see mergers as a positive option and a way of 
increasing their capacities. 
 
This leads us to the second consideration, which relates to the decisions that DATFs actually take, 
which obviously relate to a number of different issues. The quality of these decisions will be 
influenced by the degree to which there is a shared understanding within the DATF about the nature 
and spatial articulation of problem substance use. The analysis in this report of underlying risk factors 
and their spatial distribution thus has the potential to encourage such a shared understanding and 
response to problems. 
 
Exceptional factors: 
 
We should not exclude the possibility that exceptional factors might contribute to the impression of 
poor performance by a DATF. However, care needs to be taken not to expect too much from such 
explanations. In our experience, there is a tendency for local area-based initiatives to overstate the 
importance of the local. But if a good case can be made that powerful local factors exist which are 
outside the scope and influence of the DATF, these should certainly be considered. If these are 
considered important systemic factors, then they must be integrated into the Performance 
Measurement System and used to evaluate all DATFs. Otherwise, there is a risk of simply ‘explaining 
away’ poor performance by appealing to arbitrary and possible irrelevant local conditions. 
 
The Need for a Review Body: 
 
Finally, we have to address the question of what happens if a low-performing DATF has undertaken a 
review and has identified a set of explanatory factors. It clearly makes sense for these to be set out in 
a brief report and for them to be discussed by the NCC or other appropriate organ. The key purpose 
of this deliberation is to assist the DATFs in their reflection on the causes of relative 
underperformance and to assist them in undertaking the steps needed in order to improve their 
performance. One important aspect of this review process is to identify situations where a specific 
Department, Body or Agency is not dedicating sufficient attention or resources to a given area. It 
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would be helpful for each entity that is involved in the DATF system to already start reflecting on this 
issue. 
 
 
Identifying Models of Good Practice 
 
Equally important to identifying the factors that may have contributed to underperformance is the 
identification of models of good practice. In essence, the steps involved mirror the previous 
considerations, and we will restrict ourselves here to highlighting some additional considerations. 
 
It is important to recognise that high performance may simply be the result of a historically high level 
of funding, relative to need. In Section 5 we showed, for example, that certain Local DATFs in South 
Dublin appear to have received disproportionate allocations. Hence, we would expect these DATFs to 
also have above-average performance, all else being equal (i.e. merely assuming that the expenditure 
of key Departments and Agencies is not systematically biased against them). This means that 
resources may have to be gradually reduced for DATFs which, hitherto have been ‘over-funded’, even 
if they are performing well, which appears to be counter-productive. But it is important to remember 
that resource allocation is about expenditure for services to reduce harm to individuals and 
communities: unfair distributions can lead to disproportionate and avoidable harm, which demands 
attention. Of course, this result would also be encouraging, as it would provide a prima facie case that 
higher expenditure yields significant returns, and may constitute good value for money.  
 
Overall, the identification of models of good practice and their dissemination among DATFs is one of 
the most important aspects of the Performance Measurement Framework. We would therefore view 
the reviews prepared by high-performing DATFs as being just as important as those written by DATFs 
that appear to be performing below the average. 
 
 
6.5 Timeline for Implementing the Performance Measurement System 
 
It may be helpful to provide a provisional timeline for the implementation of the Performance 
Measurement System. In line with the terms of reference, this study aims to develop a Performance 
Measurement Framework that can be embarked upon from early 2017 onwards. We have written this 
report with this in mind, and with the hope that the Performance Measurement Framework and 
System can contribute to the National Drugs Strategy and to the realisation of its goals. 
 
However, this does not mean that evaluations can be made in early 2017, as the system is designed to 
be prospective rather than retrospective. Instead, a change management process should be started 
immediately with the view to agree on the key aspects of the Performance Measurement System. If 
successful, first evaluations can be made in Spring 2018, using data for the whole of 2017. This means 
that the parameters and processes involved in the System can be discussed with stakeholders and 
agreed upon before carrying out any assessments. It would also provide the time for following up the 
recommendations contained in the next Section relating to data sources and improvements to 
existing datasets. 
 
In fact, the data that are currently available are not yet of the required quality for building a 
Performance Measurement System like this, with the aims and objectives specified in the terms of 
reference of this study. We are of the opinion that to carry out such a retrospective evaluation at this 
point in time would do more harm than good. On the positive side, improved data collection is 
already ensured for 2017 on account of the new data collection protocol for the NDTRS, which will 
mean that better small-area data will be available. We feel that a first wave of DATF evaluations can 
be undertaken in early 2018, using data for the full 2017 calendar year. The Gantt chart presented in 
Figure 6.3 details the timeline we currently foresee for the implementation of the Performance 
Measurement System over the next three years. The tasks identified in the chart are described in 
detail below. 
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Figure 6.3 Gantt Chart for Implementation of the PMS 
Task Description J F M A M J J A S O N D J F M A M J J A S O N D J F M A M J J A S O N D
1.1
2017 Resource Allocations                             
using 1/3 way to DATF-RAM
1.2
Discussion of RAM in Context of NDS >> 
Finalise RAM
1.3
Discussion of PMF amongst Key 
Stakeholders
1.4
Review by DATFs of Budgetary and Project 
Implications of DATF-RAM
1.5
Discussion of possible Mergers                                 
(Bray-EC / BF-CC)
1.6
Procurement of Access to essential Data 
Sources (NDTRS/CTL/HIPE/CSO/Crime)
1.9
2018 Resource Allocations                             
using 1/2 way to DATF-RAM
2.1
DoH to commission Baseline Study using 
2016 NDTRS (and other) data
2.2 Project Planning in light of Allocation
2.3
Study identifying PSU for 2017 - 
identifying DATFs performing  
2.4
Analysis of DATFs > 1 SD to identify factors 
leading to above/below avg. Performance
2.5
Discussion of DATF Performance Reports 
by NDS Oversight Structure
2.6
If necessary, high level consultation with 
HSE, Education, Crime etc. 
2.7
Review of Perfomance Measurement 
System
2.9
2019 Resource Allocations                             
using 1/2 way to DATF-RAM
3.1
DoH to commission Study using 2017 
NDTRS (and other) data
3.2 Project Planning in light of Allocation
3.3
Study identifying PSU for 2018 - 
identifying DATFs performing  
3.4
Analysis of DATFs > 1 SD to identify factors 
leading to above/below avg. Performance
3.5
Discussion of DATF Performance Reports 
by NDS Oversight Structure
3.9
2020 Resource Allocations                             
using 1/2 way to DATF-RAM
KEY:
DoH
NDS Oversight Structure
DATFS
Data Preparation - Analysis - 
Commissioned Work
Joint DoH - DATFs - (Consultants)
2017 2018 2019
 
 
The following paragraphs describe the tasks shown in the above Gantt chart (Figure 6.3). 
 
2017_01:  Task 1.1 involves the determination of the next round of allocations to DATFs using the 
DATF-RAM. This involves the DoH deciding on the parameters to be used in the DATF-RAM, 
which includes the split between the four parts of the allocations and the transition from 
past allocations to the new allocations. This might be viewed as a preliminary allocation, to 
be finalised in February after discussion with key actors (see Task 1.2). The consultants 
recommend a 10/60/15/15 weighting and a 1/3 transition from previous to new 
allocations, to reflect the provisional character of the DATF-RAM. 
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 2017_02: Task 1.2 entails discussions about the role of the Performance Measurement Framework in 
relation to the NDS, and leads to a number of final decisions (on weightings and transition 
phases, etc.). Ideally, the Performance Measurement System would be adopted as an 
integral part of the NDS. For the DATF-RAM to be finalised, additional information will be 
required on the direct funding provided by at least some of the main actors, starting with 
the HSE.  
 
2017_03: Task 1.3 involves discussion of the Performance Measurement Framework and System with 
key stakeholders. 
 
2017_06: DATFs could then review their spending plans in light of the final allocations. Task 1.4 
comprises a discussion by each DATF of the four allocations which make up their total 
funding, as these are related to NDS objectives with regard to problem alcohol and drug 
use. 
 
2017_06: Task 1.5 addresses shortcomings in relation to the definition of DATF areas. As the 
implications of the DATF-RAM should by now be understood, this discussion could take 
place against the backdrop of projections regarding the resources that could be provided to 
these entities in the future. A small working group could address the “cleaning-up” of DATF 
boundary definitions to delineate contiguous areas which make sense from the perspective 
of service provision. 
 
2017_09: Task 1.6 As soon as discussions on the PMF and PMS have been concluded (Task 1.3), the 
DoH could take steps to negotiate access to relevant data sources, including the need for 
geocoding administrative datasets if this is not already done. 
 
2017_12: Task 1.9 DoH should address 2018 resource allocations. 
 
2017_12: Task 2.1 involves commissioning the first performance assessment of DATFs, to be carried 
out by March 2018. 
 
2018_01: Task 2.2 repeats Task 1.4, and requires DATFs to review their spending plans in light of the 
new allocations under the 2018 DATF-RAM. 
 
2018_03: Task 2.3 results in the first actual performance measurement of DATFs for the year 2017. 
 
2018_04: Having identified average performance and DATFs which performed significantly above or 
below the average, these will be asked to undertake an internal review to identify and 
discuss the factors that may have contributed to this outcome (Task 2.4). 
 
2018_07: These reports will need to be considered by an appropriate national body to ensure that 
collective learning occurs and appropriate steps are taken to identify and share models of 
good practice and to tackle the causes of local problems (Task 2.5). 
 
2018_08: Task 2.6 follows on from the previous task, and may include high-level consultations with 
the main bodies and actors represented by the DATFs (e.g. HSE, Education, Crime etc.) 
 
2018_12: Task 2.9 DoH should address 2019 resource allocations. 
 
The tasks for 2019, and any year thereafter, simply repeat the tasks for 2018, but also include an 
important new task: a review of the longitudinal aspect of performance measurement and a review of 
the PMS itself. 
 
2019_06: First Review of the PMS. 
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7 Findings and Recommendations 
 
In this section we summarise the key findings of this study and list the recommendations that flow 
from the analysis presented here. Findings include the foundations of the Performance Measurement 
Framework and Performance Measurement System, which should ideally be agreed upon by key 
stakeholders. These arguably form part of the evolving National Drugs Strategy. As we suggested 
earlier, participation in discussions and agreement with the criteria to be used for performance 
measurement can themselves generate progress towards evidence-based improvement. 
Recommendations highlight the specific actions that need to be taken in order to advance the 
development of the Performance Measurement Framework and System. 
 
 
7.1.1 Adoption of Performance Measurement Framework 
 
Findings with regard to the Logic Model 
 
The Logic Model is described in Section 3 and depicted in Figure 3.1, leading to the following findings: 
 
 Every geographical area (small area, community, DATF area) has an underlying risk of problem 
substance use which can be estimated using aggregate-level demographic and socio-economic 
variables. 
 The level of actual problem substance use in an area is influenced by the underlying risk of 
problem substance use, together with the legacy of past actions as well as local/contingent 
factors. 
 The effectiveness of interventions to counter problem substance use is influenced by past and 
current strategies of DATFs and local service providers. 
 We cannot measure the effectiveness of each kind of intervention without carrying out complex 
and expensive control trials, and there are considerable gaps in the literature on effects. This 
means that many of the measures funded under the Drugs Initiative must be assumed to have an 
impact, and that performance measures must focus on combined impacts. 
 
Findings with regard to the Performance Measurement Model 
 
At its core, the Measurement Model described in Section 3 distinguishes between ‘predicted problem 
substance use’ and ‘actual problem substance use’. By comparing these two variables we can 
determine whether problem substance use is above or below the level that we would have expected, 
given the characteristics of the DATF area. 
 
The variable ‘predicted problem substance use’ may be operationalised using the results of a Poisson 
regression model on NDTRS data, and indicates the level of problem substance use that we would 
expect to find in a given area, given its size, social composition and location. Actual problem 
substance use may be operationalised using data on treatment demand. In the short to medium term, 
rather than using a single impact measure (demand for treatment), it would be preferable to integrate 
multiple data sources, following the recommendations presented below.   
 
The Performance Measurement Model does not require any additional data to be collected by the 
DATFs. Instead, it is constructed on a logic of periodic evaluation based entirely on the intelligent use 
of existing secondary data sources and advanced statistical techniques. This provides a powerful 
evidence base that can support the aim of reducing problem substance use by encouraging innovative 
local interventions. 
 
Recommendation 
 
A Change Management Process should be initiated with a view to adopting and implementing the 
Performance Measurement Framework. 
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7.1.2 Accessing Data 
 
As the Performance Measurement System relies entirely on secondary data sources, access to these 
datasets is of crucial importance. An important part of this project was dedicated to analysing and 
screening data sources, which enables us now to formulate the following findings and 
recommendations. 
 
Findings 
 
Drug Prevalence Survey 
We carried out an in-depth analysis of the 2014/15 NACDA Prevalence Data, the results of which are 
reported in Section Four. This study provides insights into the socio-economic risk factors associated 
with various kinds of substance use, but proved to be of little use in relation to the measurement of 
problem substance use and above all failed to provide evidence at the level of DATF areas due to the 
small sample size. 
 
One important insight, however, that emerges from the analysis of the Drug Prevalence Survey is that 
most measures of substance use over a predefined period of time reflect experimentation by younger 
people living in comparatively more affluent areas. By contrast, problem substance use is known to be 
concentrated in deprived areas (particularly urban areas), as our analysis of the NDTRS confirms. As 
the DATFs are concerned primarily with tackling problem substance use, superficial use of the drug 
prevalence survey could be particularly misleading for the targeting of interventions. 
 
NDTRS 
The analysis of the NDTRS Data exceeded our expectations, yielding highly-relevant insights into the 
spatial distribution of problem substance use. We were able to model the prevalence of problem 
substance use using proxies from the Census of Population, namely (a) the adult population, (b) the 
socio-economic composition of areas, as measured by the Pobal HP Deprivation Index, (c) urban/rural 
character, as measured by an adjusted version of the CSO classification of areas and (d) the 
percentage of households living in Local Authority rented accommodation. The results show a 
significant social and spatial gradient, and the risk of problem drug use increases with urban 
deprivation, whilst problem alcohol use has a more uniform spatial distribution. 
 
Other Data Sources 
To develop a more precise measure of problem substance use, it is important to go beyond the 
NDTRS. This has the potential to improve the Performance Measurement System by increasing the 
reliability, validity and sensitivity of the key outcome variable. 
 
Recommendations 
 
Drug Prevalence Survey 
We advise pursuing the geocoding of respondents’ addresses to Small Area level and bringing the 
sampling design in line with the CSO model for household surveys, with stratification by deprivation 
score. 
 
NDTRS 
The HRB has altered the NDTRS data protocol, which now includes the recording of SA identifiers for 
each record. It is therefore feasible to use this data source in the Performance Measurement System 
from 2017 onwards. We recommend communicating this intention to the HRB and agreeing a 
timetable for receiving annual data. 
 
Other Data Sources 
Government departments and statutory agencies should work together to ensure access to other data 
sources relevant to the Performance Measurement System. Above, all, this will involve convincing 
data holders of the importance of geocoding their data and making the SA-level identifiers for each 
record available. This may require setting up protocols for the release of Research Micro-data Files 
(RMF), possibly in conjunction with the CSO. We recommend following up the following data sources 
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by obtaining a geocoded RMF and carrying out a preliminary analysis to assess quality and relevance. 
Table 7.1 below shows the full list of impact indicators that might be considered. 
 
Table 7.1  Core Impact indicators to be provided by other Data Holders 
 
Indicator Definition Source 
Patients requesting 
treatment for problem 
substance use 
Number of patients who requested treatment for 
problem drug use during calendar year 
Health Research 
Board (NDTRS) 
Patients receiving 
methadone 
Number of patients on the Central Treatment List on 
31 December of each year 
The Drug 
Treatment Centre 
Board (CTL) 
Drug-related offences The number of possession, supply, obstruction and 
other offences under the Misuse of Drugs Act during 
calendar year 
An Garda Síochána 
(PULSE) 
Drug-related hospital 
discharges 
The number of inpatient cases with a principal 
diagnosis of poisoning by opiates, sedatives, 
hypnotics, stimulants and psychotropic agents or 
involving accident or injury under the influence of 
these substances, over calendar year 
Department of 
Health (HIPE) 
Drug-related deaths The number of deaths due to poisoning by opiates, 
sedatives, hypnotics, stimulants and psychotropic 
agents or accident/injury under the influence of these 
substances, over calendar year 
Central Statistics 
Office (NDRDI) 
 
 
Relevant Government departments and agencies should work together to optimise existing surveys, 
institutional and administrative data sources in order to align with the requirements of the 
requirements of the Performance Measurement System. This would include such issues as collecting 
and coding residential addresses, improving the sampling design and identifying new indicators 
relating to such areas as health, housing, education and the criminal justice system. 
 
7.1.3 Implementation of the Performance Measurement System 
 
Findings 
 
The Performance Measurement System is based on a relativistic approach which seeks to avoid 
arbitrary, normative targets. This system compares actual problem substance use with the underlying 
risk, which is calculated by referring to socio-demographic composition and characteristics. This 
allows us to estimate the performance of each DATF, accounting for the attributes of the area, leading 
to the identification of DATFs which are performing significantly above or below the average. 
 
The provisional analysis of data from the NDTRS suggests that the broad distinction between Local 
and Regional DATFs is reflected in the estimated level of problem substance use. Local DATFs have 
estimates above 1 per cent of the adult population, whilst regional DATFs have concentrations below 
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1 per cent
59
. The Regional DATFs include, within their boundaries, some major concentrations of 
problem drug users who are typically clustered in deprived urban areas. This means that the RDATFs 
must adopt effective methods for targeting their interventions at local level. 
 
Recommendation 
 
The implementation of the Performance Measurement System should be approached as part of the 
Change Management Process for the adoption of the Performance Measurement Framework 
(Recommendation 7.1.1). 
 
 
7.1.4 Learning from the Performance Evaluation 
 
Findings 
 
The purpose of the Performance Measurement Framework for DATFs is to identify good practices and 
to generalise these throughout the system. It is therefore essential to discover which factors 
contribute to the performance of the DATFs, which raises a number of complex issues. Throughout 
the study, we have argued that true performance measurement can only be done with reference to 
the combined effect of all drug-related interventions in a given DATF area. As a consequence, it is 
essential for the DATFs to analyse all of these interventions, regardless of how they are financed, and 
to assess their adequacy in qualitative and quantitative terms. 
 
Recommendation 
 
DATFs that are found to perform significantly above or below the average should be required to 
undertake a review. The findings of this review should be submitted in written form to the NDS 
Oversight Structures. Following discussion, NDS Oversight Structures should provide detailed 
recommendations for all DATFs, involving (i) good practices to be emulated, in line with the 
specificities of the local context; (ii) new criteria to be integrated into the Performance Measurement 
System, in order to control for potential confounding factors; (iii) advice to individual DATFs regarding 
issues that might be tackled, areas requiring greater attention, services that could be improved etc. 
 
 
                                                                
59  The only exception to this is Dún Laoghaire-Rathdown, which is more similar in its values to a Regional DATF. 
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7.1.5 Resource Allocations 
 
Findings 
 
A Resource Allocation Model (DATF-RAM) is developed and described in this report, comprising an 
interactive tool. The RAM distinguishes between: problem alcohol use, problem drug use, areas of 
high problem drug use and very high problem drug use. Each of these elements represents a spending 
component. 
 
There are three DATF areas where the demand for treatment appears – on the basis of the provisional 
analysis presented here – differs greatly from the expected values: (i) Bray LDATF, where the actual 
number of treatments is about twice the expected value; (ii) East Coast RDATF, where this is about 1.6 
times higher; (iii) North-West RDATF, where the number of treatments is significantly lower than the 
expected value. In the first two cases, the DATFs in question appear to receive a high level of funding 
relative to their populations, urban-rural character and socio-economic composition. 
 
Recommendations 
 
As indicated in the Gantt chart included in Section 6, the first task to be carried out will involve the 
determination of allocations to DATFs. We recommend that this be done using the RAM, which means 
that the DPU will have to determine some of the parameters to be used, including the relative weight 
of the four components and how to move from historical spending to an evidence-based system. 
 
The consultants recommend initially applying a 10/60/15/15 weighting and a 1/3 transition from 
previous to new allocations. We also recommend consulting the DATFs to discuss these measures and 
to consider how they might be implemented as soon as possible. 
 
A dimension of improvement which we touched upon during the consultation process, but were 
unable to pursue as part of this study, is the question of measuring the quantity of resources required 
by different categories of intervention. People will only be able to access services if they are funded 
and made available to them at accessible locations. And improved knowledge of the resource 
implications of meeting certain protocols in the treatment of problem substance use may help us to 
target services at the areas and individuals who need them. We recommend exploring this question in 
greater detail in the future, with a view to assessing the ability of the system to support the 
transformation of resources into differentiated outputs that can be used to provide comparable 
services to people with similar needs, independently of where they live. 
 
7.1.6 Review of Administrative Boundaries 
 
Findings 
 
Two issues need to be addressed: (i) the case for merging certain DATFs and (ii) the perceived need to 
‘clean up’ the boundaries of the DATFs, where these include areas which are not contiguous, for 
example. Because of contingent issues during the establishment of the DTFs, there are some 
boundary issues involving EDs that were not part of the original LDTF designations, and now form part 
of regional DATFs without forming contiguous areas. This is rather arbitrary and is contrary to the 
logic of service provision and spatial planning. 
 
It has been suggested, in the past, that the large number of Local DATFs creates administrative 
difficulties and unnecessary complications in the relationship with other service providers. The latter 
are often forced to interact with multiple LDATFs within a given catchment area. The desire to 
rationalise the structure of LDATFs is understandable, and has some good arguments in its favour. For 
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example, a report by the Department of Health in 2012 proposed reducing the number of task forces 
from 24 to 19 by merging some and expanding the boundaries of others
60
. 
 
However, the analysis presented in this report provides a number of equally good arguments that 
point in the opposite direction, as there are clearly-identifiable urban neighbourhoods within RDATFs 
that experience much higher levels of problem drug use than the surrounding areas. Where this 
concentration gives rise to a significant clustering of problem drug users, it arguably merits well-
targeted and intensive community, family and school-based interventions. This will often only be 
possible if an LDATF is established with the resources and knowledge required to intervene 
intensively. In short, we find that the distinction between Local and Regional DATFs is an important 
one and should continue to be applied and perhaps even extended to Limerick City. 
 
Recommendations 
 
Two DATFs are very small in size and could be merged with their neighbouring/surrounding DATFs. 
We recommend that Ballyfermot and Canal Communities DATFs be merged to form a single entity, 
and that Bray LDATF be integrated into the East Coast RDATF. These mergers have been proposed in 
previous reviews and appear even more urgent now, in light of previous recommendations. In 
particular, the recommended shift to evidence-based funding criteria is destined to penalise these 
DATFs, given their relatively small populations, undermining their autonomy. 
 
The rationale for further mergers rests, as far as we are concerned, with the need to involve 
influential members of Government Departments, State Agencies and Voluntary Bodies in the DATFs. 
This would enable the DATFs to have a greater say in relation to local services and would arguably 
improve their ability to coordinate existing interventions and identify gaps. Such mergers should, 
however, only be considered when a formal review process has been established and on the basis of 
the results of the Performance Measurement System. 
 
We recommend that a working group be convened under the aegis of the NDS oversight structure to 
make recommendations regarding DATF boundary issues. 
 
                                                                
60  Department of Health (2012) Report on the Review of Drugs Task Forces and the National Structures Under Which They 
Operate. Dublin: Department of Health. 
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9 Appendix A Interventions under the Drugs Initiative 
 
Figure A1 LDTF Measures and Types of Activity 61 
 
Measure Category  Types of Activity 
 
Access to Treatment and Rehabilitation Outreach 
 Assessment and Referral 
 Pre-induction programmes 
 Drop-in services 
 Attending local resident groups/community groups 
 Mail shots and other advertising 
 Contacting drug users in prison 
 
Treatment and Harm Reduction Methadone dispensing service 
 One to one counselling 
 Group therapy 
 Holistic therapies 
 Needle exchange 
 
Rehabilitation Stabilisation programmes 
 Job seeking skills 
 Vocational training 
 Prison link services 
 
Education and Prevention Group Education 
 Drugs awareness courses/sessions 
 Parenting skills 
 Information dissemination 
 Information events (open days etc) 
 Personal development of young people 
 Improving school attendance 
 Early school leaver programmes 
 Youth diversion programmes 
 Develop peer drug educators 
 
Family Support Information and advice 
 One to one counselling 
 Group counselling 
 Discussion groups 
 Residential respite breaks 
 Childcare services 
 Drop in services 
 
Supply Control Community information 
 Community policing for a 
 
Education and Training of Drug Workers Community addiction training courses 
 
Research Research Studies 
 
                                                                
61  Source: Goodbody Economic Consultants 2006. Expenditure Review of the Local Drugs Task Forces. Dublin: Goodbody 
Economic Consultants, p. 19. 
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10 Appendix B Deriving ED-level Estimates of Treatment Demand 
 
Using the counts of (i) problem drug use relating to Illicit and licit substances and (ii) problem alcohol 
use from the 2014 NDTRS data for the 493 EDs that make up the Dublin, Kildare and Wicklow region, 
it is possible to undertake Poisson regressions using just four explanatory variables derived from the 
2011 Census of Population: 
 
 the size of the Adult Population (aged 15+) 
 an adjusted CSO classification of the urban-rural spectrum (5 categories) 
 the Pobal HP Deprivation Index score 
 the percentage of households in Local Authority rented accommodation
62
 
 
The reason for the inclusion of these four variables closely follows the arguments developed in the 
previous section, as well as extensive analysis by the consultants on the impact of socio-economic 
position on a large number of health outcomes.
63
 
 
Unlike small areas (SA), which are practically standardized in size
64
, EDs vary considerably, with as 
little as 50 households in some rural locations and in excess of 36,000 persons in Blanchardstown-
Blakestown in 2011. By including the size of the adult population in the Poisson regression, we simply 
scale the incidence to the size of the respective area.  
 
Inclusion of the urban-rural spectrum is the most common way to account for regional variations. 
Rather than including dummy variables for each region, which could not be meaningfully interpreted, 
inclusion of a variable to reflect the urban-rural spectrum provides for an analytical dimension which 
can directly be interpreted and used for policy making. 
 
The HP Deprivation Index is a multi-dimensional construct which represents the relative 
affluence/deprivation of an area (or spatial unit of analysis) on an exact measurement scale. The scale 
ranges broadly from -30 (most deprived) to + 30 (most affluent) with a mean of zero and a standard 
deviation of 10. The HP Index is based on indicators of educational attainment, social class, 
unemployment, lone parenthood, as well as indicators related to rural deprivation. It thus directly 
corresponds to the socio-economic indicators identified as posing risk factors in the analysis of the 
drug prevalence data (Section 4.2) and. The HP Index has been shown to provide a superior predictor 
compared to the use of individual indicators when trying to measure the social gradient in health, 
education, housing and other outcomes which are characterised by strong social gradients and serves 
as the explicit reference in recent population health research in Ireland.
65
 
 
Inclusion of the percentage of households in Local Authority rented accommodation follows directly 
from the analysis presented in Section 4.2, which points to a strong additional effect over and above 
educational attainment, social class and employment status. As the variable is not included in the HP 
Index, it offers itself as a good variable to test in combination with the others already identified. 
 
Whilst there are strong prima facie reasons to include these four variables in the Poisson regressions, 
their actual predictive power obviously has to be empirically tested. We are first applying this 
analytical model to the problem drug use indicator in the 2014 NDTRS data (Table B1) and 
subsequently to problem alcohol use (Table B2). 
                                                                
62  When updating the regression analysis using the 2016 data of the NDTRS and Census of Population, consideration should 
be given to including the percentage of housing provided by Voluntary Bodies together with Local Authority housing, as 
well as demographic indicators. 
63  Haase, T. and Pratschke, J. (forthcoming) Deprivation and Health Impact Weighting. Study commissioned by the HSE/Health 
Intelligence Unit. 
64  For confidentiality reasons, SAs are designed to contain a minimum of 50 households and a minimum of 75 persons. The 
average is just under 100 households. 
65  See Haase,T. and Pratschke, J 2012. Optimising the sampling Methodology for CSO Household Surveys. Dublin: CSO. 
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Table B1 Estimated Coefficients from Poisson Regression for Problem Drug Use 
Stratum 
Coefficient Significance 
Intercept  3.580 0.000 
Rural Areas -3.844 0.000 
Small Towns -2.297 0.000 
Towns 5,000+ -1.099 0.000 
County Boroughs and Environs -0.985 0.000 
Dublin Inner City  0.000 0.000 
Adult Population (‘000)  0.130 0.000 
HP Deprivation Index -0.050 0.000 
Percentage of Households living in Local Authority Housing  0.019 0.000 
Parameters based on analysis of 2014 NDTRS data. 
 
If we take Dublin Inner City as the reference point for the urban-rural spectrum, the parameters for 
each other category of this spectrum tells us by how much exactly the incidence of problem drug use 
changes relative to the reference category. The stepwise increase in the negative coefficient describes 
a coherent gradient as we move from Dublin Inner City to county boroughs, large towns, small towns 
and finally to rural areas, whereby the incidence of problem drug use becomes each time less likely 
relative to the previous category. The coefficient for the adult population simply tells us that the 
incidence will increase as the population of the area considered becomes larger. 
 
The negative coefficient for the HP Deprivation score tells us that with every unit increase on the HP 
Index scale, problem drug use will become smaller. As the HP Index scale ranges from -30 (most 
deprived) to +30 (most affluent), this indicates a strong social gradient, in line with the social 
gradients detected in the analysis of the Drug Prevalence data in Section 4.2; i.e. problem drug use is 
greater the more deprived an area is. 
 
The last coefficient shows the increase in problem drug use for every unit increase in the percentage 
of local authority housing, again exactly as postulated from the analysis in Section 4.2. In summary, all 
coefficients behave exactly as we had postulated and are statistically significant at <1 per cent, 
indicating that the results are robust and not due to chance. 
 
As the NDTRS data used in the regression analysis relate to only 6 out of 34 Local Authority areas, the 
next step involves extrapolating the predictions based on the regression model to the rest of the 
country. To this end, we included an extra variable which separates the estimates for County Dublin 
from those of the four other County Boroughs (Cork, Limerick, Galway and Waterford), as the capital 
city is known to have higher rates of problem drug use than the other major cities. 
 
We then aggregated the estimates for EDs to county level and compared them with the NDTRS totals, 
which can be calculated using the 2014 data. In an iterative process, we adjusted the regression 
coefficients slightly to improve the fit with the known county totals. The final coefficients are shown 
in Chapter 5 (Table 5.2). Comparing the resulting estimates with the known treatment counts from 
the NDTRS, we obtain an R
2
 of .989 and, when excluding Dublin City (an influential data point, given 
its high observed count), we get an R
2
 of .903. In other words, more than ninety percent of the inter-
county variation in problem drug use, as measured by the NDTRS data, can be estimated using just 
four Census variables. This is a remarkable finding and reinforces the simple message that the relative 
concentration of problem drug use in certain areas is strongly influenced by a social (deprivation-
affluence) and a spatial (urban-rural) gradient, as well as reflecting population size. Figure B1 shows 
the predicted counts plotted against the observed values, by Local Authority area.
66
 
 
                                                                
66  The reason for presenting this analysis at the level of local authority areas here simply derives from the fact that, outside 
Dublin, Kildare and Wicklow, this is the lowest spatial indicator available in the 2014 NDTRS data. 
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Figure B1 Predicted and Actual Problem Drug Use by Local Authority Area 
 
 
In order to obtain ED estimates of problem alcohol use, we enter the same explanatory variables into 
a new Poisson regression and obtain the coefficients shown in Table B2 below. 
 
Table B2 Estimated Coefficients from Poisson Regression for Problem Alcohol Use 
Stratum 
Coefficient Significance 
Intercept  2.185 0.000 
Rural Areas -2.771 0.000 
Small Towns -1.226 0.000 
Towns 5,000+ -0.210 0.001 
County Boroughs and Environs -0.542 0.000 
Dublin Inner City  0.000 0.000 
Adult Population (‘000)  0.113 0.000 
HP Deprivation Index -0.007 0.004 
Percentage of Households living in Local Authority Housing  0.015 0.000 
Source: Parameters based on analysis of 2014 NDTRS data. 
 
